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ABSTRACT 
 
In order to combat harmful pathogens the innate recognition part of the immune 
system uses a variety of receptors including CD14, TLR4, TLR2 and SR (MARCO). 
These receptors are expressed on most human monocytes and macrophages. CD14 
recognizes and bind lipopolysaccharide (LPS), the main causative agents of sepsis and 
endotoxic shock.  Signaling from CD14-LPS and TLR4/MD-2 complex activate the 
nuclear factor kappa B (NF-κB) family of transcription factors and JNK, a member of 
MAP kinase (MAPK) family. This signaling results in the production of the 
proinflammatory cytokines such as TNF-α and IL-1β among others. In addition, LPS 
also activates the DNA-repair and protein modifying enzyme poly (ADP-ribose) 
polymerase-1 (PARP-1). Consequently, the effect of PJ-34, a potent inhibitor of PARP 
on PARP-1 activation induced by LPS was studied on THP-1 cells.  In response to 
LPS, PJ-34 reduced the PAR formation and down regulates the expression of CD14, 
TLR2 and TLR4. However, MARCO expression was up regulated. It was also 
observed that PJ-34 reduced the production of TNF-α, IL-1β and No in response to 
LPS. PJ-34 was also involved in a reduction of the activation of NF-κB in response to 
LPS but, did not have an effect in JNK activation. The physical association of CD14 
and MARCO receptors was examined in response to LPS.  It was found that PJ-34 
reduced the colocalisation of these pair of receptors and regulates their expression at 
gene level. Furthermore, PJ-34 regulates expression of a number of proteins on the 
THP-1 cells in response to LPS. 
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CHAPTER1: Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
1.1 Innate immunity 
 
The immune system plays an important role in tissue repair after injury and inflammation-
mediated damage. It removes internal debris, dying and malignant cells and protects 
against aggression from external sources. 
The immune system in vertebrates consists of two subsystems, the innate and adaptive 
immune systems, constituting two main immune strategies. Innate immune responses are 
non-specific to a particular pathogen, but can develop rapidly after antigen exposure. The 
adaptive immune system, however, requires time to develop and is characterised by being 
highly specific. The adaptive immune response generates immunological memory, 
distinguished by enhanced immunity against a specific pathogen after subsequent 
encounters with that pathogen 
 The innate immune system requires the coordinated action of several effector cells and 
serum proteins. For example, bacterial infections are controlled by phagocytic 
neutrophils, monocyte/macrophages (M/M) and dendritic cells (DCs), which patrol the 
blood and immune organs to encounter and engulf the bacteria. Monocytes release large 
amounts of cytokines (e.g., TNF-alpha, IL-1beta, IL-6, IL-8), complement factors as well 
as proteolytic enzymes which contribute the onset of early systemic inflammatory 
response associated with acute and chronic diseases. Furthermore, monocytes also 
facilitate the transendothelial migration of macrophages to the site of injury(Antoniades et 
al., 2008). During a bacterial infection macrophages play an important role in both innate 
and adaptive immune responses in which blood circulating macrophages migrate from the 
vasculature in to extracellular compartment under influences of different endogenous and 
exogenous factors (Martinez, 2008). Intracellular bacterial or viral infections generally 
cannot be detected by phagocytes, and are controlled by natural killer (NK) cells, which 
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detect and destroy infected cells. Innate immune cells recognise and interact with 
microbes by responding to germ line-encoded pattern recognition receptors (PRRs) such 
as cluster of differentiation 14 (CD14), toll-like receptor 2 (TLR2), toll-like receptor 4 
(TLR4), the scavenger receptor macrophage receptor with collagenous structure  
(MARCO) and MD-2 (Doyle et al., 2004; Arredouani et al., 2006; Areschoug & Gordon, 
2009). These receptors detect conserved microbial structures that are not found in the 
host, designated pathogen-associated molecular patterns (PAMPs), which include 
mannans and zymosan in the yeast cell wall, and a variety of bacterial cell-wall 
components, such as lipopolysaccharide (LPS), lipopeptides, lipoteichoic acid and 
peptidoglycans (Aderem & Ulevitch, 2000; Uematsu & Akira, 2008; Xagorari & 
Chlichlia, 2008; O’Neill et al., 2013). Many of these components are able to stimulate the 
innate immune system. LPS is one of the most potent among these, inducing production 
of cytokines such as interleukins (ILs), and tumour necrosis factor (TNF) in mononuclear 
phagocytes, and it represents a central component in the pathogenesis of septic shock 
syndrome. Innate antimicrobial defence is significantly assisted by several serum proteins 
which detect and bind to microbes, thereby promoting the uptake and destruction of 
microbes by immune cells. For example, binding of LPS to CD14 is enhanced by serum 
LPS-binding protein (LBP) (Schumann, 1992; Thompson et al., 2003; Hamann et al., 
2005; Schröder & Schumann, 2005). The engagement of LPS by the host cell triggers the 
production of proinflammatory cytokines such as tumour necrosis factor alpha (TNF-α) 
and interleukins (Correia et al., 2001; Cohen, 2002; Kim & Krueger, 2015). TNF-α is one 
of the earliest major proinflammatory mediators released by macrophages when 
stimulated with LPS in vivo and in vitro. Elevated serum levels of TNF-α is associated 
with the pathogenesis of several inflammatory conditions, including sepsis (Dufour et al., 
2003; Esposito & Cuzzocrea, 2009; Kasimanickam et al., 2013; Koppolu et al., 2013), 
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rheumatoid arthritis (Edrees et al., 2005), and multiple sclerosis (Gregory et al., 2012). 
Suppression of TNF-α production has been suggested as a possible therapy in these 
diseases. The intracellular events that mediate LPS-induced TNF-α secretion have been 
the subject of intense research. Nuclear factor kappa B (NF-κB), a protein complex that 
controls transcription of DNA has been found to have an important role in the 
transcriptional regulation of many proinflammatory cytokines genes. Several stimulants, 
including bacterial LPS, can activate NF-κB which, once activated, translocate from the 
cytoplasm to the nucleus (Kim et al., 2010; Gupta et al., 2011). NF-κB family members 
are rapidly inducible, and play an important role in immune and inflammatory responses. 
NF-κB is critical in the production of proinflammatory cytokines as a response to injury 
and inflammatory stimuli (Bonizzi & Karin, 2004; Qi et al., 2012; Kumar et al., 2014).  
The poly (ADP-ribose) polymerase (PARP) protein family is a group of enzymes mainly 
involved in DNA repair that are also necessary for mammalian apoptosis (Soldani & 
Scovassi, 2002; Bürkle, 2005). PARP-1 can interact with many transcriptional factors 
(Hassa et al., 2001), and has been postulated to play a role in the regulation of NF-κB 
transcriptional activity (Meder et al., 2005; Pacher & Szabó, 2007; Cohausz & Althaus, 
2009; Kraus & Hottiger, 2013). 
 
1.2 Pathogen-associated molecular patterns  
  
Pattern-recognition receptors (PRRs) are used by the innate immune system to 
differentiate harmful pathogens (non-self) from “self”. PRRs detect conserved structures 
on microbes that are absent from the host (Janeway & Medzhitov, 2000; Postel & 
Kemmerling, 2009; Kumar et al., 2011) termed pathogen-associated microbial patterns 
(PAMPs). PAMPs include lipoteichoic acid (LTA) and LPS that are common components 
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of gram-positive and gram-negative bacteria, respectively. In addition, double-stranded 
RNA is a structural signature of several groups of RNA viruses and mannans, which are 
components of yeast cell walls (Akira et al., 2006; Veckman, 2007). 
PRRs can be classified into families based on the domains the receptors possess. The 
most common are lectin, cysteine-rich and leucine-rich repeat domains (Medzhitov and 
Janway 2000). PRRs can also recognize endogenous ligand in the host. These receptors, 
therefore, play a vital role in tissue homeostasis and host defence  (Gordon, 2002; Kawai 
& Akira, 2010; Di Gioia & Zanoni, 2015). PRRs can bind a very wide range of molecular 
ligands, including proteins, lipids, carbohydrates and nucleic acids from endogenous and 
exogenous sources. A single PRR is often able to recognize multiple ligands through 
relatively weak interactions. Some ligands, such as LPS, can bind to several distinct 
PRRs. Furthermore, different PRRs can cooperate as a receptor complex for a particular 
ligand. For example CD14, TLR4 and MD2 form a receptor complex for LPS. 
 
1.2.1 Properties of lipopolysaccharide 
 
LPS is also termed endotoxin, an important structural component of the outer membrane 
of Gram-negative bacteria (Haziot et al., 1996; Gronow & Brade, 2001; Trent et al., 
2006). LPS is vital to protect bacteria from hydrolytic degradation by other organism, and 
plays a role in the pathogenicity of bacterial infection (Hacker & Kaper, 2000; Hacker & 
Carniel, 2001; ). LPS is released from the bacteria during cell division, cell death, or as a 
result of antibiotic treatment against bacterial infection (Rice & Bayles, 2008; Tanouchi et 
al., 2013). Upon its release, LPS is recognized by M/M cells of the innate immune 
system, and it activates them. The LPS molecule is not toxic when it is released in small 
amounts, but after endotoxin reaches the blood stream and spreads in the body the 
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immune system begins to release proinflammatory cytokines such as TNF-α, interleukins 
such as IL-1, and others (Beishuizen & Thijs, 2003; De La Garza, 2005). High levels of 
endotoxin can be life-threatening, frequently causing endotoxic or septic shock (Wanecek 
et al., 2000; Wu et al., 2004; Hiromura et al., 2007). 
 
1.2.2 The structure of LPS 
 
The LPS molecule is made up of hydrophobic and hydrophilic domains and forms part of 
the outer membrane of the cell wall of gram-negative bacteria, which is impermeable to 
large molecules and hydrophobic compounds. Its function is to protect gram-negative 
bacteria from hydrophilic degradation by the other organisms in the environment. Figure 
1.1 illustrates the three component parts of LPS, (i) Lipid A, (ii) core oligosaccharide and 
(iii) O-specific side chain or O-antigen (Skurnik & Bengoechea, 2003; Loutet et al., 2006; 
Hagelueken et al., 2015). Lipid A, which binds to CD14 epitopes, contains two acylated 
GIcNAc-P residues (GIcN). The core part is made of 3-deoxy-D-manno-octulosonic acid 
(KDO), heptoses (Hep), and neutral sugars such as galactose. The outer O-antigen is 
made of repeating units of two to eight sugars. 
LPS is composed of common and unusual sugars (Fig.1.1). The polysaccharide domain is 
hydrophilic in nature and consists of two regions, the O-antigen and core oligosaccharide. 
The O-antigen is important for distinguishing between gram-negative bacteria serotype 
strains (Reyes et al., 2009; Wang et al., 2010). The core oligosaccharide is divisible into 
an inner and outer core based on the sugar groups present. The inner core is a 
carbohydrate structure made up of 3-deoxy-D-manno-2-octulosonic acid (KDo), L-
glycero-D-mannoheptose (Heptose), phosphate and ethanolamine residues. The outer core 
is made up of more common hexoses, such as glucose and galactose. Lipid-A 
(endotoxin), the hydrophobic anchor of LPS, is formed of glucosamine-based 
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phospholipids that make up the outer monolayer of the outer membrane of most Gram-
negative bacteria. The lipid A moiety of LPS is responsible for the toxic effects of LPS 
(Schromm et al., 2000; Raetz et al., 2007).  
 
 
1.2.3 The biological importance of LPS 
 
LPS at low concentrations, is able to act as an adjuvant due to its immunostimulatory 
action, causing polyclonal B-cell expansion (Hamann et al., 2005; Xu et al., 2008). 
However, high levels of LPS can have an adverse effect. High LPS levels can cause life-
threatening endotoxin shock or systemic inflammatory response syndrome (Huber et al., 
2006). CD14 is the most prominent cell protein believed to be involved in the binding of 
LPS, after LPS is released into the blood stream. CD14 is expressed mainly on monocytes 
and macrophages and triggers the production of proinflammatory cytokines (Moore et al., 
2000; Guha & Mackman, 2001; Auffray et al., 2009; Rossol et al., 2011). 
Figure 1-1: Schematic structure of LPS. LPS is composed of three main parts:  The O–antigen, the core 
and lipid A, which interacts with epitopes of CD14, and contains of two acylacted GIcNAc-P residues 
(GIcN). The core part of LPS consists of KDO, heptoses and galactose. The O-antigen is comprised of 
repeating units of two to eight sugars.  (Source from Glycoforum: Masahito Hashimoto, 2003). 
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1.3 Pattern-recognition receptors  
 
 PRRs bind their ligands through opsonization. Functionally, PRRs can be classified into 
three types: Humoral proteins (soluble) circulating in the plasma, endocytic receptors 
expressed on the cell surface, and signaling receptors expressed either on the cell surface 
or intracellular such as CD14, TLRs, scavenger and complement receptors which are cell 
surface receptors (Gordon, 2002; Lee & Kim, 2007). 
Effector cells of the innate immune system that express PRRs include surface epithelial 
cells, monocytes, macrophages and DCs. PRRs that are expressed by innate immune cells  
recognize ligands on invading organisms directly by  recognition of different conserved 
molecular patterns. In contrast, in the context of adaptive immunity, PRRs expressed in  
lymphocytes, are structurally and functionally heterogeneous proteins, germline-encoded, 
expressed by all cells, and are able to distinguish self from non-self-molecules (Janeway 
& Medzhitov, 2002). 
Soluble PRRs include soluble CD14, LBP, bacterial permeability increasing protein 
(BPI), lysozyme, C-reactive protein (CRP), defence collagens (mannose binding lectin, 
MBL) and complement (Kumagai & Akira, 2010; Gauglitz et al., 2012). Signaling via 
PRRs activate signaling pathways that induce upregulation of costimulatory molecules, 
antimicrobial effector responses and inflammation upon recognition of PAMPs. The only 
known signaling PRRs expressed on cell surface are members of the TLR family (Kopp 
and Medzhitov, 1999). However,  some PRRs, such as mitogen-activated protein (MAP) 
kinases, are expressed in the cytosol, and they are able to detect intracellular pathogens 
and initiate responses that block the pathogen’s ability to replicate (Symons et al., 2006). 
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1.3.1 Cluster of differentiation 14 (CD14)  
 
CD14 is one of the most important molecules of the innate immune system, having a 
wide-range of functions. It is well known that CD14 serves as a pattern recognition 
receptor in the innate immune system for many ligands, ranging from  parts of microbial 
cell walls to whole bacteria (Arroyo-Espliguero et al., 2004; Manukyan et al., 2005). 
CD14 has been shown to be the receptor for LPS of Gram-negative bacteria, for 
peptidoglycan (Dziarski et al., 2000), lipoteichoic acids of gram-positive bacteria 
(Cleveland et al., 1996) and  lipoarabinomannan of mycobacteria (Elass et al., 2007; 
Mishra et al., 2011). The binding of CD14 to LPS is enhanced by the serum protein LBP 
(Kitchens & Thompson, 2005; Tsukamoto et al., 2010). The role of LBP appears to be 
that of enabling LPS to dock at the LPS receptor complex by initially binding LPS and 
then forming a ternary complex with CD14. However, it has been demonstrated that in  
mice  LBP is not required in vivo for the clearance of LPS from the circulation, but  is 
required for the rapid induction of an inflammatory response after exposure to LPS in 
small amounts(Gonzalez-Quintela et al., 2013). 
 
1.3.1.1 The structure of CD14 
 
CD14 was first described as a myeloid differentiation antigen in 1981 (Griffin et al., 
1981). It has molecular weight of 55-KDa, possesses multiple leucine-rich repeats and is 
encoded on chromosome 5 (5q) in a region that also codes for growth factors, such as 
granulocyte macrophage colony stimulating factor and vascular endothelial growth factor 
receptor. CD14 is present  in soluble form (sCD14) in blood and as a membrane-bound 
form (mCD14) in myeloid lineage cells, anchored to the plasma membrane by a glycosyl-
phosphatidylinositol (GPI) moiety (Lee et al., 1993), thus CD14 is not a transmembrane 
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protein but is attached to the plasma membrane via the GPI-tail (Zanoni & Granucci, 
2013). Based on its cDNA sequence, CD14 is composed of 356 amino acids and a 19 
amino acid-long N-terminal leader peptide. After translation, the C-terminal leader 
sequence of 28–30 amino acids is replaced by the GPI anchor.   The LPS-binding site is 
located on the N terminal site of the protein (Iovine et al., 2002; Kim et al., 2005). 
CD14 occurs as a structurally symmetrical dimer that possesses a horseshoe-like 
structure. Figure 1.2 shows that the monomeric subunit of CD14 contains thirteen β 
strands, 11 of them, from β3 to β13, overlapped with conserved leucine-rich repeat (LRR) 
domains which consist of  5 to 45 motifs, each 20-30 amino acids in length, that generally 
fold into horseshoe shapes (Kim et al., 2005). All major classes of LRR proteins have 
curved horseshoe structures with a parallel sheet on the concave side and mostly helical 
elements on the convex side. The main significance of LRRs is that repeats from different 
subfamilies never occur simultaneously and have most probably evolved independently 
(Enkhbayar et al., 2004). 
The concave surface of the horseshoe-shaped
 
structure of CD14 consists of a large -sheet 
of 11 parallel and two
 
antiparallel beta strands. The convex surface contains
 
both helices 
and loops, in no regular pattern. As a result,
 
it is rough rather than smooth and contains 
several grooves
 
and pockets that are crucial for ligand binding. Dimerization in the crystal 
is mediated by residues
 
in 13 and in the loop between 12 and 13. Parallel -sheets 
from
 
the two monomers interact in an antiparallel fashion and form
 
a large and continuous 
-sheet encompassing the entire CD14 dimer.
 
The concave face and the adjacent loops are 
the most common protein interaction surfaces on LRR proteins. The elongated and curved 
LRR 3D structure provides an outstanding frame work for achieving diverse protein-
protein interactions (Kobe and Kajava, 2001). The N-terminal hydrophobic pocket is 
located on the side of the horseshoe near the NH2 terminus, and it is entirely hydrophobic 
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except for the rim. The pocket including the sub-pocket has a total volume of 820 Å3 and 
hence is large enough to accommodate at least part of the lipid chains of LPS. The 
residues on the hydrophilic rim of the main pocket are highly flexible (Kim et al., 2005).  
The N-terminal region of CD14 may be critical for binding of LPS (Jerala, 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.1.2 LPS binding site on CD14 
 
The CD14 receptor contains binding sites that bind several anti-CD14 monoclonal 
antibodies (mAbs) (Wright et al., 1990). Four regions of the binding sites for LPS and 
CD14 have been identified within the NH2-terminal of CD14.  Residues from the turn 
between the β1 and β2 strands constitute region one. Region two is the loop between the 
Figure 1-2: The structure of CD14. Two monomers of CD14 in the crystal are colored in gray and cyan. 
Disulfide bridges are shown in orange. The position of the NH2-terminal pocket is indicated by an arrow 
(Adapted from Kim et al., 2005). 
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β2 strand and the one alpha helix. LPS binding is inhibited by mAbs that recognize this 
area (Kim et al., 2005). Region three consists of residues from the β3 strand which is the 
most frequent target of LPS blocking antibodies. There are at least nine monoclonal 
antibodies that recognize the β2 and β3 strands that restrict binding of LPS by sCD14. 
Region four includes residues from the loop connecting α 2 and α3 helixes (Kim et al., 
2005). 
 
 
1.3.1.3 Different forms of CD14 protein 
 
The membrane form of CD14 protein (mCD14) is strongly expressed in human 
monocytes/macrophages present in peripheral blood, in lymph nodes and spleen. Other 
non-myeloid cell types, such as hepatocytes and several epithelial cell types, also express 
mCD14. Human monocytes express high levels of CD14 and elicit 100000 receptors per 
cell, whereas neutrophils express approximately 3000 receptors per cells (Antal-Szalmas 
et al., 1997). The soluble form of CD14 (sCD14),  produced in human plasma by 
shedding from cell-membrane (Kitchens et al., 2001; Duncan et al., 2004), and  present at 
concentrations of 12μg/mL (Ward et al., 2014). 
Administration of LPS has been shown to upregulate the expression of CD14 within the 
first 3 hrs following LPS binding to CD14. This followed by a decrease after 3-6 hrs and 
then, remarkably, the expression of CD14 increases within the first three days of gram 
negative septic shock (Landmann et al., 1996; Antal-Szalmas, 2000). The first rapid 
Figure1-3: The N-terminal region of CD14.  The amino acids in bold are the ones that have been 
deleted (Adopted from Viriyakosol and Kirkland, 1995). 
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increase is associated with the translocation of intracellular CD14 to the plasma 
membrane. The second upregulation is associated with de novo protein synthesis and 
might correlate with monocyte differentiation (Landmann et al., 1996; Antal-Szalmas, 
2000. The synthesis and expression of CD14 is regulated by several mediators.. In 
monocytes, the anti-inflammatory cytokines IL-4 and IL-13 reduce CD14 expression at 
the transcriptional level within the first two days (Ruppert et al., 1991).  
 
 
1.3.1.4 The biological functions of CD14 
 
One of the main functions of CD14 is recognition of  and binding to LPS or LPS-LBP 
complex (Wright et al., 1990; Perera et al., 2001). Studies shows that CD14-deficient 
mice are  hyporesponsive to low concentrations of LPS and highly resistant to LPS at a 
lethal dose or LPS-induced shock (Haziot et al., 1996). Teo & Hughes (2003), showed 
that CD14 is important for the recognition and phagocytosis of apoptosed cells, and in 
preventing the release of proinflammatory cytokines during phagocytosis. These results 
indicated that clearance of apoptotic cells is mediated by a receptor which interacts with 
'non-self' components (LPS) and 'self' components (apoptotic cells) produce distinct 
macrophage responses. Furthermore, CD14 also has the ability to regulate apoptosis in 
monocytes; studies on normal monocytes have revealed that the downregulation of CD14 
molecules results in monocyte apoptosis whereas increased expression of CD14 protects 
these cells from apoptosis (Heidenreich et al., 1997). However, upregulation of CD14 
caused by LPS stimulation resulted in decreased apoptosis in monocytes (Heidenreich et 
al., 1997; Carracedo et al., 2002) 
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1.3.1.5 Role of CD14 in proinflammatory cytokine production 
 
Sepsis is one the most common causes of morbidity and mortality in hospital intensive 
care units. This condition is characterised by temperature alterations and elevation of 
various cytokines in blood (Gustot et al., 2009). In gram-negative bacterial infection, LPS 
or the LPS-LBP complex binds to CD14. LBP is not essential for the binding of LPS to 
CD14, but it accelerates it binding, probably serving  as a transfer protein (Wurfel et al., 
1995). Since CD14 is a GPI-linked protein, it is incapable of signal transmission across 
the plasma membrane. Thus a membrane cofactor(s) is necessary to affect LPS-mediated 
transmembrane signaling, toll-like receptor TLR4 and myeloid differentiation factor 2 
being utilized (Akashi et al., 2000). 
The CD14-LPS complex associates with TLR4, transmitting ‘downstream’ signals which 
contribute to nuclear translocation of NF-B and production of proinflammatory   
mediators such as TNF-, IL-1 and IL-6 (Jiang et al., 2005). In addition to the CD14-
TLR4-LPS complex, another glycoprotein,  MD-2, is required for the optimal functioning 
of TLR4 (Lu et al., 2008a; Schnabl et al., 2008). CD14 is also required for TLR4-MD-2 
complex interaction with LPS (Shuto et al., 2005; Lizundia et al., 2008).  
Once the LPS is bound and the CD14-TLR4/TLR2, complex is formed, initiate an 
Intracellular signaling cascades depend on different sets of adapters. An early response to 
LPS, which involve MyD88 and MyD88-like adapter (Mal), results in the activation of 
NF-κB and AP1. Later response to LPS utilizes the TIR-domain-containing adapter-
inducing interferon-β (TRIF) and TRIF-related adapter molecule (TRAM), which leads to 
the late activation of NF-κB and IRF3, and production of cytokines, chemokines, and 
other transcription factors. Figure 1.4, shows immediate response occurs after LPS binds 
directly to the cell surface, and it takes approximately 30 minutes for LPS-induced actions 
to initiate, such as cytokine release and adhesion, after LPS binding.  This suggests that a 
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time consuming process such as internalization is necessary to enable signaling (Wurfel et 
al., 1995). 
 
 
1.3.2 Toll-like receptors (TLRs)   
 
TLRs are ancient receptors, associated with wide range of activities and their involvement 
in innate immunity was first demonstrated in Drosophila melanogaster, which has only 
innate immune responses. In Drosophila, TLRs are  essential in responses to fungal and 
bacterial infection; two signaling cascades are utilized, a toll pathway and an immune 
Figure 1-4: The signal cascade via CD14 during the inflammatory response to LPS. In gram-negative 
bacterial infection, LPS binds to CD14, and then the consequent complex binds to TLR4 which initiates a 
signal cascade initiated in the presence of MD-2. The LPS-mediated signaling leads to activation of 
transcriptional factors, including NF-B and AP-1, and release proinflammatory cytokines (Adapted from 
Takeda and Akira, 2004). 
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deficiency pathway  (Singh et al., 2003). Subsequently, TLR homologs were described in 
humans (Da Silva Correia et al., 2001). Currently 12 mammalian TLRs are known (Akira, 
et al., 2006) which contribute to signal transduction induced by PAMPs (Sabroe et al., 
2003; Singh et al., 2003). Each TLR member activates a different signaling pathway in 
response to PAMPs, which then induce a specific response such as inducing production of 
proinflammatory cytokines. In addition, TLRs control multiple dendritic cell functions 
and activate signals that are critically involved in the initiation of adaptive immune 
responses (Jiang et al., 2000; Singh et al., 2003; Iwasaki & Medzhitov, 2004). Up-
regulation of TLRs in response to microbial  such as LPS or loss of negative regulation of 
TLR signaling, as well as recognition of self-molecules by TLRs, are strongly associated 
with the pathogenesis of inflammatory and autoimmune diseases (Akira, et al., 2006). The 
TLR4 is involved in signaling pathway initiated in response to a wide variety of 
endogenous and exogenous molecules, especially LPS, and it may associate with 
increasing the risk of septic shock (Andonegui et al., 2002; Song et al., 2001) 
 
1.3.2.1 Toll-like receptor expression and structure 
 
TLRs are most prominently expressed by professional antigen-presenting cells, including 
macrophages and DCs. They are expressed by epithelial or endothelial cells, but at low or 
undetectable levels. TLRs are germ line-encoded type I integral membrane glycoproteins, 
display an extracellular domain (amino terminus), contain LRR and intracellular domains 
(Carboxyl-terminus), and have a conserved cytoplasmic portion that is essential for 
intracellular signaling (Fig.1.6). The cytoplasmic signaling domain of TLRs is 
homologous to the human IL-1 receptor (Figure 1.5) and thus named the Toll/IL-1R 
(TIR) domain. The extracellular domain of IL-R1 contains IgG-like proteins (Singh et al., 
2003).  
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Figure 1-5: The structure of toll like receptor (TLR). A transmembrane domain connects to an 
extracellular domain that is folded to form a prominent c-shaped component. A cytoplasmic domain 
projects below the cell membrane. Two identical TLR proteins coded in blue and red, associate to form a 
homodimer.  
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The first TLR ligand described was bacterial LPS, which is detected by TLR4. In recent 
years the ligands for several TLRs have been identified (summarized in Table 1.1). 
Significant variability in the structures of TLR ligands exists and they can consist of 
lipids, proteins or nucleic acids. Interestingly, some TLRs can detect ligands from several 
of these categories.  Further fine-tuning on the ligand specificity is achieved by formation 
of TLR heterodimers. For example the TLR1/TLR2 dimer detects bacterial triacyl 
lipopeptide, while TLR2/TLR6 recognizes diacyl lipopeptide structures (Takeda & Akira, 
2004). 
Figure 1-6: Schematic structure of toll like receptors (TLRs). The extracellular domain of TLRs 
contains β Leucine rich repeats, and the cytoplasmic domain contains proteins which are similar to the 
cytoplasmic domain of IL-R1. The extracellular domain of IL-R1 contains IgG-like proteins. TLR 
family members, except TLR3, use the adaptor MyD88 to activate NF-κB, leading to production of 
proinflammatory cytokines. Adapted from Biochemsoctrans: (Muzio et al., 2000). 
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Receptor Ligand Origin of ligand 
TLR1 +TLR2 Triacyl lipopeptides                Bacteria and Mycobacteria 
TLR2 (Peptidoglycan)                      Gram-positive bacteria 
 Porins  Neisseria 
 Lipoarabinomannan                                             Mycobacteria 
 Phospholipomannan                                                Candida albicans 
 Glucuronoxylomannan                                                Cryptococcus neoformans 
 Hemagglutin protein                                                  Measles virus 
 Not known                                                                                                                             HSV1, HMCV
 tGPI-mutin                              Trypanosoma 
TLR3 dsRNA    RNA viruses 
TLR4 LPS Gram-negative bacteria 
 Mannan Candida albicans 
 Glucuronoxylomannan             Cryptococcus neoformans 
 Envelope proteins                   RSV 
 HSP60, 70                               Host 
 Fibrinogen                               Host 
TLR5 Flagellin   Flagellated bacteria 
TLR2+TLR6                    Lipoteichoic acid                      Group B Streptococcus 
 Diacyl lipopeptides                   Mycoplasma    
 Zymosan     Saccharomyces cerevisiae 
TLR7/8                             ssRNA                                     Viruses 
TLR9      CpG-DNA                                Bacteria, mycobacteria and 
viruses 
 
 
 
Table 1-1: Microbial Ligands of human toll like receptors (TLRs). 
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At least some TLRs require accessory molecules for PAMP detection. For example TLR4 
requires MD2, CD14 and LBP for efficient signal transduction, while CD36 mediates the 
detection of diacylglyserols by TLR2/TLR6 dimer (Poltorak et al., 1998; Hoebe et al., 
2005). The cellular location of TLRs varies. TLRs 1, 2, 4, 5 and 6 are expressed on the 
cell surface while TLRs 3, 7, 8 and 9 are found intracellularly in endosomes (Akira et al., 
2006). Intracellular TLRs detect nucleic acids which are also produced by the host. Thus, 
it is likely that the endosomal location of these TLRs prevent uncontrolled immune 
activation by endogenous nucleic acids. 
 
1.3.2.2 Function of TLRs 
 
TLR4 binds LPS (Lu et al., 2008; Peri et al., 2010) or the LPS-LBP-MD-2 complex (Park 
et al., 2009; Peri & Piazza, 2012) and CD14 (Levy et al., 2009; Peri et al., 2010), leading 
to receptor dimerization and activation, and proximate nuclear  translocation of NF-κB 
(Guha & Mackman, 2001; Park et al., 2004). Kim & Kim, (2014) reported that 
hyporesponsiveness and hyperresponsiveness to LPS are entirely dependent on CD14 and 
associated TLR4. Both TLR4-deficient mice and mice that possess a disrupted TLR4  
gene are resistant to the immunostimulatory and pathophysiological effects of LPS 
(Arbour et al., 2000; Shi et al., 2006). Previous studies have shown that CD14 is 
upregulated by LPS (Zanoni et al., 2009). Silva et al. (2010), reported that TLR4 
expression is also upregulated by LPS, and the physical proximity between CD14 and 
TLR4 trigger LPS signaling, activate and translocate of NF-κB into nucleus. Inhibition of 
the activation of human TLR4 by LPS is considered to have potential for the development 
of innovative drugs for the treatment of sepsis and septic shock (Visintin et al., 2005; Peri 
& Piazza, 2012). 
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1.3.2.3 TLR activation and signaling 
 
TLR4 is the signal transducing receptor for LPS (Beutler, 2000; Sekine et al., 2006). LPS 
recognition by the innate immune system involves as the first step binding of the LBP to 
the LPS, which recognize by CD14. The complex then binds to TLR4 with present of MD-
2 molecules; TLR4 triggers LPS signaling and activate the MyD88-dependant or 
independent signaling pathway of TLR4 (Fig.1.7). TLR4 transduces the signal through the 
association of intracellular TIR domain, recruiting the adapter proteins. TIR-domain-
containing adaptor molecules are recruited to the intracellular domain of TLR4. Five 
adaptor molecules have been identified:  myeloid differentiation factor 88 (MyD88), TIR-
domain-containing adaptor inducing IFN-β (TRIF), TIR-domain-containing adaptor 
protein (TIRAP; also known as MyD88 adaptor-like, Mal), TRIF-related adaptor molecule 
(TRAM) and sterile alpha and HEAT/Armadillo motif protein (SARM). Among these 
MyD88 and TRIF are significant in TLR signaling, both mediating  activation of 
downstream signaling (Akira, et al., 2006; Jerala, 2007). MyD88 is used by all TLRs 
except TLR3, while TRIF signaling is used by TLR3 and TLR4. TIRAP/Mal is required 
for interaction of MyD88 with TLR2 and TLR4, while TRAM enables TLR4-TRIF 
interaction ( Akira, et al., 2006; Tanimura et al., 2008).  The fifth adaptor protein SARM 
was recently shown to negatively regulate TRIF signaling (Carty et al., 2006; Peng et al., 
2010). Downstream TLR signaling includes several phosphorylation and ubiquitination 
steps where TNF receptor-associated factor family proteins and IRAKs, together with 
cellular ubiquitination machinery, play a key role (Akira, et al., 2006; Lu et al., 2008). 
Ultimately, TLR signaling results in the activation and nuclear translocation of NF-κB, 
interferon regulatory factors (IRFs) and mitogen-activated protein kinase (MAPK)-
regulated transcription factors. These transcription factors regulate the expression of a vast 
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majority of anti-microbial genes including proinflammatory cytokines, chemokines and 
IFNs. 
 
 
 
 
Figure 1-7: Schematic overview of the Toll-like receptor TLR4 signaling pathway. LPS binds to LPS-
binding protein (LBP) and then binds to TLR4 on the cell membrane with two co-receptors (CD14 and 
myeloid differentiation protein (MD-2), activating myeloid differentiation factor 88 (MyD-88)-dependent 
and MyD-88-independent TLR4 signaling via different adaptor proteins. The MyD88-dependent pathway 
signals through activation of ikB kinase (IKK) and mitogen activated protein kinase (MAPK) pathways, 
which in turn leads to activation of the transcription factors nuclear factor (NF)-kB and activator protein 
(AP)-1, respectively.  These control the expression of proinflammatory cytokines and other immune related 
genes. In addition, phosphatidylinositol 3-kinase (PI3K) and AKT are also important factors downstream of 
MyD88 that mediate NF-κB activation. The MyD88-independent pathway is mediated by the TIR domain-
containing adaptor inducing interferon-b (TRIF), which activates interferon regulatory (IRF) 3 and induces 
the expression of interferon (IFN)-β and IFN-responsive genes. 
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1.3.3 Scavenger receptors  
 
Scavenger receptors (SRs) were  originally identified and named based on  their ability to 
bind and internalize modified lipoprotein (Greaves & Gordon, 2005).The SR family is 
comprised of large type I and type II transmembrane glycoproteins expressed at high 
levels by macrophages and DCs, and  at a low level by some endothelial cells. SRs have 
the capacity to bind modified low-density lipoprotein (LDL) and other polyanionic 
ligands. SRs have been  divided into eight classes, A to H (Fig.1.8), based on congruity of 
structure (Plüddemann et al., 2007). 
Since the SR superfamily is too large to describe each family member. Class A (SR-A) 
scavenger receptors have been shown to recognise a range of polyanionic molecules and 
play a vital role in microbial recognition and clearance.  These SRs have been shown to 
bind both gram-positive and gram-negative bacteria (Thomas et al., 2000). Hampton and 
colleagues (2000) proposed that SR-A might be involved in antimicrobial host defence, 
based on their observation that SR-A could bind lipid A, an integral part of LPS. SR-A 
also recognises the gram-positive cell-wall component LTA (Dunne et al., 1994). SR-A 
has been shown to play a role in both infection and inflammation. SR-A-deficient
 
mice  
show increased susceptibility to Staphylococcus aureus and Streptococcus pneumonia 
infection (Thomas et al. 2000; Arredouani et al., 2006). However, these animals were 
more susceptible to endotoxic shock as a result of increased proinflammatory cytokine 
secretion in response to additional LPS challenge. 
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1.3.3.1 The structure of class A SRs 
 
Class A SRs are homotrimeric type II transmembrane glycoproteins SR-A1(Gough et al., 
1998; Nakamura et al., 2001) (Fig. 1.8), which has a short N-terminal cytoplasmic 
domain, a single transmembrane domain, and large extracellular protein comprised of a 
spacer, an α-helical-coiled-coil domain, a collagenous domain, and C-terminal scavenger 
receptor cysteine-rich (SRCR) domain  (Martínez et al., 2011; Qiu et al., 2013). SR-AII is 
shorter than SR-AI as it lacks of the SRCR domain (Sarrias et al., 2004). MARCO is 
structurally similar to SR-AI, but lacks an α-helical coiled-coil domain and has  a much 
longer collagenous domain  (Sankala et al., 2002). In comparison to SR-AI, SRCL-I 
contains a C-terminal c-type lectin domain instead of a SRCR domain, and an additional 
extracellular serine/threonine-rich region. The SRCL- II isoform lacks the c-terminal 
lectin domain (Nakamura et al., 2001). Jiang et al. (2006) suggested that SCARA5 has 
 
Figure1-8: Schematic structure of the different classes of scavenger receptors. Scavenger receptors 
are grouped together into classes based on their structural homology and are structurally very diverse. 
The domains are indicated in the key. Adapted from (Pluddemann et al 2006) 
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five domains and its extracellular portion is composed of a long spacer, a short 
collagenous domain and a SRCR domain.  
 
1.3.3.2 Scavenger receptor localisation  
 
SRs are most abundantly  expressed in  macrophages, particularly Kupffer cells,  alveolar 
macrophages, and macrophages in the spleen and lymph nodes (Murray & Wynn, 2011; 
Hussell & Bell, 2014). Fibroblasts, endothelial cells, smooth muscle cells and DCs also 
express SRs (Husemann et al., 2002). Transient expression of bovine SRs on cultured 
cells shows that SRs are mainly expressed in the ER, nuclear envelope, and Golgi 
apparatus of non-macrophage cells, whereas in macrophages and macrophage-like cells 
they are present on the plasma membrane but also localize to endosomes (Naito et al., 
1991). The expression and activity of SR-A were reported to be downregulated by LPS in 
the human monocyte cell line (THP-1), through TNF-α secretion. In contrast, their 
expression is upregulated by LPS in both peritoneal macrophage and mouse cell lines 
J774 and RAW264.7 (Fitzegerald et al., 2000). 
 
1.3.3.3 Role of MARCO and SR-A in host defence 
 
SR-AI/AII that are associated with atherosclerosis express on macrophage-derived foam 
cells during atherogenesis, which suggests the role of these types of SR in this process 
(Linton & Fazio, 2001; Van Eck et al., 2005). MARCO expression in the atherogenesis 
plaque has not been proven. SR-A has been implicated in several diseases, including 
Alzheimer disease and diabetes. It binds to β-myeloid protein and advanced glycation end 
product (AGE) modified protein (Granucci et al., 2003; Canton et al., 2013). AGE is a 
hetrogenous group of proteins or lipids linked to both oxidative stress and inflammation 
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and they are found in many tissues. AGE are involved in protein cross linking and have 
been identified in pathological tissues, such as the kidney of  patients with diabetic 
nephropathy and chronic renal failure, atherosclerosis lesions and amyloid fibrils in 
haemodialysis-related amyloidosis (Basta et al., 2004; Hodgkinson et al., 2008). 
Macrophages from SR-A deficient mice show a decrease in the phagocytosis of apoptotic 
thymocytes. Therefore, it was proposed that SR-A may play a role in the removal of 
apoptotic cells (Platt et al., 2000). SRs were originally identified based on their ability to 
scavenge modified lipoproteins, these molecules have been shown to recognize and bind 
to modified and unmodified host derived molecules or microbial components. As a major 
subset of innate pattern recognition receptors, scavenger receptors are mainly expressed 
on myeloid cells and function in a wide range of biological processes, such as 
endocytosis, adhesion, lipid transport, antigen presentation, and pathogen clearance. 
Scavenger receptor has been implicated in the clearance of LPS in macrophage-like J774 
cells(Czerkies et al., 2013). Also LBP and mCD14 augment LPS clearance (Gutsmann et 
al., 2001a). It seems likely from these and other studies that LPS clearance is a separate 
event from LPS signal transduction(Leon-Ponte et al., 2005). In addition, scavenger 
receptors play a crucial role in maintenance of host homeostasis, in the pathogenesis of a 
number of diseases, e.g., atherosclerosis, neurodegeneration, or metabolic disorders. 
Emerging evidence has begun to reveal these receptor molecules as important regulators 
of tumour behaviour and host immune responses to cancer (Yu et al., 2015). MARCO 
also has a role in the regulation of the cellular response to heat shock protein (Kobayashi 
et al., 2000), and plays a role in adhesion and spreading processes.  The expression of 
MARCO in spleen macrophages in the spleen marginal zone  contributes to retention of 
marginal zone B cells (Karlsson et al., 2003; Kellermayer et al., 2014) . Evidence for this 
came from specific binding of soluble MARCO to these cells, and inhibition of the 
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binding with antibody against MARCO. The ligand for MARCO in marginal zone B cells 
has not been identified (Karlsson et al., 2003). Besides LPS, SR-A also binds lipoteichoic 
acid
 
from gram-positive bacteria or the bacteria, such as Staphylococcus aureus and 
Mycobacterium tuberculosis (Dunne et al., 1994; Thomas et al., 2000). MARCO is able 
to bind gram-negative and gram-positive bacteria (Peiser et al., 2002; Huang et al., 2012). 
Cross-competition studies with LPS and several other SR
 
ligands have shown other SRs, 
expressed on Kupffer
 
and liver sinusoidal endothelial cells, involved in the binding of 
LPS (Knoll et al., 1995; Nedredal et al., 2003). SRs have been implicated
 
in the clearance 
of damaged and apoptotic cells  (Terpstra & van Berkel, 2000; Yu et al., 2015). This 
recognition
 
by SRs may be explained by the structural similarities between
 
cell 
membranes and lipoproteins. Both consist of phospholipids,
 
cholesterol, and glycoprotein. 
Oxidative damage to a lipoprotein
 
particle may create epitopes that resemble the epitopes 
exposed
 
by cells that undergo apoptosis or by senescent erythrocytes,
 
such as membrane 
phosphotidylserine (PS). PS is, under normal conditions, confined
 
to the inner leaflet of 
cell membranes, but on apoptosis or
 
aging, when the aminophospholipid asymmetry is 
destroyed, PS
 
becomes exposed on the outer leaflet, providing a signal for
 
removal (Züllig 
et al., 2007). Some SRs have been shown to bind liposomes
 
containing PS (Plüddemann 
et al., 2007) and SR ligands, such as oxidized low density lipoprotein and poly
 
I, inhibit 
the binding of damaged and apoptotic cells (Terpstra & van Berkel, 2000), further 
suggesting a role of SRs in the removal of damaged
 
and apoptotic cells. MARCO is also 
described as a ligand for uteroglobulin-related protein-1, which is expressed on bronchial 
epithelial cells (Heinzmann et al., 2003). 
In addition to microbial components, MARCO and SR-A recognize unopsonized 
environmental particles, such as TiO2, FeO2, SiO2 and latex beads (Shifu & Gengyu, 
2005; Kanno et al., 2007). MARCO appears, in fact, to be the major receptor on lung 
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alveolar macrophages (AM) for these particles. This notion is based on the work of 
Palecanda et al. (1999) who showed  that particle binding by SRs is sensitive to general 
SR inhibitors. In addition, binding is largely retained in SR-A-KO AMs. Palecanda et al. 
(1999) generated an antibody that blocked binding of the unopsonized particles by 
hamster AMs. This antibody was found to be directed against MARCO (Palecanda et al., 
1999). Recently, a similar approach was used to demonstrate  the major role that MARCO 
confers in  particle binding in human AMs (Arredouani et al., 2005a). Studies with SR-A 
and MARCO-KO mice have provided direct evidence that these SRs afford a protective 
role in the host defence. SR-A KO mice were more susceptible than  wild-type controls to 
infection with  Listeria monocytogenes and staphylococcus aureus (Blanchet et al., 2014; 
Thomas et al., 2000), and  with the viral pathogen HSV-1(Auerbuch et al., 2004). The 
study with S. aureus indicated that opsonin- independent bacterial phagocytosis is 
significantly decreased in macrophages lacking SR-A. This might be the reason for the 
susceptibility of SR-A KO mice to the infection with this bacterial strain (Thomas et al., 
2000). LPS-treated SR-A KO mice primed with Bacille Calmette-Guerin, a live 
attenuated Mycobacterium bovis vaccine, were highly susceptible to a subsequent LPS 
challenge, with increased production of TNF-α and IL-6 (Haworth et al., 1997).  
 
1.4 Regulation of cytokine and chemokine gene expression  
 
Microbial infection leads to rapid production of inflammatory cytokines and chemokines. 
The expression of these genes is regulating mainly at a transcriptional level by binding of 
transcription factors to their target elements on gene promoters. Generally cytokine and 
chemokine genes are regulated by activation of transcription factors such as NF-κB, 
interferon regulatory factors, AP-1 and STAT. Transcription factor pathways, mainly 
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activated via pattern recognition receptors and cytokines which activate these 
transcription factors, thereby creating positive (and negative) feedback mechanisms. Both 
direct PRR-mediated and indirect cytokine-mediated mechanisms are involved in the 
regulation of cytokine and chemokine production during microbial infections. 
 
1.4.1 The nuclear factor kappa B (NF-κB) 
 
Nuclear factor kappa B (NF-κB) is a family of inducible gene transcription factors, 
expressed in most cells. Salminen et al., (2008) showed that NF-κB is a master regulator of 
inflammatory and innate immune responses. It has been implicated in several inflammatory 
diseases due to its function as a regulator of proinflammatory gene expression (Li & 
Verma, 2002; Kravchenko et al., 2008). The present study investigates innate immune 
mechanisms of severe sepsis. NF-κB plays a vital role in sepsis, involving innate immune receptors 
and poly (ADP-ribose) polymerase (PARP) enzymes. 
 
1.4.1.1 Structure of NF-κB family members  
 
The NF-κB family in mammals consists of five proteins (Fig. 1.9): NF-κB1 (p105/p50), 
NF-κB (p100/p52), ReL-A (p65), ReL-B and c-ReL. All members of the NF-κB family 
have a conserved ReL-homology domain (RHD) (Li and Verma, 2002; Vallabhapurapu & 
Karin, 2009). The DNA binding domain, nuclear localization signals (NLS), dimerization 
domains and the IκB binding domain are located within a REL-homology domain. The 
NF-κB proteins c-ReL, ReLB and p65 (REL-A) also contain a transactivation domain. 
NF-NF-κB refers to a heterodimer of two proteins, a p65 subunit (also called ReL-A) and 
a p50 subunit, and it is most abundant form of the protein (Sasaki et al., 2005) (Fig. 1.10). 
p50–c-ReL dimers also occur (Sarnico et al., 2009). Both p50–ReL-A and p50–c-ReL 
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dimers are regulated by interactions with inhibitor of κB (IκB) proteins, which maintain 
their cytoplasmic localization. ReL-B can act as a transcriptional activator and a repressor 
of NF-κB dependent gene expression, while REL-A is responsible for most of NF-κB 
transcriptional activity, due to the presence of a strong transactivation domain 
(Ramakrishnan et al., 2013). 
 
 
 
 
 
Figure 1-9: The schematic structure of NF-κB family proteins and their inhibitory molecules (IκB). 
Abbreviations; LZ (red)  leucine zipper, RHD (green) REL-homology domain, GRR( orange)  glycine rich 
regions and IκB (blue) inhibitor of κB proteins. (Source: Li and Verma, 2002). 
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Under unstimulated conditions NF-κB proteins are retained in the cytoplasm in 
association with IκB proteins. Upon activation, the inhibitory proteins are phosphorylated 
by IκB kinases (IKKα/β/γ) that subsequently enable the translocation of NF-κB dimers 
into nucleus (Li & Verma, 2002). In the nucleus NK-κB dimers bind to their target DNA 
sequences and associate with co-activation proteins such as cAMP responsive element 
binding protein to enhance transcription. The NF-κB pathway is induced by a variety of 
factors, including cytokine action, activity following PRR-mediated microbe detection, 
and DNA damage (Kawai & Akira, 2007; Salminen et al., 2008). 
 
1.4.1.2 Role of NF-κB in inflammatory responses 
 
NF-κB is one of the key regulators of proinflammatory gene expression and mediates the 
transcription of proinflammatory cytokines (TNFα, IL-1, IL-2, IL-6, IL-12, and GF-CSF) 
(Souza et al., 2008; Lawrence, 2009), chemokines ( RANTES, MIP-1α, MCP1) (Holgate 
Figure 1-10: The structure of the active form of NF-κB. The most active form of NF-κB consists of two 
subunit. p50 (green) and p65 (red) 
 (Source: from http://www.web books.com/MoBio/Free/Ch4H3.htm). 
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et al., 1997; Vilá et al., 2007; Yi et al., 2014) adhesion molecules (ICAM-1, VCAM, E-
selectin) (Lawrence, 2009; Zhong et al., 2012; Xiao et al., 2014) and inducible factor 
enzymes or proinflammatory enzymes like COX-2, hemeoxygenase-1, iNOS (Surh et al., 
2001; Ferrante et al., 2008). 
NF-κB is normally retained in the cytoplasm ; it is in an inactive form associated with the 
inhibitory molecules of KappaBs (IkBs) (Li & Verma, 2002). Activation of NF-κB occurs 
by two different pathways: the classical and the alternative pathway (Orange et al., 2005). 
The classical pathway of NF-κB activation (Fig. 1.11), is the most relevant to this study 
and is triggered by signaling through TLRs. Activation of NF-κB occurs upon cell 
exposure to stimuli, for example cell stress, the effect of proinflammatory cytokines such 
as TNF-α, ILs, LPS, and viral infection. LPS activate NF-κB via phosphorylation of 
inhibitor of NF-κB kinase subunit alpha (IKK1) and sometimes inhibitor of NF-κB kinase 
subunit beta (IKK2) in the inhibitory kappa β-kinase complex. The activator factors may 
directly activate the IKK, which causes phosphorylation and degradation of IκB, which 
results in the freeing of NF-κB heterodimers. The heterodimers then translocate into the 
nucleus and bind to the appropriate promoter regions. These results in expression of 
transcriptional factor genes are responsible for production of proinflammatory cytokines 
such as IL1, IL6, IL8 and TNF-α (Orange et al., 2005).  
The activation of NF-κB occurs after a signal from TLR4, transmitted via the MyD88 
pathway, which initiates when CD14 binds to LPS and then transfers to TLR4.  
Activation of TLR4 causes phosphorylation of IκB by IKK (IκB kinase). The degradation 
of IκB occurs through the ubiquitin system. The freed NF-κB (p50-ReL-A) translocates 
into the nucleus and activates gene expression. The newly synthesized IκB can enter the 
nucleus, where it is helps to remove the NF-κB from the DNA and  export it back to the 
cytoplasm where it  normally resides (Hinz et al., 2012; Schuster et al., 2013). It has b 
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been found that PARP enzymes, especially PARP-1 are required for NF-κB  activation 
(Hassa et al., 2001; Nakajima, 2004; Veuger et al., 2009; Castri et al., 2014). Castri et al. 
(2014) found that PARP-1 plays an important role in the activation and relocation of NF-
κB to the cytoplasm. 
 
 
 
 
 
Figure 1-11: Activation and translocation of NF-κB into the nucleus. This schematic diagram shows 
that NF-κB is retained in the cytoplasm by IκB. TLRs transmit the signal from the LPS/CD14 complex via 
the MyD88 pathway and cause phosphorylation of IκB by IKK (IκB kinase). Freed NF-κB (p50-ReL-A) 
enters the nucleus and activates gene expression. The newly synthesized IκB can enter the nucleus, pull 
NF-κB off DNA and export NF-κB back to the cytoplasm (Source: Gilmore, 1999).  
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1.5 The mitogen-activated protein kinase family (MAPK) 
 
Protein kinases are enzymes that have the ability to modify other proteins by covalently 
attaching a phosphate group to them. The most common protein kinases, serine/threonine 
kinases, act on serine and threonine, tyrosine kinases act on tyrosine, while dual-
specificity kinases act on all three amino acids. Such phosphorylation of proteins can 
affect their enzymatic activity, protein-protein interaction, protein location in the cell, or 
their propensity for degradation by proteases such as mitogen-MAPKs (Widmann et al., 
1999). Responses to LPS are characterized by activation of multiple intracellular 
pathways, including the MAPK, NF-κB and AP-1 pathways (Chen et al., 2012; Lu et al., 
2012). 
Mitogen-activated protein MAPKs include the extracellular signal-regulated  kinases 
(ERKs), c-Jun N-terminal kinases (JNKs), and  p38 MAPK-activated protein kinases 
(Johnson et al., 2002; Roux & Blenis, 2004). MAPKs phosphorylate specific 
serines/threonines of target protein substrates. The resultant signals  transduce to 
downstream pathways and activate numerous transcription factors, with induction of 
genes encoding inflammatory molecules (Raman et al., 2007; Huang et al., 2009). The 
elicited cytokines are believed to be responsible for cell proliferation, differentiation, 
immunoregulation, and cytotoxicity of bacteria  (Lamkanfi et al., 2007). MAPKs are key 
mediators driving the production of inflammatory cytokines during sepsis (Liu et al., 
2012; Frazier et al., 2012). Activation of the MAPK pathway occur after LPS stimulation 
in MyD88 knockout mice, with delayed kinetics compared with wild type mice, 
suggesting MyD88 involvement, but not essential, in LPS-induced MAPK activation and 
that other MyD88-independent pathways exist (Andreakos et al., 2004; Bandow et al., 
2012). Recently an adaptor molecule homologous to MyD88, Mal/Tirap, has been shown 
to be involved in the activation of  MAPK by TLR4 (Andreakos et al., 2004; Laird et al., 
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2009). In a fashion similar to that of MyD88 knockout mice, Tirap knockout mice 
demonstrate delayed activation of  MAPK after LPS exposure (Kawai et al., 1999; Kaisho 
et al., 2001). These findings point to the presence of other pathway independent of 
MyD88 and Mal/Tirap, which lead to the activation of the MAPK after LPS stimulation.  
 
1.5.1 JNK subfamily proteins  
 
JNK proteins are encoded by three genes, JNk1, JNk2 and JNk3. JNk1 and JNk2 encode 
ubiquitously expressed JNK proteins, whereas the JNk3 protein product is primarily 
found in the brain, heart and to a lesser extent in the testis (Kumar et al., 2015). 
Alternative splicing of the jnk transcripts results in 10 different JNK isoforms, each of 
which may target different transcription factors (Dreskin et al., 2001; Manassero et al., 
2012) JNK1 and JNK2 have four isoforms each (α1, α 2, β1 and β 2). JNK1 α 1, JNK1 β 
1, JNK2 α 1 and JNK2 β 1isoforms all have a molecular weight of 46 kDa, whereas JNK1 
α 2, JNK1 β 2, JNK2 α 2 and JNK2 β 2 isoforms are larger due to an extended C-terminus 
and their molecular weight is 54 kDa. JNK3 has two isoforms, JNK3 α 1 (46 kDa) and 
JNK3 α 2 (54 kDa) (Dreskin et al., 2001). In this study the effect of PARP inhibitor PJ-34 
on the activation of the JNK cascade, after induction of PARP-1 activity by LPS, was 
investigated.  
 
1.5.2 JNKs and inflammation 
  
LPS binds to LBP in the plasma and is delivered to the cell surface receptor CD14. Next, 
LPS is transferred to the transmembrane signaling receptor toll-like receptor 4 (TLR4) 
and its accessory protein MD2. LPS stimulation of human monocytes activates several 
intracellular signaling pathways that include the IkappaB kinase (IKK)-NF-κB pathway 
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and three mitogen-activated protein kinase (MAPK) pathways: extracellular signal-
regulated kinases (ERK) 1 and 2, C-Jun N-terminal kinase (JNK) and p38. These 
signaling pathways in turn mediate multiple downstream events leading to the activation 
of AP-1 and NF-κB, which results in induction of a range of inflammatory cytokines 
(Guha & Mackman, 2001; Kim & Kim, 2014). Therefore, inhibition of the activation of 
MAPKs, Akt, NF-κB and AP-1 may have potential therapeutic applications (Park et al., 
2011). JNKs have been isolated and characterized as stress-activated protein kinases on 
the basis of their activation in response to inhibition of protein synthesis (Mehan et al., 
2011). They were found to bind and phosphorylate the DNA binding protein c-Jun and to 
increase its transcriptional activity. C-Jun N-terminal kinase is a component of the AP-1 
transcription complex, which is an important regulator of gene expression. AP-1 
contributes to the control of many cytokine genes and is activated in response to 
environmental stress, radiation, and growth factors of all stimuli that activate JNKs. 
Regulation of the JNK pathway is extremely complex and is influenced by many MAP 
kinase kinase kinases (MKKKs). As depicted in the Signal Transduction Knowledge 
Environment JNK Pathway Connections Map, there are 13MKKKs that regulate the 
JNKs. This diversity of MKKKs allows a wide range of stimuli to activate this MAPK 
pathway. JNKs are important in controlling  apoptosis (Chen, 2012). The inhibition of 
JNKs enhances chemotherapy-induced inhibition of tumour cell growth, suggesting that 
JNKs may provide a molecular target for the treatment of cancer. JNK inhibitors have 
also shown promise in animal models for the treatment of rheumatoid arthritis 
(Bogoyevitch, 2005). The pharmaceutical industry is bringing JNK inhibitors into clinical 
trials for both diseases.  
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1.6 Poly (ADP-ribose) polymerases (PARP) 
 
Poly (ADP-ribose) polymerase (PARP), also known as poly (ADP-ribose) synthetase 
(PARS), is an abundant nuclear enzyme located in the nucleus of eukaryotic cells, and 
becomes active in the presence of DNA damage. PARP activation results in cleavage of 
NAD+ to nicotinamide and poly (ADP-ribose) to form long or branched (ADP-ribose) 
polymers (PAR) on glutamic acid residues of a number of acceptor proteins. These 
proteins are associated with chromatin and PARP itself. PARP-catalysed NAD
+
 
polymerization is referred to as poly ADP-ribosylation (Soriano et al., 2001; Tentori & 
Graziani, 2005). Over activation of PARP is considered to play a role in various patho-
physiological conditions, including septic shock, via activation of NF-κB  in response to 
LPS (Soriano et al., 2001; Cuzzocrea, 2005). 
 
1.6.1 Structure and types of PARP enzymes 
 
The PARP family contains 17 members that differ from one another in structure, serving 
different functions in the cell (Fig. 1.12). PARP-1, which is involved in repair of single-
stranded DNA (ssDNA) breaks, consists of three main domains: the N-terminal DNA-
binding domain (DBD), the auto-modification domain (AMD) and the C-terminal 
catalytic domain. The DBD domain contains two zinc fingers which are responsible for 
DNA binding and some protein-protein interaction  (angelier et al., 2011; Sun et al., 
2014)Some PARP enzymes (PARP-1 and Vault PARP) have an auto-modification 
domain containing a BRCT motif, which is common in DNA repair and cell-cycle 
proteins (Nguewa et al., 2005). The catalytic domain contains the active site of PARP-1, 
also termed the ‘PARP signature’ (highly conserved in eukaryotes), which consists of a 
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50-amino acid sequence. The ‘PARP signature’ is characteristic of all types of PARP 
enzymes (Bürkle, 2005). 
Apart from PARP-1, PARP-2 is the only PARP isoform that it is activated by DNA strand 
breaks. Despite the absence of the auto-modification domain from PARP-2, it displays 
auto-modification properties similar to PARP-1, but its DNA binding domain is very 
different from that of PARP-1(Huber et al., 2004). The DBD domain of PARP-2 is differs 
from that of PARP-1 in size and it lacks the two zinc fingers and the BRCT motif. PARP-
2 is targeted to the nucleus. The catalytic domain of PARP-3 is similar to that of PARP-2, 
but PARP-3 displays a smaller DNA-binding domain (Bürkle, 2005). The vault/PARP-4 
has a BRCT domain similar to that in the auto-modification domain of  PARP-1 (Hassa & 
Hottiger, 2005). The DBD domain of tankyrase-1 contains a His-Pro-Ser-rich (HPS) 
domain, and the C-terminus of tankyrase displays homology to the PARP-1 catalytic 
region (Bürkle, 2005). Tankyrase-2 displays a domain structure that is similar to 
tankyrase-1 except for the N-terminal HPS domain, which is missing in tankyrase-2 
(Bürkle, 2005). The tankyrase-2 enzyme was reported to interact with several other 
proteins such as insulin-responsive amino peptidase (IRAP) (Sbodio et al., 2002). Poly 
(ADP-ribose) glycohydrolase (PARG) is an important enzyme that possesses both 
endoglycosidic and exoglycosidic activity. It is responsible for the catabolism of the poly 
(ADP-ribose) polymer (Min & Wang, 2009; Finch et al., 2012). As a result of the 
combined action of PARPs and PARG, poly (ADP-ribose) undergoes a dynamic turnover 
in live cells (Bürkle, 2005). 
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1.6.2 Poly (ADP-ribose) polymerase-1 (PARP-1)  
 
 PARP-1 appears to play a critical role in many biological processes. These include DNA 
repair and maintenance of genomic stability, transcriptional regulation, centromere 
function and mitotic spindle formation, centrosomal function, structure and vault 
particles, telomere dynamics, trafficking of endosomal vesicles, apoptosis and necrosis 
(Bürkle, 2005). PARP-1 and PARP-2 are activated by ssDNA breaks and  serve important 
functions  in DNA repair and expression of both PARP-1 and PARP-2 and⁄ or DNA 
Figure 1-12: Schematic structure of some members of the PARP family of enzymes. Different types of 
PARP enzymes and their domains are represented. Abbreviations: BRCT, BRCA1 C-terminus; DBD, 
DNA-binding domain; HPS, His-Pro-Ser-rich domain; MVP-BD major vault binding domain; NLS, 
nuclear localization signal; SAM, sterile α-module;  SH3, src homology region; TM, transmembrane 
domain; VIT, vault protein inter  alpha-Trypsin domain; VWA, von Willebrand factor type A domain; ZF; 
zinc finger. (Source: Bürkle, 2005). 
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strand break-dependent poly(ADP-ribosyl)ation is essential during early embryo- genesis 
(Schreiber et al., 2002). PARP-1 or PARP-2 knock out mice provided evidence for these 
roles. When PARP-1/-2, inactivated the cell susceptibility to DNA damaging agents 
increases and strand break re-joining is inhibited (Tentori and Graziani, 2005). One of  
the PARP-1’s most important functions, which is relevant to this study, is the regulation 
of the production of inflammatory mediators (; Sodhi et al., 2010; Liu et al., 2012; Scalia 
et al., 2013). Activation of PARP-1 plays an important role in the upregulation of 
inflammatory cascades through interactions with transcription pathways such as NF-κB, 
JNK, AP-1 (Hunter et al., 2012; Scalia et al., 2013). 
 
 
1.6.3 PARP enzymes and mechanisms of proinflammatory cytokine 
production 
 
Poly (ADP-ribosy)lation is a posttranslational modification of DNA binding protein in 
eukaryotic cells (Yung et al., 2004; Schreiber et al., 2006; Ahel et al., 2008). PARP-1 is 
activated by DNA strand breaks. Subsequently, PARP-1 synthesizes polymers of poly 
ADP-ribose from NAD
+
 to promote DNA repair (Kim et al., 2005b; Schreiber et al., 
2006). Over-activation of PARP-1 depletes NAD
+
 and adenosine triphosphate (ATP) and 
eventually leads to necrotic cell death by energy failure (Ying et al., 2003; Alano et al., 
2010). There is evidence that PARP acts as a co-activator in NF-κB-mediated 
transcription (Nakajima et al., 2004).  (Hunter et al., 2012) have indicated the likelihood 
that NF-κB is regulated by PARP-1. Several reports have shown that PARP-1 plays a 
pivotal role in  NF- κB activation independently of energy depletion by binding directly 
to NF-κB (Hassa et al., 2005; Hunter et al., 2012)or poly ADP-ribosylating it (Oliver et 
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al., 1999; Laudisi et al., 2011) and that inhibition of PARP-1 can attenuate this activation 
(Shaposhnikov et al., 2011). 
NF-κB is
 
activated and translocate to the nucleus by a specific signal from TLR4 after 
binding to the CD14-LPS complex. It has been shown that treating mice with LPS results 
in rapid activation of NF-κB in macrophages from PARP positive mice (Oliver et al., 
1999). Activation of PARP has been shown to occur upon endotoxin administration 
(Oliver et al., 1999; (Shall & De Murcia, 2000). This result in degradation IκB, an 
inhibitor of NF-κB, permitting its nuclear translocation, upon which NF-κB activates 
genes concerned with inflammatory or immune responses, such as inducible nitric-oxide
 
syntheses, IL-1, IL-6, and TNF-  (Oliver et al., 1999; Cuzzocrea, 2005). PARG and poly 
(ADP-ribosy) lation play a critical role in the re-localization of nuclear p65/NF-κB to the 
cytoplasm in addition to its possible effect on NF-κB-dependent transcription (Cuzzocrea, 
2005; Shaposhnikov et al., 2011). 
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1.7 Role of CD14 and PARP enzymes in diseases 
 
CD14 receptor has been reported to be related to many diseases, and regulation of CD14 
gene expression plays a critical role in many inflammatory diseases. Antal-Szalmas, 
(2000) reported that diversion of mCD14 and sCD14 expression levels from their normal 
range is associated with many diseases. PARP activation plays a role in the pathogenesis 
of various cardiovascular and inflammatory diseases (Murakami et al, 2004). Published 
research suggests that CD14 and PARP may significantly contribute to the overall 
inflammatory response related to LPS. Since PARP and CD14 receptors are related to 
many diseases, this study will discuss only those diseases that might be related to the 
CD14 receptors and PARP via activation of NF-κB-mediated transcription. This 
knowledge will help to expand the options for effective intervention, so that inflammatory 
diseases can be treated or prevented. Activation of CD14 and PARP has been shown to 
contribute to the pathogenesis of Gram-negative sepsis and various inflammatory 
diseases.  
 
 
1.8 Role of CD14 and PARP in sepsis/septic shock 
 
Gram-negative bacterial infection, which results in overproduction of proinflammatory 
cytokines such as IL-1, IL-6, and TNF-α and eventually results in multiple organ failure 
(Frink et al., 2009). Septic shock is a severe form of sepsis, defined as sepsis-induced 
hypertension. Septic shock is associated with elevation in body temperature and collapse 
in heart and respiratory rate (Annane et al., 2005; Hunter & Doddi, 2010; Schortgen et al., 
2015). 
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1.9 Pharmacological effect of anti-CD14 and PARP enzymes  
 
One might predict that blocking of CD14 and PARP with inhibitors will reduce the 
inflammatory response to LPS, because both are key regulators of the pathogenesis of 
inflammatory diseases. It has been suggested that anti-CD14 and PARP inhibitors may be 
valuable for treating septic shock or other inflammatory diseases (Freeman & Natanson, 
2000; Veres et al., 2003; Annane et al., 2005; Szabo, 2007; Peralta-Leal et al., 2009). 
 
 
1.9.1 Anti-CD14 antibody 
 
CD14 is a receptor for LPS, and blocking of CD14 activity by anti-CD14 is an important 
therapeutic strategy. It has been found that anti-CD14 antibodies protected rabbits from 
death and prevented hypotension in LPS injected rabbits (Haziotet al., 1996). 
Furthermore, mice with over-expression of CD14 had an increased susceptibility to LPS-
induced shock (Ferrero et al., 1993; Furusako et al., 2001; Nakamura et al., 2003), while a 
recombinant anti-CD14 monoclonal antibody significantly decreased LPS-induced shock 
in animal models and that cause by human  endotoxaemia (Verbon et al., 2003; Kim & 
Kim, 2014). Furthermore, inflammatory responses such as cytokine release and 
granulocyte activation were strongly inhibited by anti-CD14 monoclonal antibodies 
(Verbon et al., 2003) 
 
1.9.2 PARP inhibitors  
 
Several studies have reported that PARP inhibition has an anti-inflammatory effect. For 
instance, PARP-1 plays a role in transcriptional control during CD14 activation, and  
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PARP-1 activity-dependent regulation of NF-κB is a novel pharmacological target in the 
better management of the treatment of inflammatory disorders (Szabo, 2002). Evidence 
indicates that PARP-1-deficient mice are resistant to lethality induced by LPS, and 
inhibitors of PARP-1  are promising tools for therapeutic intervention (Cepeda et al., 
2006; Pacher & Szabó, 2007; Godon et al., 2008). Inhibition of PARP improves the 
survival rate of mice subjected to endotoxin  (Szabó et al., 2004; Godon et al., 2008). A 
specific PARP inhibitor, PJ-34, based on a modified 6 (5H) phenanthridinone structure, 
increased endotoxic shock survival rate and had various anti-inflammatory effects in 
animal models of endotoxaemia  (Huang, 2009; Chevanne et al., 2010; Mazzone & Nistri, 
2011; Scalia et al., 2013). Use of PARP inhibitors may be a promising approach to 
alleviate asthma attacks (Cuzzocrea, 2005; Virág, 2005). This research study was 
intended to improve our understanding of the role of innate immunity and CD14-PARP 
interactions in complex inflammatory diseases. 
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AIM OF THE STUDY 
 
1. To assess the role of PARP activation in the regulation of CD14, TLR4, TLR2 and SR 
receptor expression in human macrophages, following treatment with LPS, in the 
presence and absence of PARP inhibitor.  
2. To determine whether the presence of LPS can overcome the effect of the PARP      
inhibitor. 
3. To investigate CD14 and SR receptor associations on the cell membrane with or 
without the presence of LPS. 
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CHAPTER 2: Materials and Methods 
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2.1 Materials 
2.1.1 General Laboratory chemicals 
 
All chemicals used in this study including tissue culture reagents were purchased from 
Fisher scientific (UK). DMSO and poly (ADP-ribose) polymerase inhibitor (PJ-34), 
Lipopolysaccharide (LPS) from E. coli, serotype EH100, Phorbal 12-myristate 13-acetate 
(PMA), 1,25-dihydroxyvitamin D₃ (VitD₃) and accutase were purchased from (Sigma 
Aldrich, UK). ELISA kit for measuring TNF-α and IL-1β were bought from e bioscience 
(UK). A nuclear extract kit was purchased from active motif kit (UK). 
 
 
2.1.2 Tissue culture 
2.1.2.1 Cell line 
 
The human monocytic cell line (THP-1),  is cell line derived from acute monocytic 
leukaemia patient with distinct monocytic markers, was purchased from Health protection 
agency culture collection (HPACC) (UK).The cell was grown in different size tissue 
culture grade flasks, which were purchased from NUNC (Denmark). 
 
2.1.2.2 Cell culture media 
 
Human monocytic Leukemia THP-1 cells were grown in suspension culture in RPMI-
1640 (PAA, UK), which was supplemented with 10% (v/v) heated- inactivated fetal calf 
serum (FCS) (PAA, UK), the culture was maintained at 37
o
C in an air humidified 
atmosphere of 5% (v/v) CO2. 
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2.1.3 Antibodies 
 
Antibodies Purified monoclonal Mouse anti- human either anti-CD14 (Clone 26ic, H14), 
anti-human TLR4 (Clone HTA 125), anti-human TLR2 (Clone TLR2.1), anti-human SR 
(Clone PLK1), poly clonal rabbit anti-human NF-κB , poly clonal rabbit anti-human JNK  
and  FITC goat anti-mouse IgG antibody all were purchased from (Biolegend, UK) and 
PE donkey anti-rabbit and FITC goat anti-mouse antibodies were purchased from (Sigma, 
UK). Goat anti mouse antibodies conjugated with Alex 488 (green) or Alex 555(red) were 
purchased from (Biolegend, UK).  
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2.2 Methods 
2.2.1 Tissue culture 
2.2.1.1 Thawing of cells 
 
Cryogenic vials with 1×10
6
 cells/ml in a 9:1(v/v) solution of FCS: dimethyl sulfoxide 
(DMSO) was removed from liquid nitrogen. Special precautions were taken which 
included using a protective mask and heavy padded gloves. Cells were thawed rapidly at 
37
o
C and then transferred using a sterile glass pipette to a 10ml centrifuge tube containing 
5ml of fresh complete medium to dilute out the DMSO. After centrifugation for 5 minutes 
at 1300 rpm (34 xg), the medium was removed, the cell pellet was resuspended in 5 ml of 
fresh medium, and the number of the cells was counted using a haemocytometer. A final 
concentration of 1×10
5
 cells/ml was transferred to either a flask or cell culture plate. Cells 
were cultured at 37
o
C in humidified a tissue culture incubator with 5% (v/v) CO2. 
 
2.2.1.2 Routine passaging and prolongation of cell culture 
 
THP-1 cells are suspension cells, growing continuously in RPMI-1640 supplemented with 
10% (v/v) FCS. Cells were sub cultured twice a week when the culture reached about 70-
80% of maximum density, either by dilution of the old cell culture to fresh medium or by 
increasing the volume of the stock culture by adding a fresh medium. The cell suspension 
was transferred to a centrifuge tube and was centrifuged for 3 minutes at 1300 rpm (32 
xg). After that the medium was removed, the cell pellet was re-suspended in 5 ml of fresh 
medium and a proper mixing was carried out by continuous pipetting up and down to 
avoid the formation of cell clamps. Finally, the cells number was counted by using a 
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haemocytometer and diluted to a final concentration of 1×10
5
 cells/ml. Cells were 
cultured at 37
o
C in a humidified incubator with 5% (v/v) CO2 
 
. 
2.2.1.3 Determination of cell number 
 
The cells were resuspended thoroughly by pipetting up and down the cell suspension, 
using a pipette, and then the cell suspension was transferred to a haemocytometer and 
drawn under the cover slip by capillarity. The cells in an average of 5 to 10 squares were 
counted using the 10X objective. The number of cells was calculated by averaging these 
counts and dividing by the number of the squares, and finally that number multiplied 
by1×10
4 
to obtain the number of the cells per/1ml of stock. 
  
 
2.2.1.4 Cell viability assay  
 
The cells viability was determined by mixing equal amount (100µ l) of 4% (w/v) trypan 
blue exclusion and THP-1 cell culture, mixed and left for 5 mins. After that cells from the 
mixture were transferred to a haemocytometer and drawn under the cover slip and cells 
were counted as indicated above. The cells stained with blue color were counted as dead 
cells and unstained cells counted as viable cells. From these counts the percentage of cell 
viability can be determined as following: (total cells – dead cells) × 100/total cells (Butler 
and Spearman, 2007). 
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2.2.1.5 Freezing of cells 
 
A cell line which is free from contamination can be stored for long term as a frozen stock 
in liquid nitrogen. The cells were frozen down by culturing them to grow to log phase, 
and the suspension prepared for freezing down with DMSO (Cryopreservative agent). 
After determine cell number per ml in the cell suspension, the cell suspension was 
centrifuged for 5 mins at 1300 rpm (32 xg) and the supernatant discarded, the cell pellet 
was resuspended in a 9:1 (v/v) mixture solution of FCS: DMSO. One ml of mixture 
solution was added to 1×10
7
 cells/ml in cryogenic tube. The cryotubes were sealed tightly 
to avoid any leakage and wrapped up with cotton were to provide a sufficient insulation to 
slow down the freezing process, then placed into a box which was transferred 
immediately to be stored in a freezer at -80
o
C. Finally, after reaching this temperature, the 
cryotubes were transferred to liquid nitrogen to be stored at -196
o
C for long term storage. 
 
 
2.2.2 Proliferation studies 
2.2.2.1 The effect of PARP inhibitor PJ-34 on the THP-1 cell viability 
 
To assess the cytotoxic effect of PARP inhibitor PJ34 on THP-1 cells, THP-1 cells at 
density of 5x10
4  
cells/ml were plated in 30 mm cell culture plate and after 24 hours of 
seeding, different concentrations of (5, 10, 20, and 30 µM) of PARP inhibitor PJ34 were 
added to the cultured cells. Cells were counted at 48 hrs and 72 hrs from seeding time. 
Trypan blue was used to stain the dead cells by mix equal amount of cell culture with 
trypan blue and incubate for 3-5 mins and haemocytometer were prepared and cell 
counted. The percentage of cell viability was calculated as following: Total cell number- 
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dead cell number divided by total cell number x 100. Dead cells stained with trypan blue 
and live cells remain unstained (Fig. 3.5). 
 
2.2.2.2Treatment of THP-1 cell with hydrogen peroxide to induce DNA 
damage 
 
THP-1 5x10
4
 were differentiated in chamber slide with PMA 5 ng/ml for 72 hrs then the 
media replaced with fresh media incubated with different concentrations (0, 50,100 and 
250 µM) of H2O2 for 10 mins and cell then washed and fixed with paraformaldehyde 4% 
w/v for 15 min on ice and then washed and incubated with monoclonal mouse anti-human 
PAR antibody for 45 min and washed. Afterward cells were incubated with goat anti- 
mouse antibody labelled FITC for another 30 mins. The slide was examined under 
confocal microscopy. Bio-Rad Radiance 2000 and images were analysed by using image- 
J software. 
 
 
2.2.2.3 Cell differentiation 
 
THP-1 cells were differentiated with two differentiation inducer reagent, phorbal 12-
myristate 13-acetate (PMA) and 1, 25-dihydroxyvitamin D₃ (vit.D3) for different 
concentrations and time course were carried out. THP-1 cells at final density of 5x10
5 
cells/ml were treated with different concentrations (0, 5, 10, 20, and 30 ng/ml
) 
of
 
PMA 
and incubated for 72 hrs, concentration of 5 ng/ml was used for time course experiment 
(24, 48, 72 and 96 hrs). For differentiation with vit.D3, cells at density of 2x10
5 
cells/ml 
were treated with (0, 50, 100, 150 and 200 nM) of vit.D3 and incubated for 72 hrs and 
concentration of 100 nM
 
was used for time course experiment (24, 48, 72 and 96 hrs). 
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The difference in the cells number used with each differentiation inducer was because 
PMA inhibit cell proliferation, whereas Vit.D3 not affecting the cell proliferation. For 
flow cytometry experiments, adherent cells were detached from the plastic surface with 
accutase.  
 
2.2.3 Flow cytometry to detect cell surface receptors 
 
Flow cytometry was used to detect cell surface receptors, this was achieved by passing 
the cells in suspension buffer fluid sheath and exposure them to a beam of laser. Flow 
cytometry uses different lasers for illumination, during exposure of the cells to the laser 
beam, they are characterized individually based on their scattered light and emitted 
fluorescence, which collected and filtered and finally converted to digital value and the 
quantities of the labelled cells can be analysed using computer. There are two types of 
light-scattering, forward scattering related to the cell size and side scattering related to the 
cell granularity. Samples run and (10,000 cells) was acquired for each sample and 
analysed with specific software and geometric mean of each sample was calculated 
 
 
2.2.3.1 Cell surface staining for flow cytometry 
 
Indirect immunofluorescence staining was used to prepare cells for flow cytometry 
analysis. This method includes two steps:  The first step includes incubation of cells with 
specific primary antibody to detect the antigen of interest and the second step includes 
incubation of cells with secondary antibody labelled to fluorochrome which binds to the 
primary antibody to locate the antigen. Differentiated cells were washed twice with 
phosphate-buffered saline (PBS) and incubated with accutase for 5-7 mins at 37
0
C. Cell 
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suspensions (2.5x10
5
cells/ml) per sample were centrifuged at 1200 rpm for 2-3 minutes, 
supernatants were discarded. The cell pallets resuspended in cold blocking buffer [PBS 
supplemented with 0.1% (w/v) bovine serum albumin (BSA)] for 10-20 min. The cells 
were incubated with concentration of 0.5mg/ml at 1:50 dilutions of primary monoclonal 
mouse anti-human either (anti-CD14 clone 26ic or anti-TLR4 clone HTA 125 or anti-
TLR2 clone TL2.1 and anti-MARCO for 45 mins at 4
0
C, after washing twice with 
blocking buffer. Cells were incubated with secondary antibody goat anti mouse IgG 
labelled FITC for further 30 mins and washed twice with blocking buffer. Afterward cells 
were fixed with 4% formaldehyde for 15-20 mins on ice, washed and resuspended in 350 
µl blocking buffer. Finally, cells were transferred into FACS tubes and analysed by flow 
cytometry (Aria cell sorter or Accuri 6) and results analysed with Flo-Jo software version 
8.8.6 (Tree Star Inc., Ashland, OR, USA).  
 
 
2.2.4 Immunofluorescence labelling of antigens for microscopy 
2.2.4.1 Immunofluorescence labelling methods 
 
Immunofluorescent labelling was achieved by two ways, direct and indirect. The first 
way, is direct immunofluorescence can be achieved by using antibody against the 
molecule of interest is chemically conjugated to a fluorochrome. The second way is 
indirect immunofluorescence, which includes two steps, in which the first step is using a 
primary antibody specific for the antigen of interest is unlabelled and the second step 
using secondary antibody tagged with a fluorochrome. The secondary antibody should be 
raised against the animal in which the primary antibody was produced. Interaction of the 
primary antibody with the secondary antibody which labelled with a fluorochrome can 
then be visualised using ultra violet and laser equipped microscopy techniques. 
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2.2.4.2 Single immunofluorescence labelling of antigen 
 
THP-1 cell were differentiated in Lab-Tek 8 well slides (Thermo Fisher Scientific) at a 
density of 7.5x10
4
 cells/well, for three days with PMA (5 ng/ml). The culture medium 
was aspirated from the wells and cells were incubated with different concentration of 
H2O2 for 10 min, and then washed with PBS pre warmed at 37
0
C. The cells fixed with 4% 
(w/v) paraformaldehyde for 15 mins on ice and pearmeabilized with 0.01% triton 100X 
and washed with PBS after each step. The cells were blocked with blocking buffer [2% 
(w/v) BSA in PBS] for 1 hr at 4 
0
C. Cells incubated with 100 μl antibody dilutions per 
well primary mouse anti-human mAbs: anti-PAR (clone 10H) at a dilution of 1 μg/100 μl 
in blocking buffer [1% (w/v) BSA in PBS] for 1 hr at 4
0
C. After the incubation, samples 
were washed three times with PBS and  then incubated for 1 h with goat anti-mouse IgG 
antibodies conjugated with Alexa Fluor® 448 (Invitrogen, Carlsbad, CA, USA) at a 
dilution of 0.25 μg/100 μl. The cells were thoroughly washed with PBS thereafter, 
chamber disassociated and removed from the slides. The slides were air dried in the dark 
and then mounted with vectashield hardest mounting medium (Vector Laboratories, 
Burlingame, CA, USA), covered with the coverslips number 1.5 and the slide were 
visualised using confocal microscopy Bio-Rad Radiance 2000. 
 
 
2.2.4.3 Detection of cell surface receptors by immunofluorescence  
doubles labelling 
 
Un-differentiatedTHP-1 or THP-1 cell were differentiated in Lab-Tek 8 well slides 
(Thermo Fisher Scientific) at a density of 7.5x10
4
 cells/well with PMA (5 ng/ml) for 72 
hrs. The culture medium was aspirated from the wells and the cells were washed with 
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PBS pre-warmed at 37
0
C. The cells were fixed with 4% (w/v) paraformaldehyde for 15-
20 mins on ice and washed with PBS. All subsequent steps were carried out at room 
temperature, otherwise stated. Cells were incubated with blocking buffer [2 % (w/v) BSA 
in PBS] for 1 hour. Staining was done in sequence for each antigen. The cells were 
incubated with 100 μl antibody dilutions per well using the following primary mouse anti-
human mAbs: anti-CD14 (clone 26ic) and mouse anti-human MARCO (clone PLK1) at a 
dilution of 1 μg/100 μl in blocking buffer[ 1% (w/v) BSA in PBS] for 1 h at 4
0
C. After 
the incubation cells were washed twice with PBS. Cells were then incubated for 30-45 
mins with goat anti-mouse IgG antibodies conjugated with  Alexa Fluor® 555 or Alexa 
Fluor® 488 (Invitrogen, Carlsbad, CA, USA) at a dilution of 0.25 μg/100 μl. Cells were 
blocked again with 2% blocking buffer before second round of primary and secondary 
antibody staining. For staining cell nuclei, 4',6-diamidino-2-phenylindole (DAPI) (Sigma-
Aldrich) was used at a 1:250 dilution in PBS. The cells were thoroughly washed with 
PBS thereafter, chamber disassociated and removed from slides. The slides were air dried 
in the dark and mounted with vectashield hardest mounting medium (Vector Laboratories, 
Burlingame, CA, USA), covered with the coverslips number 1.5 and cells images 
obtained with Nikon Air confocal microscope. 
 
 
2.2.5 Confocal microscopy 
2.2.5.1 Principle of confocal microscope 
 
The confocal laser scanning microscopy is a valuable instrument that uses a laser to 
provide an excitation light attached to computer to build up and analyse digitalized 
images to observe only at the plane of focus. The laser confocal microscopy provides 
three-dimensional images by reconstructing the serial optical sections of thick specimen. 
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The laser light reflected off a dichroic mirror and hits two mirror which are mounted on 
motors, and these motor scan the laser across the sample. The dye in the sample 
fluoresces, and the emitted light gets descanted by the same mirrors used to scan the 
excitation light from the laser. Then only the emitted light passes through dichroic mirror 
and focused onto the pinhole, and the light that passed the pinhole is measured by 
detector. The fluorescent light signal transformed into an electrical signal by a computer. 
A cell or tissue images can be sectioned optically, and these images at different depths 
can be compared. These images can be analysed individually, or regenerate three 
dimensional images by assembling a stack of these two dimensional-images from 
successive focal planes, and the presented image pixel corresponds to the relative 
intensity of detected fluorescent light. The confocal microscope provides clear images by 
excluding all out of focus information. In this study two different types of confocal 
microscopes were use a Bio-Rad Radiance 2000 and images were analysed by using 
image J software and Nikon A1R laser scanner use software NIS-elements AR 4.13.01  
 
2.2.5.2 Image acquisition  
 
For colocalisation study cell images were acquired using a Nikon A1R confocal 
microscope with a plan-apochromatic violet corrected (VC) 1.4 numerical aperture (N.A.) 
60x magnifying oil-immersion objective. Cell images were acquired in four different 
channels, using one-way consecutive line scans.  The Alexa Fluor 488 was excited at 
488nm with laser power 7.8 Arbitrary Units (AU), its emission collected at 525/50nm 
with a PMT gain of 140 AU (Green channel).  The Alexa Fluor 555 signal was excited at 
561nm with laser power 2.1 AU, and collected at 595/50nm with a PMT gain of 117 AU 
(Red channel). The DAPI was excited at 405nm with laser power 3.2 arbitrary units (AU), 
and its emission collected at 450/50nm with a PMT gain of 118 AU. Finally the 
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differential interference contrast images were acquired using the transmitted light detector 
at a gain of 103 AU. The scan speed used was ¼ frames/s (Galvano scanner) and no offset 
was used. The pinhole size was 34.5μm, approximating 1.2 times the Airy disk size of the 
1.4 N.A. objectives at 525nm. Scanner zoom was centred on the optical axis and fixed to 
a lateral magnification of 55nm/pixel and a Nyquist factor of 2.54 and 2.79 for Alexa 
Fluor 488) and Alexa Fluor 555 respectively. The axial step size was 140nm, with 40-50 
image planes per z-stack. Single or isolated cells with reasonable signal strength in both 
channels were examined letting accurate quantitation of the flat plasma membrane and 
uncrowded receptor distribution. 
In order to validate a reliable colocalisation with this method, optimisation of samples 
were achieved with taking in account the following conditions. First, saturated pixels 
were avoided, because it may represent lost information thus not used for quantitation. 
Therefore, all the values above the dynamic range were not recorded. Second, Using 
datasets that acquired with the correct sampling parameters as described by the Nyquist-
Shannon reconstruction theorem (Nyquist, 1928; Shannon, 1949). Briefly, the smallest 
structure in an image, as determined by the microscope’s resolution using Abbe’s 
criterion, should be represented by at least two pixels and  higher sampling (three to four 
pixels) is also acceptable, while under sampling must be avoided. Third, aberrations were 
minimised in the imaging setup. This was done by using objectives corrected for spherical 
(‘plan’) and chromatic aberrations (achromatic, apochromatic and apochromatic violet-
corrected (VC), depending on the number of colours corrected for). In addition, uni-, not 
bi-directional scanning, zooming in to the centre of the field of view, and separating 
colours in line scanning rather than full-frame mode was done as measures for minimising 
aberrations. 
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2.2.5.3 Colocalisation analysis 
 
A novelty method mentioned in (Jabeen et al., 2013) was followed for this analysis. The 
colocalisation approach uses MATLAB software (version R2010b with Image Processing 
Toolbox; Math Works Inc., Natick, Massachusetts) and is based on a 3D blob-like feature 
detection algorithm introduced by Obara and coworkers (2013). All steps are based on 
analysis in 3D. The algorithm is divided into two stages: candidate location detection, and 
candidate location pruning. After acquisition of separate datasets for both molecules, the 
fluorescent intensity of particles is enhanced while suppressing the noise by convolving 
the image with a 3D Laplacian of Gaussian (LoG) kernel. The LoG kernel size is 
controlled by user-defined radius r. Local maxima, detected by morphological opening, 
are then used to define all locations of particles brighter than their immediate 
surroundings. This process continues until a user-defined low intensity bound T (separate 
for each channel, to allow for datasets where noise levels are markedly different) is 
reached. This is the threshold below which no particles can be safely identified because of 
image noise. In order to accurately measure colocalisation of particles in the dual colour 
fluorescence images, their centroid positions were pinpointed at subpixel resolution using 
weighted centroids. A local matching procedure then performed an exhaustive search for 
correct matches between the two vectors of intersecting positions, using the expected 
average radius of the surrounding circle of light r. For each position in one channel, we 
calculated the Euclidean distance for every position in the other channel. If the distance of 
the closest pair is smaller than the maximum colocalisation distance d, then the pair is 
added to the list of matches and removed from the input vectors All candidate locations 
are pruned to eliminate spurious locations due to image noise. The procedure is repeated 
until there are no more matches satisfying the maximum colocalisation distance 
condition. Receptor pairs were deemed to colocalise if they did not exceed the diameter 
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determining the approximate size of a single particle’s PSF. A tight boundary was chosen 
for this PSF, measuring 165nm in x and y, and 412nm in z. Receptor pairs with their 
centroids further apart than 165nm were classified as non-colocalising. These remaining 
positions in both datasets are then labelled as unmatched. 
 
 
2.2.5.4 Visualisation 
 
After loading the program’s Graphical User Interface (GUI) and a 3D dataset for each 
channel, the algorithm is run by pressing the ‘Colocalisation’ button. Results can then be 
viewed in five different ways: 1) Stacks: Centroid positions of all identified particles are 
marked by red dots in the image stacks, and sliders (in the ‘Stacks’ box of the GUI) allow 
moving through the different z-planes. To verify how exactly a super-resolved centroid is 
positioned inside a fluorescent blob, a high zoom can be applied. 2) Maximum intensity 
projections. To visualise an entire dataset in one image, projections of each image stack 
are available (‘Projection 1’ and ‘Projection 2’ in the ‘Plot’ box) figure 2.1, with green 
and red asterisks marking unmatched (non-colocalising) particles, green and red asterisks 
with blue circles indicating colocalisations. 3) Scatterplot: Produces an isometric 
perspective view of particles shown as asterisks (green and red for each channel), and 
colocalisations encircled in blue. The numbers for colocalisations and particles detected 
in each channel are also indicated. 4) Distance map: A colour-coded 3D distance map is 
used to visualise colocalisations. Each colocalisation is shown as a single sphere, with a 
coded colour indicating the distance between the two colocalising particles (Fig. 2-1). 
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Figure: 2-1:  Colocalisation detection and quantification of CD14 and MARCO receptors on PMA-
differentiated THP-1 cells. (A) Three-dimensional image of PMA–differentiated THP-1 cell showing blue 
(nucleus), green (SR), red (CD14), and yellow/orange possibly colocalised particles. (B) Three-dimensional 
scatter plot of single cell depicting the relationship between SR (MARCO) (green asterisks) and CD14 (red 
asterisks). Blue circles designate colocalisedCD14 and SR molecules. Total number of red, green and 
colocalised spots per cell is quantified. (C) Colour-coded 3D scatter plot for Euclidean distance map of 
colocalised particles. The colour scale indicates the distance between the centroids of colocalised pairs 
ranging from 0.059 µm-0.21 µm (colocalisation distance threshold d=0.22 µm). The corresponding histogram 
represents colocalisation distance on the x-axis and the number of colocalisations on the y-axis. Note that grid 
for cellular dimensions uses microns. 
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2.2.6 Protein Immunoblotting assay 
 
Protein Immunoblotting assay also known as wester blotting, is one of the most 
commonly used techniques in bioscience laboratories for the detection of specific proteins 
in cell culture supernatants and cell lysates. This assay is assembly of size-based protein 
separation and antibody based protein detection. This assay is involves multi-step process 
and described as follows 
 
 
2.2.6.1 Preparation of cell lysate and protein quantification 
 
 Cell pallet from suspension cells or adherent cells, were washed twice with PBS lysed or 
frozen down at -80
0
C until used for cell lysates. To prepare whole or cytoplasmic cell 
lysate active nuclear kit was used. Cells pellet from suspension cells culture or adherent 
cell after detached with using accutase were washed twice with PBS by centrifugation for 
5 mins at 1300 rpm (32 xg). Cell lysate was prepared according Active Motif kit 
manufacture protocol was followed. Total protein concentration was determined by the 
Bradford Assay (Sigma Aldrich, UK) following the manufacturer’s instructions. 
 
 
2.2.6.2 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Proteins are able to move in an electric field at rate which is determined by their charge 
mass and their shape. Proteins can be separated according to their mass by treating them 
with sodium dodecyl sulphate (SDS). At neutral pH, one SDS molecule binds to each 
amino acid, and because SDS molecule carries negative charge, therefore SDS bound 
amino acid repel each other, so that protein chain will remain unfolded and strengthened. 
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The change in the protein chain and its mass will determine the rate of the movement in 
the gel. In the SDS-PAGE two types of gels are used; first, a stacking gel which has a low 
concentration of acrylamide, subsequently proteins will move rapidly through it. Second, 
the running or resolving gel which uses a higher concentration of acrylamide, therefore 
proteins move slower through it giving better resolution. 
 
 
2.2.6.3 SDS-PAGE system 
 
The mini gel apparatus was assembled as indicated in the Bio-Rad instruction for casting 
discontinuous polyacrylamide gels.  Two glass plates were assembled using four clamps 
the outer glass 8.3cm× 10.2cm and inner glass 7.3cm ×10.2cm with a space of 0.75mm 
between them for the comb and a mark was drawn underneath each of the teeth of the 
comb to facilitate loading. To prepare 12% w/v running gel, the mixture of running gel 
solution was poured between the glass plates until the mark, then distilled water was 
poured on the top of the running gel to line up the edge of the gel, and allowed to 
polymerize for 45 mins at room temperature. After that the water was removed by tipping 
up the gel plates and the surface carefully dried with filter paper. The stacking solution 
5% w/v was then prepared and overlay at the top of the resolving gel, a comb inserted and 
was left to set for 25 mins. One well per gel was loaded with 5µl of molecular weight 
marker proteins (Sigma Aldrich, UK). The remaining wells were loaded with 15µg cell 
lysate mixed with sample buffer at ratio of 4:1 (total volume 25µl). At the start the gels 
were run at 50 volts for 45 mins and then after, at 100 volts until the dye front almost 
reached the bottom of the plate, at that point the electrophoresis was terminated. 
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2.2.6.4 Western blotting 
 
When the SDS-PAGE approached the end of its run, the protein bands transferred to a 
polyvinylidene difluoride (PVDF) membrane (Immobilon-FL, Merck Millipore, Merck 
KGaA, Darmstadt, Germany) and this known as western blotting which carried out with 
Bio-Rad transfer system. The (PVDF) membrane was beforehand soaked in methanol for 
1 min and then washed with distilled water and soaked in transfer buffer. Whatman filter 
paper, gel and filter pads were pre-soaked in transfer buffer. The cassette was placed in a 
shallow tray containing transfer buffer, the pre-wetted filter pad was placed on the black 
side of the cassette and a sheet of Whatman filter paper was placed on the filter pad. The 
gel was removed from the electrophoresis chamber after the lower corner of gel marked 
with blade and the gel inverted on the Whatman filter paper. Then PVDF membrane 
placed on the gel after cutting the lower corner to match the gel. The sandwich was 
completed by placing another piece of Whatman filter and filter pad on the top of PVDF 
membrane. The cassette was locked properly with the white latch and placed in the 
electrophoresis module. Finally the cassette was placed in the tank filled with transfer 
buffer pre chilled to 4
o
C and the cooling buffer help to keep the temperature as low as 
possible during the transferring. The transferring was run at 30 volts overnight or for 1hr 
and 20 mins and after completion of the run, PDVF membrane was removed from the gel 
keeping the protein side upside. The membrane was then blocked with 5% skimmed milk 
blocking buffer for 1 hr at room temperature with constant rocking. After that the 
membrane was incubated in 10 ml of fresh tPBS containing 10µl of the primary antibody 
at dilution 1:1000 for 2-3 hrs at room temperature with constant rocking. The membrane 
was then washed for 30 mins with wash buffer, changing the wash buffer each 10 mins. 
Afterward the membrane was incubated with 10µl of secondary antibody labelled FITC at 
dilution 1:1000 for 30 mins; the membrane was washed for 30 mins with wash buffer, 
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changing the wash buffer each 10 mins with constant rocking, then the membrane 
scanned with ODYSSEY infrared imaging system (Li-Cor Bioscience). PageRuler™ Plus 
Pre stained Protein Ladder from Fermentas (Thermo Fisher Scientific) was used and this 
prestained protein MW marker is designed for monitoring the progress of SDS-
polyacrylamide gel electrophoresis, for assessing transfer efficiency onto PVDF, nylon 
and nitrocellulose membranes, and for estimating the approximate size of separated 
proteins that have been made visible with gel stains or Western blot detection reagents. 
 
 
2.2.7 Enzyme-link immunosorbent assay (ELISA) 
 
This technique is one of the most common immunological assays which highly 
characterized with its versatility, sensitivity and specificity and ease of automation. The 
colored product formed indicated for directly proportional to the amount of antigen that 
bond to antibody. In this the technique, a standard curve with known concentrations of 
antigen of interested can be plotted in order determine the unknown antigen in 
experimental samples. ELISA kits ready set go supplied from e-biosciences were used to 
measure accurately and precisely the TNF-α, IL-1β level produced by cells. 
 
 
2.2.7.1 Assay procedure 
 
TNF-α, IL-1β level were measured in culture supernatants by ELISA ready set go (e-
biosciences, Cambridge, UK) following the manufacture recommendations. In brief 96-
well microplates (Nunc MaxiSorp) were coated with capture antibody overnight. The 
plate were aspirated and washed three times with wash buffer, then inverted and blotted 
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on absorbent paper to remove any residual buffer. Following washing the wells blocked 
with 200 µl/well of 1x assay diluent and incubated for 1 hr at RT followed by washing as 
previously. 100 µl/well of diluted standard (500 pg/ml of TNF-α, IL-1β) were added to 
appropriate wells in order to plot standard curve, 2-fold serial dilution carried out and 
100µl/well of experimental samples were added to the rest of the wells. The plate was 
sealed and incubated at 4
0
C overnight followed by a total of 5 washes then, the detection 
antibody (100 µl) diluted in 1X assay diluent was added and the plate was incubated at 
RT for another hour. Followed washing, 100 µl/well of Avidin-HRP diluted in 1X assay 
diluent was added into each well and the sealed plate was incubated at RT for 30 minutes. 
Followed aspiration and washing 7 times. Substrate solution (tetramethylbenzidine) added 
to each well and plates were incubated for 15 mins at room temperature and the reaction 
was stopped by adding 50 µl of 1M H3PO4. The optical density of each well was 
measured at 450 nm using micro plate reader (Versa Max). 
 
 
2.2.8 Polymerase chain reaction PCR 
 
The polymerase chain reaction (PCR) or some called ''Molecular photocopying'' is one of 
cheap and fast technique used in molecular biology which eased copy or amply a single 
target segment of DNA and generate thousands or millions of particular DNA sequence. 
The technique used in medical and biological research laboratories for variety 
applications such as DNA cloning for sequencing or functional analysis of genes, 
diagnosis of hereditary diseases, identification of genetic fingerprints used in forensic 
science and DNA paternity test and detection and diagnosis of infectious diseases.  
 PCR procedure involves three steps carried out in repeated cycles. The first step is 
(denaturation), during this step the denaturation, or separation, of the two strands of the 
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DNA molecule is achieved by heating the starting material to temperatures of about 95°C, 
and the two strands become a template on which the new strands will built up. The second 
step is (annealing) during this step the temperature is reduced to about 55°C, so that the 
primers can anneal to the template. The third step (extension) in this step the temperature 
is raised to about 72°C, and the DNA polymerase begins adding nucleotides onto the ends 
of the annealed primers. At the end of the cycle, which lasts about five minutes, the 
temperature is raised and the process begins again. The number of copies doubles after 
each cycle. Usually 25 to 35 cycles produce a sufficient amount of DNA. 
 
   
2.2.8.1 Primer design 
 
The pearl primer software was used to design the forward and reverse primers for CD14, 
MARCO and cyclophillin. In design of the primer all the factors that have a vital role in 
the PCR reaction and product generating such as whether the primers are for standard or 
real time PCR, length of the primers, the repeated and the amount of GC pairs in the 
primer, the annealing temperature (Tm). The designed primers were supplied by Fisher 
scientific (Invitrogen).  
 
 
2.2.8.2 RNA extraction 
  
Total RNA from undifferentiated and PMA-differentiated THP-1 cells grown in a 100 
mm glass culture plate was extracted using TRI-reagent (Sigma Aldrich) according to the 
manufacturer’s instructions. Briefly, cells lysed directly by adding 1 ml of TRI-reagent to 
glass culture plate and cell lysate homogenized by contentious pipetting, finally the 
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mixture transferred to 2 ml eppendorf tube and left to stand for 5 mins at room 
temperature. Afterward 200 µl of chloroform was added to each tube and shacked 
vigorously for 15 secs and allowed to stand for another 2-15 mins and mixture at 
centrifuged at 12,000 xg for 15 mins at 2-8
o
C, the mixture  separated in there phases, red 
organic phase containing, and proteins, an interphase containing DNA, and a colorless 
upper aqueous phase containing RNA. The aqueous phase transferred to a clean tube and 
0.5 ml of 2-propanol per ml of TRI-reagent used was added to each tube and mixed and 
allowed to stand for 5-10 mins, afterward the tubes centrifuged at 12,000xg for 10 mins at 
2-8
o
C, the RNA in the sample at the end of centrifugation form a pellet on the side and 
the bottom of the tube. The supernatant was removed and the pellet washed with 1 ml of 
75% ethanol per 1 ml of TRI-reagent used in the sample preparation, the sample vortexed 
and centrifuged at 7000 xg for 5 mins at 2-8
o
C, the RNA pellet dried for 5-10 mins by air- 
dryer or under vacuum. Finally, appropriate volume of sterile double distilled water added 
to the RNA pellet and mixed by pipetting up and down with Gilson pippete on a water 
bath at 55-60
o
C for 10-15 mins and stored at -80
o
C until used. The concentration and 
quality of RNA were assessed with Nano drop machine and the purity of RNA extract 
were examined by run the RNA extract in 1% agaros gel. 
 
 
2.2.8.3 Preparation of cDNA  
 
Appropriate volume of RNA containing 2 µg of was mixed with 1 µl of random hexamer 
(Thermo scientific, UK) in PCR tube and the volume of the mixture made-up to 12 µl 
with sterile double distilled water and tubes were placed in PCR machine (GeneAmp
TM
 
PCR system 9700 ) and heated to 65
o
C for 10 mins. As soon as the 10 mins finished the 
sample tubes were placed on ice straight away as any dealing will renaturation of the 
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secondary structures. With sample on the ice 4 µl of 5x buffer (enzyme buffer), 2 µl of 10 
mM of dNTPs (Thermo scientific, UK), 1 µl of water and 1 µl of the reverse transcriptase 
enzyme (Thermo scientific, UK) were added to PCR tube, with keeping all the reagent on 
the ice. Finally, the PCR tubes were placed again in PCR machine and run on program as 
following, 37
o
C for 2 mins, 42
o
C for 1 hr, 70
o
C for 5 mins ( to inactivate the enzyme) and 
at 12
o
C forever and the cDNA kept on ice or stored at -20
o
C. 
 
 
2.2.8.4 Real time polymer chain reaction (qRT-PCR) 
 
 Real time PCR (qRT-PCR) was carried out utilizing 20µl of PCR reactions for each 
sample which is prepared as following; 10 µl master mix of SyBr Green (SensiFAST
TM
) 
real time PCR kit (Bioline, UK) aliquot in 96 well PCR plate, 1.6 µl of primer mix 
consisting of the forward and reverse primers each present at a concentration of 5 µM, 
sterile distilled water 7.4 µl and 1 µl of cDNA. An RT-PCR film seal was properly placed 
and the plate spun briefly to insure that the liquid placed in the bottom of the wells and 
then the plate was placed on the qRT-PCR machine (CFX 96, Bio-Rad) run for specific 
number of cycling and temperature. 
 
 
2.2.9 LPS uptake assay 
 
THP-1 cells at density 1x10
5
 cells /ml were differentiated in 8 wells chamber slides (Lab 
tech, Millipore) with PMA (5 ng/ml) for 72 hrs then the media was removed and chamber 
slide washed with sterile PBS and cells were stimulated with media free serum for 
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another 24 hrs. Afterward cells were stimulated with LPS 055: B5 100 ng/ml labelled 
FITC (Sigma Aldrich, UK) in present and absence of PARP inhibitor PJ-34 10 µM 30 
mins prior to stimulation with LPS for (15, 30, 60 and 120 mins). The slide then washed 
with PBS and fixed with 4% paraformaldehyde for 15 mins on ice and washed with PBS 
and air dried in dark. Mounting media was placed on the slide then cover with cover slip 
with consideration of no air bubble trapped between the slide and the cover slip. The 
cover slip sealed with Marabu Fixogum rubber cement (Marabuwerke GmbH & Co. KG, 
Tamm, Germany). The slide was examined and imaged with Nikon (wide field 
microscope). 
 
 
2.2.10 Nitric oxide determination by Gries reaction 
 
Nitric oxide (NO) production reflect an important immunological response, which can be 
detected by chemiluminescence, citrulline assay and electron paramagnetic resonance 
(EPR).The Griess reagent is the most common technique used to detect NO in biological 
samples and this system described for the first time by Griess in 1879 and this system 
based on the fact that NO degrades in aqueous solution to nitrite (NO2
-
) one of two 
primary stable formation of NO. This system is used a chemical reaction of sulfanilamide 
and N-1-napthylethylenediamine dihydrochloride (NED) under acidic conditions and can 
be used to detect NO in biological samples like tissue culture medium and plasma. Nitrite 
is detected in samples by formation red pink colour which formed initially as a reaction 
between the NO2
-
 in the biological sample with sulphanilimide which form diazonium salt 
and with adding the azo dye agent (NED) the pink colour develope. 
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2.2.10.1 Procedure for determination of nitrite concentration 
 
A stock nitrite standard solution of a 100 μM nitrite solution (Promega; CAT#G2930) 
was prepared by diluting 0.1 M nitrite standard 1:1000 in the RPMI-1640 medium, 
supplemented with 10 % FCS. Serial dilution of twofold were performed in triplicate to 
generate the nitrite standard reference curve (100, 50, 25, 12.5, 6.25, 3.13 and 1.56 μM), 
then 50 μl of the samples were dispensed in triplicate in wells allocated for the samples. 
50 μl of the sulfanilamide solution (Promega; CAT#G2930) was added to all 
experimental samples wells by using a multichannel pipetter, and incubated for 10 mins at 
room temperature and finally  50 μl of N-1-napthylethylenediamine dihydrochloride 
(NED) solution (Promega; CAT#G2930) was added to all wells and incubated for 10 
mins at room temperature and protected from light. Absorbance was measured using a 
Versa Max microplate reader equipped with 520 nm and 550 nm filters. 
 
 
2.2.11 Co-Immuno-precipitation assay 
 
To study the interaction of CD14 and MARCO receptors on PMA-differentiated THP-1 
cells in presence and absence of PJ-34 in response to LPS 100 ng/ml. Cells were lysed as 
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described in section 2.2.4 and 1 mg cell lysate of each sample was incubated with 4 µg of 
anti-CD14 antibody overnight at 4°C. Afterward 40 µl of protein A/G agarose (Santa 
Cruz,) was added and kept overnight on a rotator at 4°C. The samples were spun down for 
30 seconds at 1500 rpm and the supernatant was discarded. The beads then were washed 
three times using cold PBS. Loading buffer containing DTT 50 µl were added to each 
sample and then boiled to 90
o
C for 5 mins. Then 20 µl of each sample was loaded in each 
well of SDS-PAGE gel and they were left for 30 mins at 50 V and the rest was 120 V. 
The gel was then transferred to PDVF membrane for 1 hr. and 20 mins at 100 V on ice. 
The membranes were then blocked 5 % of non-fatty milk for 1 hr. followed by washing in 
tPBS for 30 mins. The membranes were then incubated either with anti-CD14 or anti- 
MARCO for 3-4 hrs. The membranes washed with tPBS three times 10 mins each with 
changing the tPBS. The membranes were then incubated with secondary goat anti-mouse 
antibody for 30 min followed by washing with tPBS for three times each time for 10 mins 
with changing the tPBS. The membranes were finally scanned using the Odyssey Infrared 
Imaging System from Li-cor Biosciences. 
 
 
2.2.12 Proteomic analysis of THP-1 cell line 
2.2.12.1 Preparation of cell lysate 
 
THP-1 cells cultured and differentiated in 100 mm cell culture dishes (Nunc, UK) with 
PMA (5 ng/ml) for 72 hrs, and 1×10
7
 cells were used per sample for cell lysate. Cells 
were detached from culture dishes by accutase, counted and washed with PBS as 
described earlier (Section 2.2.1.2). Cell lysate was prepared by resuspended the cell pellet 
in 1 ml of the protein extraction buffer prepared in the Lab. (Urea 7 M, Thiourea 2 M, 
CHAPS 4%, 50 mM Tris base, all reagents were purchased from (Sigma Aldrich, UK). 
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Cells were vortexed and kept on ice for 5 min. Cell lysates were spun at 20,000 ×g for 20 
mins; supernatant was transferred into prechilled clean micro centrifuge tube and stored at 
-80
0
C until further used. Protein concentration of cell lysates was determined with 
Bradford assay using Bradford reagent (Sigma Aldrich, UK) following manufacturer's 
instructions. 
 
 
2.2.12.2 First dimensional gel Isoelectric electrical focusing (IEF) 
 
Immobiline dry strip gel pH 4-7NL, 17cm (Bio-Rad, UK) used in this study was 
rehydrated in immobiline dry strip reswelling tray. The dry strip was rehydrated overnight 
at room temperature in 300ul of rehydration buffer (Urea 7 M, Thiourea 2 M, CHAPS 
4%, protease inhibitor cocktail 1X, DTT 20 mM, ampholyte 1%, bromophenol blue 0.1 
%, SDS 0.05%) containing 50 μg of sample proteins. The IPG strip was covered by using 
2~3ml of (immobiline Plus One dry strip cover fluid) (GE Healthcare Bio-Sciences AB). 
After rehydration, the IPG strip was briefly rinsed with double distilled water to remove 
crystallized urea.  
 Isoelectric focusing step was performed in clean IPG-Phor washed and cleaned with Strip 
holder cleaning solution (GE Healthcare Bio-Sciences AB). The Etten IPG Phor mainfold 
was covered with 108 ml of Immobiline PlusOne dry strip cover fluid and  each 
rehydrated strips were placed in individual lanes of Ettan IPG strip holder (GE Healthcare 
Bio-Sciences AB) under the fluid using tweezers with keep the positive end of the strip 
towards the anode end of the mainfold. Hydrated filter wicks in cathode (-ve) end were 
hydrated with 150 µL of 100 mM DTT placed between the IPG strips and the electrodes. 
Whereas, the anodic (+ve) filter wick was hydrated with 150 µL double distilled water. 
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The lid was closed and IPG-Phor programme was run according to the programme below. 
A holding step at the end was added to so that it could be left overnight. 
Step1          200 V           500 V hrs  
Step2          500 V           500 V hrs  
Grad3       1000 V           800 V hrs  
Grad4    10,000 V      16,500 V hrs  
Step5     10,000 V        6,200 V hrs  
Step6          200 V                  24 hrs  
At the end of the programme, computer was disconnected and IPG-Phor was stopped. The 
paper wicks were removed with tweezers and discarded. The IPG strips were placed in a 
petri dish, after rinsed deionized water, labelled and stored at –80
0
C for later use. 
 
 
2.2.12.3 SDS-PAGE preparation 
 
For second dimension gel electrophoresis PROTEAN® II System (BIO-RAD, UK) was 
used. The outer glass plate size 20x20 and the inner glass plate 16x20 were washed with 
hot water and detergent and rinsed with deionized water and cleaned with 70% ethanol, 
dried, assembled with 1.5 mm spacers and clipped into the casting frame according to 
Bio-Rad manufacture instruction. Assembled glasses were checked for any leakage by 
pouring deionized water between the two glass plates. Non-leakage system, the water 
tipped and the system was dried with hair dryer airflow. The gel solution 12% SDS 
PAGE was made with water, 1.5 M Tris-HCl and 30% acrylamide, the solution was 
placed in a flask and degassed for 15 minutes at ambient temperature. The TEMED, APS 
and SDS were added and mixed by stirring. The gel solution was poured in between glass 
plates, avoiding any air bubbles, to level 1 cm below the inner glass plate. The top of the 
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gels was covered with (water saturated isopropanol 80%) and allowed to polymerise 
overnight. 
2.2.12.4 Equilibration of the IPG strips  
 
In order to perform the second dimension gel run, IPG strips subjected to isoelectric 
focused proteins should be equilibrated and reduced. For each strip 20 ml of frozen 
equilibration buffer thawed. In one tube of 10 ml equilibration buffer 100 mg of DTT was 
added while in the other 10 ml equilibration buffer 250 mg of iodo-acetamide and left to 
mix gently. The strip incubated in equilibration buffer containing 1% DTT for 20s min 
and after that incubated with equilibration buffer that contain 4% iodo-acetamide for 
another 20 min. Both incubation steps were carried out at room temperature. The IPG 
strips were rinsed with 1X electrophoresis buffer and placed on the top of SDS-PAGE. 
 
 
2.2.12.5 Assembly and running of second dimensional gel 
 
Agarose sealing solution was heated to liquefy. IPG strips were trimmed from each end 
up to 0.6 cm thus giving a final length of 15.8 cm. A small square of paper electrode wick 
(2×3 cm half thickness) was loaded with 10 µl of molecular weight marker and placed on 
the top of left hand corner of the gel. IPG strip was placed on the top of 12% SDS PAGE 
gel with the acidic side facing the glass plate hinge and sealed with agarose solution, 
avoiding any air bubbles to be trapped between the strip and the top of the gel. 
Electrophoresis tank was filled with 2.5 L of gel running buffer. The gels with strips were 
removed from the casting assembly and clipped onto the core unit of the protean tank. 
The core unit was lifted into the tank, running buffer was added to the top of the upper 
buffer chamber and air bubbles were removed with a glass rod. The lid was fitted to the 
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tank and cables were connected to the power PAC (Bio-Rad, Power Pac 1000). 
Electrophoresis was carried out first at 50 volts for 30 minutes and then at 150 volts for 
about 4.5 hours or until the bromophenol blue dye front had reached to the lower end. The 
core unit was then removed from the tank, disassembled and gels were removed from the 
clamps. The spacers were loosened and one edge of the glass plate was lifted up with a 
spatula. Gel was placed in a glass container containing gel fixing solution. 
 
 
2.2.12.6 Protein visualisation  
 
For visualization of protein spots, a modified silver staining protocol was extracted from 
(Gromova & Celis, 2006). Gels were washed with deionized water and fixed overnight in 
fixing solution. After that the gel washed with 20% methanol for 20 minutes with 
changing the wash buffer three times. The gel sensitized with 0.02% sodium thiosulfate 
for 1 min and washed with deionized water twice, each for 1 minute. Staining was done 
with 0.2% silver nitrate solution for 20 mins followed by a careful wash twice with 
deionized water for a maximum of 1 min each time. The gels were developed with 
sodium carbonate 6% and 0.0004 sodium thiosulfate for 2-5 mins until spots appear, and 
reaction was stopped by add 12% acetic acid with constant shaking for 10 mins. The gels 
were stored in 1% acetic acid at 4
0
C. 
 
 
2.2.12.7 Gel scanning and spot analysis 
 
Gels were scanned using the scanner (Epson image scanner III) with Lab Scan 6.0 
software. First the scanner was calibrated and set to use the transparent settings at 300 dpi 
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with the blue filter. The scanner surface was cleaned with 70% ethanol and a little purite 
water was poured on the surface. The gel was placed directly on the scanner, previewed 
and air bubbles were smoothed out if any. Scan area of the gel was then selected and 
scanned. Gel images were saved as mel and tif files. Scanned gel images were 
characterised with Progenesis SameSpot software package (Nonlinear Dynamics Limited, 
UK). 
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CHAPTER 3: The role of the poly (ADP-ribose) polymerase inhibitor 
PJ-34 on the expression of LPS receptors on THP-1 cells 
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PART Ι: Immunofluorescence analysis of poly (ADP-ribose) polymer 
synthesis PMA-differentiated THP-1 cells in presence and absence of 
PJ-34 in response to H2O2 
 
3.1.1 Introduction  
 
Immunofluorescence (IF) or cell imaging techniques depend on the use of antibodies 
(Abs) to label a specific antigen with a fluorescent dye (termed fluorophores or 
fluorochromes), and require that cells be fixed.  Cells are incubated, with antibody, 
allowing accurate detection of cognate cellular antigens. This is achieved by estimating 
the relative antibody affinity.  Both monoclonal (mAb) and polyclonal Abs can be used to 
localise the antigen of interest.  mAbs are more specific than polyclonal Abs,  recognizing 
a specific epitope on an antigen.  However, cross-reactivity of mAbs may still occur 
because the epitope recognised can be present on other proteins. Polyclonal Abs are 
generally less specific than mAbs, since they constitute a mixture of antibodies, each 
recognising a different epitope.  
The nuclear enzyme PARP-1 converts β-nicotinamide adenine dinucleotide (NAD+) into 
polymers of poly (ADP ribose) (PAR), which participate in regulated nuclear homeostasis 
Schreiber et al., (2006). In the present study monoclonal anti-PAR antibody clone 10H 
has been used to detect the presence of PAR polymer,  with  confocal microscopy used to 
visualize the presence of PARP-1 activity in the human acute monocytic cell line THP-1  
(Barbierato et al., 2012). Previous studies have indicated that, when activated,  PARP-1 is 
involved in a cytotoxic pathway associated with tissue injury or inflammation, as 
evidenced by direct protein interaction with transcription factors (NF-kB) and/or poly 
(ADP-ribosyl)ation of transcription factors. PARP-1 is a multifunctional protein which 
can regulate transcription in a variety of ways, and transcriptional control of the 
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inflammatory response. Primarily, PARP adds ADP-ribose units to transcription factors, 
preventing them re-binding to DNA. Modulation of transcription factor binding activation 
takes place via   pathways for signal transduction and gene expression (Hao & O’Shea, 
2012). The purpose of this chapter was to detect the activation of PARP-1 in THP-1 cells 
upon oxidative stress and synthesis of poly (ADP-ribose) polymer in response to H2O2. 
The role of the PARP inhibitor PJ-34 in protection against DNA damage and the effect of 
PJ-34 on THP-1 cells viability were assessed.  
 
 
3.1.2 Method and materials 
 
3.1.2.1 Confocal microscopic analysis 
 
Confocal microscopy was used to detect PAR polymer upon PARP-1 and DNA damage 
of THP-1 cells.THP-1 cells were differentiated 5 ng/ml of PMA for 72 hours and then 
cells were treated with 0, 50, 100 and 250 µm H2O2 for 10 min and cells fixed and stained   
as described in section 2.2.4.2. Confocal images were acquired by laser-scanning confocal 
microscopy with an Olympus microscope equipped with a Radiance 2000 confocal setup 
(Bio-Rad), as described in section 2.2.5.1. 
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3.1.2.2 The toxicity of PJ-34 on THP-1 cells 
 
The cytotoxicity effects of PJ-34 on THP-1 cell viability were determined as following; 
THP-1 cell (5x10
4
cell/ml) incubation with 5, 10, 20 and 30 µM PJ-34 for 48 hrs and the 
viability of THP-1 cells were assessed as mentioned in section 2.2.1.4. 
 
 
3.1.3 Results 
 
3.1.3.1 Poly ADP-ribose synthesis in THP-1 cells 
 
Oxidative damage to DNA elicited by oxidative agents such as H2O2, either at low or high 
concentration, is able to cause single DNA strand breaks. These activate PARP-1, which 
is a damage-responsive enzyme with a role in repair of single-stranded DNA (ssDNA), 
leading to poly-ADP-ribose synthesis (Fisher et al., 2007; Heeres & Hergenrother, 2007; 
Krietsch et al., 2012); PARP-1 is the major PAR-producing enzyme in eukaryotes. In this 
experiment, H2O2 was used to induce DNA-damage-dependent activation of PARP-1 and 
PAR polymer formation. Poly ADP-ribosylation was detected using indirect IF. THP-1 
cells were treated with 50, 100 and 250 µM H2O2. Controls comprised untreated samples.  
 
 
3.1.3.2 Poly ADP ribose synthesis in THP-1 cells after treatment with 
different concentrations of H2O2 
 
Fluorescent images of THP-1 cells were obtained with a Bio-Rad confocal microscope 
(Fig. 3.1 A). Control cells, untreated with H2O2, did not show any formation of PAR 
polymer. However, in cells treated with 50 µM H2O2 (Fig. 3.1 B) a small amount of PAR 
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polymer was detected, as shown by the presence of fluorescence foci in the nucleus. 
Following treatment with 100 µM H2O2, the amount of PAR polymer within nuclei 
significantly increased (Fig. 3.1 C). However, treatment with 250 µM H2O2 did not 
significantly raise PAR polymer synthesis (Fig. 3.1 D). This indicates the depletion of the 
cell energy. Therefore, maximal PAR polymer formation is induced in PMA-
differentiated THP-1 cells after treatment with 100 µM H2O2, so this concentration was 
used in all experiments (Fig.3.2). The presence of the PAR localization is reveal the 
distribution of chromatin-bound, PARP-1, PAR associated among various fraction 
sheared and nuclease-digested THP-1 cell chromatin in response to H2O2. The increase in 
the size of the nuclei suggest that H2O2-induce cell damage which associated with 
induction of various cell death program that could be involved directly in body defense 
reaction. The viability of PMA-differentiated THP-1 cell were examined in response to 
100 MH2O2 with 4% exclusion trypan blue.  
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Figure 3-1: Poly ADP-ribose formation in PMA-differentiated THP-1 cells after treatment with 
different concentrations of H2O2. THP-1 cells were differentiated with 5 ng/ml phorbol 12-myristate 
13-acetate on a cover slide for 72 hrs. Incubation of cells was then carried out with and without different 
concentrations of H2O2 (50, 100 and 250 µM) for 15 mins at 370C. The cells were washed with 
PBS/BSA and cells were fixed with 4% (w/v) paraformaldehyde for 20 mins on ice, then permeabilised 
with 0.01% Triton X100 for 10 mins Cells were washed and incubated with primary  monoclonal 
antibody mouse anti-human PAR polymer (10H), followed by secondary antibody goat anti-mouse IgG 
labelled FITC. Green fluorescence images were obtained using a confocal microscope (Bio-Rad 
Radiance 2000) and analysed with Image-J software version 1.50g (National Institute of Health, USA). 
PAR polymers are indicated with a white arrow. Panel A: Fluorescence image of untreated cells. Panel 
B: Fluorescence image of cells treated with 50 µM of H2O2. Panel C: Fluorescence image of cells treated 
with 100 µM of H2O2. Panel D: Fluorescence image of cells treated with 250   µM of H2O2. 
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3.1.3.3 The capacity of PJ-34 in lowering poly ADP ribose polymer  
synthesis in THP-1 cell following treatment with 100µM of H2O2 
 
Monocytes differentiated into macrophages, they are the resident tissue phagocytes and 
sentinel cells of the innate immune response. THP-1 cells differentiated with PMA 
induced changes in cell morphology and strong adhere to the surface indicating of 
differentiation. These cells shows increased in cytoplasmic to nuclear ratio, increased 
mitochondrial and lysosomal numbers. Macrophages shows resistance to apoptotic 
stimuli, a high phagocytic and expressed a cytokine profile that resembled in response to 
 
Figure 3-2: The effect of H2O2 on poly ADP-ribose formation in PMA-differentiated THP-1 cells. 
The percentage of integrated fluorescence intensity which is proportional to the poly 
ADP-ribose) synthesized upon treatment with different concentration of H2O2, was 
determined using the ImageJ software package (National instates of health, USA). The 
fluorescence intensity obtained from cells treated with 100 µM H2O2 was set at 100%. 
The results represent the mean ± S.D. for three independent experiments. 
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TLR ligands, in particular with marked TLR2 responses(Daigneault et al., 2010). This 
experiment was design to assess the capacity of PJ-34 to lower the level of PAR polymer 
formation induced by H2O2. This is desirable, since PAR polymer, a product of PARP-1 
activity, is a cell death signal (Andrabi et al., 2006).. Samples were observed using a Bio-
Rad 2000 confocal scanning laser microscope (Bio-Rad, Inc, Hemel Hemstead). 
As shown in figure 3.3, the control cells treated with 100 µM H2O2 only. (Fig. 3.2 A) The 
effect of 1 µM PJ-34 (Panel B) in THP-1 cells was limited, since the cells still produced a 
considerable amount of PAR polymer. PAR polymer, present in the nucleus, is 
manifested by fluorescence foci, indicated in figure 3.2 by a white arrow for comparison 
with control (cells treated with only 100 µM H2O2, panel A). THP-1 cells treated with 10 
µM PJ-34 showed a significant decrease in PAR formation (Fig. 3.3, panel D) and the 
cells formed few fluorescence foci compared to control cells treated with 100 µM H2O2 
only. PAR polymer was not generated by cells treated with 20 and 30 µM PJ-34 (Fig. 3.3, 
panels E and F). This result demonstrates that PJ-34 is a potent inhibitor of poly ADP-
ribosylation. It was observed that inhibition of poly ADP-ribosylation increased 
proportionately with increasing concentration of PJ-34. Figure 3.4 shows the percentage 
of integrated fluorescence intensity of PAR polymer produced in response to 100 µM 
H2O2.   PAR polymer formation in cells was inhibited by 25% ±  and 69% ± when cells 
were treated with 1 and 5 µM PJ-34 prior to stimulation with 100 µM H2O2. Cells treated 
with 10 µM PJ-34 displayed decreased PAR polymer formation, peaking at 9%. Cells 
treated with 20 and 30 µM PJ-34 exhibited an integrated fluorescence density of only 2% 
and 1% respectively.
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Figure 3-3: The effect of PJ-34 on poly ADP-ribose synthesis in PMA-differentiated THP-1 cells 
stimulated by H2O2. THP-1 cells were differentiated with PMA 5 ng/ml for 72 hrs. The cells were then 
incubated without or with 1, 5, 10, 20, 30 µM PJ-34 PARP inhibitor for 30 mins prior to stimulate with 100 µM 
of H2O2   for 15 min at 37
0
C. The cells were washed with PBS/BSA and Cells were fixed with 4% (w/v) 
paraformaldehyde for 20 mins on ice, and then permeabilised with 0.01% Triton X100 for 10 mins. Cells were 
washed and incubated with primary  monoclonal antibody mouse anti-human PAR polymer (10H), followed by 
secondary antibody goat anti-mouse IgG labelled FITC. Green fluorescence intensity was obtained using a 
confocal microscope (Bio-Rad Radiance 2000). PAR polymers are indicated with a white arrow. Panel A: 
Fluorescence intensity of cells treated with 100 µM of H2O2. Panel B: Fluorescence intensity of cells treated 
with 1 µM PJ-34 and 100 µM of H2O2. Panel C: Fluorescence intensity of cells treated with 5 µM PJ-34 and 100 
µM of H2O2.  Panel D: Fluorescence intensity of cells treated with 10 µM PJ-34 and 100 µM of H2O2. Panel E: 
Fluorescence intensity of cells treated with 20 µM PJ-34 and 100 µM of H2O2. Panel F: Fluorescence intensity of 
cells treated with 30 µM PJ-34 and 100 µM of H2O2. 
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3.1.3.4 The effect of different concentrations of PJ-34 on THP-1 cell 
viability 
Figure 3.5 shows that PJ-34, at concentration of 5 and 10 µM, had no effect on THP-1 
cell viability at 24 and 48 hours from adding the inhibitor. In contrast, 20 and 30 µM PJ-
34 significantly reduced THP-1 cell viability (p < 0.05). 20 µM PJ-34 reduced THP-1 cell 
viability by 20% and 35% at 24 and 48 h from incubation of the cells with PJ-34 
respectively (Fig. 3.5). Furthermore, 30 µM PJ-34 also reduced the viability, the lowest 
viability peaking at 55% and 40% at 24 and 48 h from seeding time respectively (p < 
0.05). Therefore the concentration of 10 µM PJ-34 to be used as a higher concentration 
 
Figure 3-4: The effect of PJ-34 on poly ADP-ribose synthesis in PMA-differentiated THP-1 cells stimulated 
by H2O2. The fluorescence intensity obtained from PMA-differentiated THP-1 cells which is proportional to the 
poly ADP-ribose synthesized upon treatment with   different concentration of PJ-34, is shown,   following 
stimulation with 100 µM of H2O2, Data were analysed using the ImageJ software package (National instates of 
health, USA). The fluorescence density for cells treated with 100 µM H2O2 was set at 100%. The results represent 
mean integrated fluorescence intensity (counts/µM
2
) ± S.D. for three independent experiments. 
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without affecting the cell viability when incubate with cells up to 48 hrs. Figure 3.6 shows 
cell viability of THP-1 cells treated with 10 µM PJ-34 for 48 h, the viable cells remain 
unstained, whereas the dead cells stained blue colour.  The data results suggest that  
3.1.4 Conclusion  
 
In this set of experiments it has been shown that PARP-1 activated upon treatment of 
THP-1 cells with H2O2, which caused DNA damage and formation of ADP-ribose 
polymers. A concentration of 100 µM H2O2 was used as the highest concentration 
inducing DNA damage and induces maximal PAR polymer formation. The PJ-34 PARP 
inhibitor afforded a high level of protection against DNA damage induced by H2O2 10 
µM PJ-34 was the highest concentration that blocked PARP activation upon H2O2-
 
 
Figure 3-5: The effect of PJ-34 on THP-1 cell viability. THP-1 cells were cultured at a density of 
5X10
4
 cells/ml in RPMI-1640, supplemented with 10% (v/v) FCS, at 37
o
C, in a humidified atmosphere 
with 5% (v/v) CO2.  After 24 hrs, different concentrations of PJ-34 (0, 5, 10, 20 and 30 µM) were added 
to the cell cultures. Control samples were left untreated.  THP-1 cells were incubated at 37
0
C with 
different concentrations of PJ-34 for the indicated times. The significance different P < 0.05 vs. control 
(cells) is indicated with (*) and NS no significant diference. The data presented are the mean ± SD of 
three independent experiments. 
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induced DNA damage. Treatment of the cells with 20 and 30 µM PJ-34 had a strong 
adverse effect on THP-1 cell viability. Therefore, 10 µM PJ-34 was identified as the 
highest concentration of PJ-34 to inhibit PARP-1 activity in response to DNA damage 
without affecting cell viability, and this amount was used in subsequent experiments.  
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PART II: The role of PJ-34 in the expression of LPS receptors on 
differentiated THP-1 cell in response to LPS. 
3.2.1 Introduction 
 
The innate immune system utilizes protein receptors that are expressed on 
monocytes/macrophages, dendritic cells and some other cell types, including epithelial 
and endothelial cells. Pattern recognition receptors (PPRs); include Toll-like receptors 
(TLRs), RIG-I-like receptors, NOD-like receptors, and C-type lectin receptors. 
Lipopolysaccharide (LPS) is the major constituent of the outer cell wall of gram-negative 
bacteria and is the principal mediator of inflammatory responses to these pathogens. LPS 
is recognized by number of serum and cell surface PPRs, which cooperate to induce LPS 
signaling. The LPS signaling pathway is mediated through interaction between the acute 
phase protein CD14 and LPS-associated co-receptors. CD14 is unable to transduce LPS 
signaling alone, because it lacks a trans-membrane domain (Antal-Szalmaset al., 2000). 
Therefore, CD14 functions by binding to LPS and transferring it to other cell surface 
receptors to trigger LPS signaling (Hazoit, et al., 1996). LPS binding protein (LBP), a 
lipid transfer protein, recognizes and binds the lipid A portion of LPS and augments the 
immune response to LPS. LBP is an acute-phase protein that is synthesized principally in 
hepatocytes, and its production is greatly increased by stimulation with interleukin (IL)-1 
or IL-6 (Gutsmann et al., 2001; Schröder & Schumann, 2005) . Consequently, elevated 
LBP serum levels have been described in  severe sepsis (Blairon et al., 2003). 
Toll-like receptor 4 (TLR4) is associated with CD14 in inflammatory responses to LPS. 
TLR4, a type 1 trans-membrane receptor, appears to associate with myeloid 
differentiation protein-2 (MD-2) on the cell surface. MD2 and TLR4 are involved in 
binding LPS, and make up the LPS receptor complex involved in the cellular recognition 
of and signaling by LPS (Miller et al., 2005). Recent studies have implicated high-
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mobility group box 1 (HMGB1), a nuclear protein with inflammatory cytokine activities, 
in stimulating cytokine release (Andersson et al., 2002; Yang et al., 2002; Yamada & 
Maruyama, 2007). HMGB1 is released during cell injury and necrosis, or is actively 
secreted during immune cell activation, making it an important player in both sterile and 
infection-associated inflammation. To date, eight candidate receptors have been 
implicated in mediating biological responses to HMGB1. These are the receptor for 
advanced glycation end products (RAGE),  TLR2, TLR4, TLR9, Mac-1, syndecan-1, 
phosphacan/protein-tyrosine phosphatase-ζ/β, and CD24. TLR4, a pivotal receptor for 
activation of innate immunity and cytokine release, is required for HMGB1-dependent 
activation of macrophage TNF-α release, but the mechanism of HMGB1-dependent 
cytokine release is unknown (Yang et al., 2002; Harris & Andersson, 2004; Yang & 
Tracey, 2010). 
Monocytes express TLR2 which recognize products from gram negative and gram 
positive bacteria(Schaaf et al., 2009). MD-2 physically associates with both TLR4 and 
TLR2, but the association with TLR2 is weaker than with TLR4. Also, MD-2 and TLR2 
and TLR4 enhance each other's expression(Dziarski & Gupta, 2000). The expression of  
TLR2 on monocytes up-regulated in response to LPS (Ashida et al., 2005). The TLR2-
mediated response to stimulation was dependent on NF-κB  signalling, results in releasing 
of  proinflammatory cytokines such as TNF-α and IL-1β (Chowdhury et al., 2006). 
Scavenger receptors (SR) are another family of receptor proteins expressed on 
macrophages and recognize and bind both endogenous and exogenous molecules. SRs are 
structurally unrelated receptors functionally defined by their ability to recognise modified 
low-density lipoprotein (Mukhopadhyay and Gordon, 2004; Peiser et al., 2002). 
Macrophage receptor with collagenous domain (MARCO), a class-A SR, plays a pivotal 
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role in the transduction signaling of LPS via TLRs (Peiser et al., 2002; Bowdish & 
Gordon, 2009).  
This study investigated the expression of innate recognition receptors expressed on 
differentiated and undifferentiated THP-1 cells, with or without stimulation with LPS. 
The effect of PJ-34 PARP inhibitor on the expression of these receptors in response to 
LPS was additionally investigated. 
 
 
3.2.2 Methods 
3.2.2.1 Cell differentiation 
 
To enhance the expression of LPS recognition receptors, THP-1 cells were induced to 
become macrophage-like cells with different concentrations of PMA and Vit.D3 (see 
section 2.2.2.3). 
 
 
3.2.2.2 Cell culture assay 
Undifferentiated and differentiated THP-1 cells were grown in RPMI-1640 medium 
containing 10 % FCS in 50 ml cell culture flasks at 37
o
C in a humidified 5 % CO2 
incubator. 
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3.2.2.3 Flow cytometry 
 
Differentiated THP-1 cells were detached from the cell culture petri dish using accutase 
and undifferentiated THP-1 cells were washed with PBS, primary antibodies for anti-
(CD14, TLR2, TLR4 and SR-MARCO) followed by incubation with secondary antibody 
conjugated FITC. Sorting was performed on a FACS Aria cell sorter (Becton Dickinson 
Biosciences), as outlined in section 2.2.3.1. 
 
 
3.2.3 Results 
 
3.2.3.1 Assessment of the expression of CD14, TLR2, TLR4 and 
MACRO in THP-1 cell in presence and absence of LPS 
 
Cell lines provide an excellent and convenient tool for studying questions related to 
variety biological topics, including LPS recognition and signaling in septic shock.  The 
THP-1 cell line is  considered   representative of the early stage of monocytic 
differentiation (Tsuchiya et al., 1980; Qin, 2012). THP-1 cells have been used to study the 
expression of the LPS recognition receptors CD14, TLR4, TLR2 and the macrophage SR 
MARCO (Diya Zhang et al., 2008). Cytokine profiles and the role of PJ-34 in regulating 
cytokine expression after LPS stimulation have also been studied (Pyriochou et al., 2008; 
Scalia et al., 2013; Wang et al., 2013). 
The level of expression of protein receptors essential for LPS recognition was assessed in 
native THP-1 cells in the presence and absence of 100ng/ml LPS, with cells exposed to 
LPS for 4h hours. The cells were analysed on a BD Aria flow cytometer (Becton 
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Dickinson Biosciences) and the results analysed with Flow-Jo software. Antibody 
isotypes (negative control) used for detecting expression of the proteins studied  are 
shown in Figure 3.7 Untreated cells (Fig. 3.7 A) showed that THP-1 cells express 
moderate levels of cell surface CD14 , while TLR2, TLR4 and MARCO were expressed 
at low levels. However, after LPS stimulation for 4 h, the cells displayed a slight increase 
in CD14, TLR2 and TLR4 expression (Fig. 3.7 A, C and D). MARCO, by contrast, 
decreased upon stimulation with LPS (Fig. 3.7 B). 
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3.2.3.2 Differentiation of THP-1 cells induced by PMA and vit.D3 
 
The action of differentiation inducers was studied to investigate the effect of PJ-34 on 
LPS receptor expression and cytokine profiles in THP-1 cells. In these experiments, 1, 
 
Figure 3-6: The expression of CD14, MARCO, TLR4 and TLR2 in THP-1 cells, assessed by flow 
cytometry. THP-1 cells were incubated with or without 100 ng/ml of LPS at 37
0
C in RPMI 1640 media 
supplemented with 10% (v/v) FCS for 4 hrs. Cells were washed and incubated with primary mouse anti-human 
(CD14 or MARCO or TLR4 and TLR2) monoclonal antibody for 45 mins, washed again, and then incubated 
with secondary antibody (goat anti-mouse IgG labelled FITC). IgG1 was used as the isotype for CD14 and 
MARCO, while IgG2b was used as the isotype for TLR2 and TLR4. Samples were analysed using an Aria 
flow cytometer (Becton Dickinson Biosciences) and Flow-Jo Vx.0.7 flow cytometry analysis software (Flow-
Jo LLC, Ashland, USA) was used to analyse the data. A: represents CD14 expression B: represents MARCO 
expression. C: represents TLR2 expression and D: represents TLR4 expression. Black colour histograms 
represent isotypes. Red colour histograms represent receptors expression on untreated cells. Blue colour 
histograms represent receptor expression on THP-1 cells treated with LPS 100 ng/ml. 
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25-dihydroxyvitamin D3 (Vit.D3) and phorbol 12- myristate 13-acetate (PMA) were used 
to induce cell maturation. Figure 3.8 shows THP-1 cells in culture media RPMI-1640 
supplement with 10% FCS. In the presence of PMA, the cells were spindle-like and 
strongly adhered to surfaces in comparison with cells treated with vit. D3 caused a change 
in cell shape to that typical for macrophages and the cells were only slightly adhering. 
 
Since maturation of monocytes is accompanied by changes in the levels expression of 
certain cell-surface markers, the effect of PMA and vit.D₃ on the expression of CD14, 
MARCO, TLR2 and TLR4 was examined (Fig. 3.8 and 3.10).  Maturation of THP-1 cells 
was induced, with the cells exposed to different concentrations of PMA (0, 5, 10, 20 and 
30 ng/ml) and vit.D₃ (0, 50, 100, 150 and 200 nM) for 72 hrs. Cell-surface expression of 
CD14, MARCO, TLR2 and TLR4 was detected on stained cells by indirect 
immunofluorescence. The cells were incubated with the correct concentration of  specific 
primary monoclonal mouse anti- human antibodies for CD14, MARCO, TLR2 and TLR4 
for 45 min, followed by  incubation  with goat anti mouse labelled FITC for 30 minutes. 
Figure 3-7: Differentiation of THP-1 cells with Vit.D3 and PMA. Phase contrast photographs. (A) 
Untreated THP-1 cells, (B) differentiated THP-1 cells treated with 100 nM of vit.D3 for 72 hours and (C) 
THP-1 cells treated with PMA 5 ng/ml for 72 hours. 
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The expression of protein receptors was detected using an Aria flow cytometer/sorter   
(Becton Dickinson Biosciences) with the data analysed using Flo-Jo software.  
Differentiation of THP-1 cells with PMA and vit.D₃, up-regulate the expression of CD14, 
MARCO, TLR2 and TLR4; each of PMA and vit.D₃ had a different effect on the 
expression of each protein. The highest level of expression of all the proteins was 
detected in THP-1 cells treated with PMA 5 ng/ml and vit.D₃100 nM (Fig. 3. 8 & Fig. 
3.10). 
Figures 3.8 A, show that the expression of CD14 in PMA-differentiated THP-1 increased 
about tenfold. Whereas, vit.D₃ increased the expression of twice the amount of CD14 as 
that in THP-1 cells differentiated using PMA (Fig. 3.10 A). MARCO expression 
increased one fold in PMA-differentiated THP-1(Fig. 3.8 B) while, the cells differentiated 
with vit.D₃ showed an approximately eight fold increase of MARCO expression (Fig. 
3.10 B). The expression of TLR4 and TLR2 in PMA-differentiated cells increased four 
and three fold respectively (Fig. 3.8 C & D). However, the expression of TLR4 and TLR2 
in cells differentiated with vit.D₃ was much higher than in cells differentiated with PMA, 
roughly about 6 folds and 5 fold, respectively (Fig. 3.10 C & D). The FMI CD14, 
MARCO, TLR4 and TLR2 expression on THP-1 cells differentiated with PMA and 
vit.D₃ are represented in fig.3.9 and fig. 3.11. Subsequently, experiments of time course 
series was conducted for (24, 48, 72 and 96 h of differentiation), using PMA 5 ng/ml and 
Vit.D3100 nM, was used to detect CD14, TLR4, TLR2 and MARCO expression in the 
cells. Receptor expression steadily increased over the time, peaking at 72 hrs, and then 
decreased at 96 hrs of differentiation 
 (Fig. 3.12), the results show that cells differentiated with vit.D3 show higher expression  
of the receptors compared to PMA differentiated cells represented as bars (Fig. 3.12). 
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Figure 3-8: The effect of different concentrations of PMA on the expression of CD14, MARCO, 
TLR4 and TLR2 in THP-1 cells, assessed by flow cytometry. THP-1 cells (5x10
5
 cells/ml) were 
incubated without or with 0, 5, 10, 20, 30 ng/ml of PMA d at 37
0
C in RPMI 1640 media supplemented 
with 10% (v/v) FCS for 72 hrs. Cells were washed and incubated with primary mouse anti-human 
(CD14 or TLR2 or TLR4 and MARCO) monoclonal antibody for 45 min, washed again, and then 
incubated with secondary antibody (goat anti-mouse IgG labelled FITC). IgG 1k was used as the isotype 
for CD14 and MARCO, while IgG 2b was used as the isotype for TLR2 and TLR4. Samples were 
analysed using an Aria flow cytometer (Becton Dickinson Biosciences) and Flowing software version 
2.5.0 (Turku centre for biotechnology, University of Turku, Finland) was used to analyse the data. A: 
Represents the expression of CD14. B: Represents the expression of MARCO. C: Represents the 
expression of TLR4 and D: Represents the expression of TLR2. Grey histograms represent isotypes, 
green histograms represent untreated cells (control),  red histograms represent cells treated 5 ng/ml of 
PMA, blue histograms represent cells treated with 10 ng/ml of PMA, brown histograms represent cells 
treated with 20 ng/ml of PMA and purple histograms represent cells treated with 30 ng/ml of PMA.   
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Figure 3.9: Bar figure represents the effect of different concentrations of PMA on the expression of 
CD14, MARCO, TLR4 and TLR2 in THP-1 cells, assessed by flow cytometry. A represents the 
expression of CD14, B: represent the expression of MARCO, C: represent the expression of TLR4 and 
D: represent the expression of TLR2.  Bar colors represents, Gray  isotype, green untreated cells, red 
cells treated 5 ng/ml PMA, blue  cells treated 10ng/ml PMA, brown bcells treated 20 ng/ml PMA, purpel 
cells treated 30 ng/ml PMA. Values represent the mean ± SD from three experiments. 
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Figure 3-10: The effect of different concentrations of Vit. D3 on the expression of CD14, MARCO, 
TLR4 and TLR2 in THP-1 cells, assessed with flow cytometry. THP-1 cells (5x10
5
 cells/ml) were 
incubated without or with 0, 50, 100, 150 and 200 nM of vit.D3 at 37
0
C in RPMI 1640 media supplemented 
with 10% (v/v) FCS for 72 hrs. Cells were washed and then incubated with primary mouse anti-human 
(CD14 or TLR2 or TLR4 and MARCO) monoclonal antibody for 45 mins, washed again, and then 
incubated with secondary antibody (goat anti-mouse IgG labelled FITC). IgG1k was used as the isotype for 
CD14 and MARCO, while IgG2b was used as the isotype for TLR2 and TLR4. Samples were analysed 
using an Aria flow cytometer (Becton Dickinson Biosciences) and Flowing software version 2.5.0 (Turku 
centre for biotechnology, University of Turku, Finland) was used to analyse the data. A: Represents the 
expression of CD14. B: Represents the expression of MARCO. C: Represents the expression of TLR4 and 
D: Represents the expression of TLR2. Grey histograms represent Isotypes, green histograms represent 
untreated cells (control), red histograms represent cells treated 50 nM of vit.D3, blue histograms represent 
cells treated with 100 nM of vit. D3, brown histograms represent cells treated with 150 nM of vit. D3and 
finally purple histograms represent cells treated with 200 nM of vit. D3. 
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Figure 3-11:  Bar figure represent the effect of different concentrations of vit.D3 on the expression of 
CD14, MARCO, TLR4 and TLR2 in THP-1 cells assessed by flow cytometry. A: represent the 
expression of CD14, B: represent the expression of MARCO, C: represent the expression of TLR4 and D: 
represent the expression of TLR2. Bars represents; Gray isotype, green untreated cells, blue cells treated 50 
nM vit.D3, red cells treated 100 nM vit.D3, brown cells treated 150 nM vit.D3 and purpel cells treated 200 
nM vit.D3.Data represents three differentexperiments. Values represent the mean ± SD from three 
experiments. 
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Figure 3-12: The expression of CD14, MARCO, TLR4 and TLR2 in THP-1 cells in response to PMA 
and vit.D3 time course.  THP-1 cells were differentiated in the presence of 5 ng/ml of PMA and 100 nM 
of vit.D3 for the indicated times. The changes in the expression of receptors were detected using Aria flow 
cytometry (DB, Becton Dickinson Biosciences) and data analysed with flowing software version 2.5.0 
(Turku centre for biotechnology, University of Turku, Finland). Results are plotted as the geometric mean 
of two independent experiments. Maximum expression of the receptors was achieved at 72 hrs. 
Differentiate of THP-1 cells with vit.D3 results in greater expression of the receptors than cells 
differentiated with PMA. A: Represents the expression of CD14. B: Represents the expression of 
MARCO. C: Represents the expression of TLR4. D: Represents the expression of TLR2. Blue colour 
represents cells that treated with PMA and red colour represents cells that treated with vit.D3. 
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3.2.3.3 The effect of PJ-34 on the expression of CD14, TLR2, TLR4 and  
MACRO in PD/THP-1 cells in response to LPS 
 
To study the role of PJ-34 in membrane expression of CD14, MARCO, TLR4 and TLR2 
in PD/ THP-1 cells, 25x10
4 
cells/ml were incubated with or without 10 µM of PJ-34 for 
30 mins  and then stimulated with LPS  100 ng/ml  for 4 hrs.  The cells were stained by 
indirect fluorescent staining using mouse anti-human monoclonal antibodies for CD14, 
MARCO, TLR4 and TLR2 proteins after a 45-mins incubation period. The cells were 
then incubated with FITC goat anti-mouse IgG for 30 minutes. Cells stained with IgG1k 
and IgG2b were used as isotype (negative) control. The samples were analysed using a 
FACS Aria cell sorter (Becton Dickinson Biosciences) and the data analysed by Flo-Jo 
software.  
Figure 3.11 represents the expression of CD14, MARCO, TLR4 and TLR2 in PMA-
differentiated THP-1 cells treated with or without 10µM PJ-34 for 30 mins prior to 
incubate with LPS 100 ng/ml for 4 hrs. Filled histograms (grey colour) represent the 
isotype control (negative control) column A, and non-filled histograms represent the 
expression of the receptors (Fig. 3.11 column B). The expression of CD14, TLR4 and 
TLR2 on PMA-differentiated THP-1 cells increased when the cells were incubated with 
LPS alone while the expression of MARCO decreased (Fig. 3.11 column C). Cells treated 
with PJ-34, prior to stimulate with LPS, exhibited a decrease in the expression of the 
CD14, TLR4 and TLR2 receptors (Fig. 3.11 column D). Whereas the expression of 
MARCO increased in cells treated with PJ-34 prior to stimulate with LPS (Fig.3.11 D). 
Figure 3.12 represents MFI of CD14, MARCO, TLR2, and TLR4 on PD/THP-1 cells in 
response to of LPS 100 ng/m in presence and absence of PJ-34 10µM. 
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Figure 3-13: The effect of PJ-34 on CD14, MARCO, TLR4 and TLR2 expression in PD/THP-1 cells in 
response to LPS. THP-1 cells were differentiated with 5 ng/ml for 72 h, cells were incubated without or with 
10 µM of PJ-34 for 30 m prior to stimulation with LPS 100 ng/ml in RPMI 1640 media supplemented with 
10% (v/v) FCS in a humidified atmosphere at 370C for 4 hrs. Cells were washed and incubated with primary 
mouse anti-human (CD14 or TLR2 or TLR4 and MARCO) monoclonal antibody for 45 min, washed again, 
and then incubated with secondary antibody (goat anti-mouse IgG labelled FITC). IgG1K was used as the 
isotype for CD14 and MARCO, while IgG2b was used as the isotype for TLR2 and TLR4. Samples were 
analysed using an Aria flow cytometer (Becton Dickinson Biosciences) and Flowing Software v. 2.5.0 
(Centre of biotechnology, Turku University, Finland) was used to analyse the data. Column A: Isotype 
(Negative control). Column B: Untreated cells. Column C: Cells treated with LPS. Column D: Cells treated 
with PJ-34 and then stimulated with LPS. Filled histograms represent isotypes and unfilled histograms 
represent expression of receptors. 
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Figure 3-14:  Bar figure representsthe effect of PJ-34 on CD14, MARCO, TLR2 and TLR4 
expression in PD/ THP-1 cells in response to LPS. ar figure represents. Bars colors represents; 
Black isotype, blue untreated cells, red cells treated with LPS 100 ng/ml and green cells treated with PJ-
34 10 µM . Data represents three different experiments. Values represent the mean ± SD from three 
experiments. 
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3.2.4 Conclusion  
 
Native THP-1 cells express a moderate level of CD14 and low levels of MARCO, TLR4 
and TLR2. The expression level of CD14, TLA4 and TLR2 slightly increased when THP-
1 cells were stimulated with LPS 100 ng/ml. Whereas, MARCO expression decreased in 
LPS-treated cells. 
In this study two different stimuli, PMA and vit.D3 were used to differentiate THP-1 cells. 
PMA has greater differentiation effect as reflected by increased adherence and induce a 
higher level of proinflammatory cytokines in response to LPS. This was consistent with 
previous studies which identified the differentiation in PMA and vit.D3 stimulated THP-1 
cells (Daigneault et al., 2010). THP-1 cells differentiated with PMA and vit.D3 shows Up-
regulation in the expression of CD14, MARCO, TLR4 and TLR2 and released greater 
level of proinflammatory cytokines than non-differentiated cells. Although vit.D3 
differentiated cells shows higher receptors expression, PMA was used as its level of 
cytokines release was greater in cells, as this study investigate the role PARP enzyme in 
the regulation of LPS receptors and production of pro-inflammatory cytokines. The 
expression of CD14, TLR4 and TLR2 receptors increased in PMA-differentiated cells, 
when the cells were stimulated with LPS only. In contrast, cells treated with PJ-34, prior 
to LPS stimulation, showed a decrease in the expression of the receptors. Contrariwise, 
MARCO expression decreased in THP-1 cells treated only with LPS, and increased when 
the cells were treated with PJ-34 prior to exposure to LPS. 
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CHAPTER 4: Measurement of production of cytokines and nitric oxide 
by THP-1 cells 
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4.1 Introduction  
Innate immunity is controlled by cytokines, which are produced predominantly by 
monocytes, macrophages and dendritic cells, with some  released by other cell types such 
as  T cells, NK cells, endothelial and epithelial cells. Proinflammatory cytokines such as 
tumour necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) are essential in 
modulation of immunity and the inflammatory response. TNF-α is a notable inflammatory 
cytokine made mainly by mononuclear phagocytes, NK cells, activated lymphocytes and 
activated vascular endothelial cells. The mode of action of TNF-α is incumbent in septic 
shock after its release by macrophages activated by lipopolysaccharide (LPS) and other 
bacterial products. TNF-α also mediates  acute inflammation by interaction with other 
inflammatory mediators such as IL-1 and IL-6  (Suharti et al., 2003; Lin & Tang, 2007; 
Rossol et al., 2011).  
LPS, a component of the outer membrane of gram-negative bacteria, is one of the most 
potent innate activating stimuli known. The inflammatory mechanism  of LPS involves 
the secretion of nitric oxide (NO) in various tissue as well as by monocytes and 
macrophages (Titheradge, 1999; Bultinck et al., 2006). NO is a small molecule with  roles 
in many physiological and pathological responses, including circulation, blood pressure, 
platelet function, host defence  and neurotransmission in the central nervous system and 
peripheral nerves (Moncada et al., 1991; Bogdan et al., 2000). 
NO is produced at different levels by different types of cells, such as neurons, endothelial 
cells, platelets, and neutrophils, in response to inflammation. Its production controls many 
important functions of PMNs, including chemotaxis, adhesion, aggregation, apoptosis, 
and PMN-mediated bacterial killing (Sethi & Dikshit, 2000). NO is produced through the 
action of nitric oxide synthases (NOSs), a group of enzymes that generate NO from the 
amino acid L-arginine. NOSs convert arginine into citrulline, with NO produced during 
the process. Oxygen and NADPH are necessary co-factors. Three isoforms of NOS have 
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been identified, based on their activity: neuronal NOS (nNOS or NOS1), inducible NOS 
(iNOS or NOS2) and endothelian NOS (eNOS or NOS3). The general mechanism of NO 
production is as follows. 
 
 
 
iNOS is expressed in many cell types, including macrophages, neutrophils, dendritic cells, 
endothelial cells and epithelial cells. NOS1and NOS3 are less ubiquitous, but there is 
evidence to indicate they are critical for a normal physiology (Bogdan et al., 2000; 
O’Neill, 2011). iNOS is involved in the immune response, the production of NO by iNOS 
lasts much longer than from other isoforms of NOS. iNOS produces high concentrations 
of NO in the cell, this is because iNOS capability to bind tightly to calmodulin, even at 
very low cellular concentrations of calcium. 
NO production plays a crucial role in host defence against intracellular pathogens. 
However, whether NO-dependent control of intracellular organisms primarily implicates 
cell-intrinsic or alternatively cell-extrinsic activity of NO is still not clear. For instance, 
NO production by infected phagocytes might enable these cells to individually control 
their pathogen burden. Alternatively, the ability of NO to diffuse across cell membranes 
may be critical for infection control (Olekhnovitch et al., 2014).  
 Studies conducted by O’Neill, 2011; Seow et al., 2013, reported that the production of 
proinflammatory cytokines in response to LPS is regulated by the nuclear transcription 
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factor NF-κB /Rel complex. When immune the cells treated or exposed to LPS, NF-κB is 
activated and translocated into the nucleus from the cytoplasm. This results in expression 
of several critical transcriptional genes related to septic shock pathogenesis, such as TNF-
a, interleukin 1β, interferon-β (INF-β), adhesion molecules (ICAM-1 and E-selectin) and 
iNOS (Chandel et al., 2000; Bultinck et al., 2006; Jang et al., 2006; Rossol et al., 2011). 
PARP-1 is also  involved in the regulation of inflammatory processes associated with NF-
κB  (Chaitanya et al., 2010; Ohanna et al., 2011; Scalia et al., 2013) 
The main objective of this part of the study was to determine the effect of LPS, and the 
involvement of PARP activity, on TNF-α, IL-1b and NO production. Whether or not 
PARP activity is required for the induction of NF-κB activation in THP-1 or in the PMA-
differentiated THP-1 cells (PD/THP-1) was also examined. 
 
 
4.2 Method 
 
4.2.1 ELISA  
 
The level of TNF-α and IL-1β produced by undifferentiated THP-1 cells and THP-1 cells 
differentiated by treatment with PMA 5 ng/ml and vit.D3 100 nM of for 72 hrs, was 
measured by ELISA assay. Cells, at density 1x10
6 
cell/ ml, were stimulated with an 
increasing concentration of E. Coli EH100 (Ra mutant) LPS (10, 50, 100 and 1000 
ng/ml) or 100 ng/ml  of  LPS in the presence and absence of 10 µM PJ-34 or 1µg/ml of 
antibodies (anti-CD14, anti-TLR4, anti-TLR2, anti-MARCO, anti-NF-κB or anti-JNK-1)  
for 30 mins.  Control samples were left untreated. Samples were incubated at 37
o
C in a 
humidified tissue culture incubator with 5% (v/v) CO2 for 4 hrs. The samples were 
centrifuged at hourly intervals at 1200 rpm (32 xg) for 5 mins. and the supernatants were 
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transferred to clean Eppendorf tubes and stored at -80
0
C. 100 µl of each sample was used 
to measure the TNF-α, and IL-1β levels (see 2.2.7.1). 
 
 
4.2.2 Western blotting  
 
Undifferentiated THP-1 cells and PD/THP-1 were cultured in a 100 mm culture plate and 
were treated with or without 10 µM of PJ-34. After 30 mins prior to stimulation with LPS 
(1µg/ml) for 15, 30, 60 and 120 mins., cells were lysed with a Nuclear Extract Kit (Active 
Motif, UK), and the manufacturer’s protocol was followed to prepare the cytoplasmic or 
the whole cell lysate. Protein concentration in each sample was quantified with Bradford 
assay and plate was read with a plate reader (Versa max). The cell lysate was kept at -
80
o
C until the analysis was carried out. Cell lysate from cytoplasmic extract, 15 µg, and 
whole cell lysate were loaded on a 12% SDS page-gel. After electrophoresis, protein was 
transferred to a polyvinylidene fluoride membrane (Immobilon-FL, Merck Millipore, 
Merck KGaA, and Darmstadt, Germany). Membranes were blocked with 5% w/v 
skimmed milk in PBS for 1 h. The membrane containing the cytoplasmic extract was 
probed with-rabbit anti-human NF-κB -65 (clone poly 6226, Biolegend , UK) at a dilution 
of 1:1000 µl in 5% skimmed milk in western wash buffer (tPBS).  tPBS contain 2.42 g 
Tris base, 8g NaCl and was diluted to 1 L with distilled water, adjusted to pH 7.6, with 
0.5 ml Tween-20 then added. The membrane containing whole-cell lysate was incubated 
with rabbit anti-human JNK-1 (clone poly6331, biolegend, UK), and incubated for 1-2 hrs 
on a rocker. The membranes were then washed three times with wash buffer; 10 mins 
each wash, changing the wash buffer. The membranes were subsequently incubated with 
secondary antibody, IRDye® 700CW Donkey anti-rabbit IgG, or IRDye® 800CW goat 
anti-mouse IgG (Li-Cor Bioescieces, Lincoln, NE, U.S.A), at a dilution of 1:10000 The 
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primary mAb, mouse anti-human α-Tubulin (clone 10D8, Biolegend, UK), was used as a 
control at a dilution of 1:1000. Membranes were scanned and analysed with a Li-Cor 
scanner infrared imaging system using Odyssey software (Li-Cor Bioscience). 
 
 
4.2.3 Nitric oxide measurement 
 
NO produced by the undifferentiated THP-1 cells and PD/THP-1was evaluated by 
measuring nitrite/nitrate (NO2
-
) accumulation in  culture supernatants using the Griess 
reaction. Cells were seeded at 2.5×10
5 
cells/ml in RPMI-1640 medium supplemented with 
10% (v/v) FCS in a 96-well plate. The plate was treated with 10 µM of PJ-34 for 30 mins, 
subsequently stimulated with 100 ng/ml LPS, and then incubated in a tissue culture 
incubator at 37
o
C in a humidified atmosphere of 5% (v/v) CO2. Following incubation, 
supernatants were collected by centrifuging the cells at 1200 rpm for 5 mins every hour 
and were stored at -80
o
C. Finally, 50 µl of each sample was used to measure nitrite 
concentration as described in section (2.2.6.1). 
 
 
4.3 Results 
4.3.1 Secretion of TNF-α and IL-1β in undifferentiated and  
differentiated THP-1 cells in response to LPS 
 
To investigate the inflammatory response of the human monocytic cell line THP-1 and 
PMA, vit.D3 differentiated THP-1 cells to LPS, cells, at density of 1x10
6
 cells/ml, were 
stimulated with increasing concentrations (0,1 ,10, 100, 1000 ng/ml) of E. coli EH100 (Ra 
mutant) LPS for 4 h and TNF-α  and  IL-1β levels in culture supernatants determined 
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using ELISA. Figure 4.1 and 4.2, shows that native THP-1 cells and vit.D3 and PD/THP-
1differentiated cells secreted more TNF-α than IL-1β in response to LPS for the same 
incubation period. 
As shown in figure 4.1, undifferentiated cells were found to respond weakly to LPS 
stimulation, producing approximately~35 pg./ml of TNF-α, whereas THP-1 cells 
differentiated with vit.D3 and PMA significantly produced higher level of TNF-α 
production in response to LPS. The production of TNF-α in vit.D3 differentiated cells 
reached peak of 273 pg/ml, while the level in PD/THP-1 peaked at 600 pg/ml (Fig. 4.1). 
In addition the production of TNF-α by different types of cells increases with increasing 
LPS concentration and the maximum level produce in cells treated with 100 ng/ml LPS 
for 4 h (Fig. 4.1). Also the production amount of IL-1β was significantly higher in 
differentiated cells than undifferentiated cells. In PD/THP-1 the level of IL-1β produced 
was higher than vit.D3 differentiated cells and reached level of 182.12  pg/ml and 63.12 
pg./ml respectively while, undifferentiated cells produced only  21.87 pg/ml at 4 hrs 
incubation and obtained in cells incubated with LPS 100 ng/ml (Fig. 4.2).  
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Figure 4-1: The TNF-α secretion by undifferentiated cells, vit.D3 and PMA differentiated THP-1 
cells in response to LPS. Untreated THP-1 cells, THP-1 cells differentiated with vit.D3 100 nM for 72 
hrs  THP-1 cells differentiated with  PMA 5 ng/ml  for 72 hrs, (1x10
6
 cell/ml) were stimulated with the 
indicated concentration (0, 1, 10, 100 and 1000 ng/ml) of E.coli LPS for 4 hrs. TNF-α concentration in 
the cell-free culture supernatant was determined by ELISA. Values represent the mean ± SD from three 
experiments.  
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Figure 4-2: The IL-1β-α secretion by undifferentiated cells, vit.D3 and PMA differentiated 
THP-1 cells in response to LPS. Untreated THP-1 cells, THP-1 cells differentiated with vit.D3 100 
nM for 72 hrs  THP-1 cells differentiated with  PMA 5 ng/ml  for 72 hrs, (1x10
6
 cell/ml) were 
stimulated with the indicated concentration (0, 1, 10, 100 and 1000 ng/ml) of E.coli LPS for 4 hrs. 
IL-1β concentration in the cell-free culture supernatant was determined by ELISA. Values represent 
the mean ± SD from three experiments.  
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4.3.2 The effect of PJ-34 on TNF-α and IL-1β production by THP-1 and  
PD/THP-1 cells after LPS exposure. 
 
In response to deferent stimuli PARP-1 n enzyme in eukaryotic cells activated as a result 
for DNA damage and result in release of transcription factors specific for stimulant. LPS 
cause DNA damage and release transcription factors gene of many cytokines such as 
TNF-α, IL-1β and many others. In this set of experiments the effect of a potent PARP 
inhibitor (PJ-34) was investigated regarding activation of PARP upon DNA damage in 
response to LPS. This effect was measured over time incubation with LPS 100 ng/ml. 
base to the literatures the highest concentration of TNF-α release after 4 hrs exposure to 
LPS. 
Figure 4.3 and Fig 4.4 show the level of TNF-α produced by THP-1 cells and PD/THP-1 
cells, were treated with or without 10 µM PJ-34 for 30 mins prior to stimulation with 
100 ng/ml LPS. TNF-α released by both cell lines in response to LPS was observed to 
increase with increasing incubation time. THP-1 cells produced very little TNF-α, 
roughly 5pg/ml compared to cells differentiated with PMA, which produced about 50 
pg/ml TNF-α (Fig. 4.4). Treatment of PD/THP-1 cells with PJ-34 had no significant 
effect reached peak of ~18.49 pg/ml. In contrast, in PD/THP-1 cells   TNF-α production 
lowered by 33% and reached peak 400 pg/ml (Fig.4.3 & Fig. 4.4) 
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Figure 4-3: The effect of PJ-34 on TNF-α secretion by undifferentiated THP-1 cells in response to 
E. coli LPS. Undifferentiated THP-1 cells (1x10
6
cell/ml) were stimulated with LPS 100 ng/ml in 
presence and absence of 10µM of PJ34 for 30 mins for the indicated ties .Supernatant was collected for 
TNF-α analysed by ELISA at the indicated time intervals. Data were analysed statically by two way 
analysis variance (ANOVA). (NS) non-significant difference, (*) Significant difference of cell treated 
with LPS V control, whereas (#) significant difference p<0.05 cells treated with PJ-34 and LPS V cells 
treated with LPS. Values represent the mean ± SD from three experiments. 
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Figures 4.5 & fig. 4.6, shows the cells treated with 10 µM PJ-34 reduced the amount of 
IL-1β produced by the both undifferentiated and PD/THP-1 cells in response to 100 ng/ml 
LPS. Figures 4.5 and 4.6 show that 10 µM PJ34 had no effect on the amount of IL-1β 
produced by both types of cells after LPS exposure, compared to non-treated cells. 
Production of IL-1β increased significantly over the time incubation (P<0.05) in response 
to 100 ng/ml LPS in both types of cells compared to non-treated cells. The highest 
amount of IL-1β produced by THP-1 cells after 4 hrs of LPS stimulation was about 21.97 
pg/ml (Fig. 4.5). Whereas the PD/THP-1 cells produced amount of IL-1β reached the 
peaked of 181.93 pg/ml (Fig. 4.6). 
 
Figure 4-4: The effect of PJ-34 on TNF-α secretion by PMA-differentiated THP-1 cells in response to 
E. coli LPS. PMA-differentiated THP-1 cells (1x10
6
 cell/ml) were stimulated with LPS 100 ng/ml in 
presence and absence of 10µM of PJ34 for 30 mins for the indicated times, Supernatant was collected for 
TNF-α analysed by ELISA at the indicated times. Data were analysed statically by two way analysis 
variance (ANOVA). (NS) non-significant difference, (*) Significant difference of cell treated with LPS V 
control, whereas (#) significant difference p<0.05 cells treated with PJ-34 and LPS V cells treated with 
LPS. Values represent the mean ± SD from three experiments. 
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While, cells treated with 10µM of PJ-34 30 mins prior to LPS stimulation shows a 
significant reduction in the amount of IL-1β produced (p<0.05). Production of IL-1β in 
native THP-1 cells was reduced by 33%, reaching 18.49 pg/ml (Fig. 4.5). PD/THP-1 cells 
produced only 127.85 pg/ml IL-1β (Fig. 4.6). 
 
Figure 4-5: The effect of PJ-34 on IL-1β secretion by undifferentiated THP-1 cells in response to E. coli 
LPS. Undifferentiated THP-1 cells (1x10
6
 cell/ml) were stimulated with 100 ng/ml of LPS in presence and 
absence of 10µM of PJ34 for 30 minutes for the indicated times, supernatant was collected for IL-1β analysis 
by ELISA at the times intervals shown. Data were analysed statically by two way analysis variance 
(ANOVA). (NS) non-significant difference, (*) Significant difference of cell treated with LPS V control, 
whereas (#) significant difference p<0.05 cells treated with PJ-34 and LPS V cells treated with LPS. Values 
represent the mean ± SD from three experiments 
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4.3.3 The role of CD14, TLR2, TLR4 and MARCO in the production of  
TNF-α and IL-1β by PD/THP-1 cells in response to LPS 
 
Differentiated THP-1 cells with PMA produced higher level of proinflammatory cytokine 
TNF-α and IL-1β in response LPS compared with undifferentiated and vit.D3 
differentiated THP-1 cells (Fig. 4.1 and 4.2). This experiment was carried out to 
investigate the role of LPS receptors and the effect of PJ-34 on the production of TNF-α 
PD/THP-1 cells. Monocytes and macrophages express CD14, toll-like (TLRs) (Chávez-
Sánchez et al., 2010) and MARCO (Gordon & Taylor, 2005) on the cell surface.  CD14 
Figure 4-6: The effect of PJ-34 on IL-1β secretion by PMA-differentiated THP-1 cells in response to 
E. coli LPS. PMA-differentiated THP-1 cells (1x10
6
 cell/ml) were stimulated with 100 ng/ml LPS in 
presence and absence of 10µM of PJ34 for 30 mins for the indicated times, supernatant was collected for 
IL-1β analysis by ELISA at the time intervals shown. Data were analysed statically by two way analysis 
variance (ANOVA). (NS) non-significant difference, (*) Significant difference of cell treated with LPS V 
control, whereas (#) significant difference p<0.05 cells treated with PJ-34 and LPS V cells treated with 
LPS. Values represent the mean ± SD from three experiments. 
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has been proposed as the first host pattern recognition receptor involved in the recognition 
of most bacterial components (Triantafilou & Triantafilou, 2002) and facilitates the 
expression of inflammatory molecules via activation of the TLRs (Levy et al., 2009). 
Based on the inhibitory effect of antibodies to CD14, TRL2, TLR4 and MARCO on TNF-
α and IL-1β production in monocytes/macrophages, we suppose that these molecules are 
all important in the signal chain induce by LPS. It was found that levels of TNF-α 
secreted by PD/THP-1 cells  increased  over the times  in response to LPS (100 ng/ml) 
and reached peak of ~ 611 pg/ml after 4 hrs LPS stimulation compared to untreated cells 
(Fig 4.7 & 4.8). Cells incubated with anti-human CD14(26ic) , TLR4(HTA 125) and 
TLR2 (TLR2.1) antibodies for 30 mins prior to stimulate with LPS, however, showed a 
reduced TNF-α production in response to LPS (Fig. 4.7).  
Incubation of cells with anti-CD14 antibody minimized  TNF-α secretion, although it 
slightly increased over the course of incubation, reaching ~180 pg/ml at 4 hrs of LPS 
stimulation  (Fig. 4.7).While, more TNF-α was secreted after incubation of LPS-
stimulated cells with anti-TLR4 and TLR2 antibodies During the incubation period, anti-
TLR2 contributed to a greater level of  TNF-α production than anti-TLR4; where  TNF-α 
levels reached ~ 440 and ~380 pg/ml respectively (Fig. 4.7). 
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Figure 4.8 shows that treatment of LPS-stimulated PD/THP-1 cells with anti-human 
MARCO antibody (PLK1) and PJ-34 significantly (p<0.05) reduced the TNF-α levels 
over the incubation period, which reached ~ 460 and ~ 400 pg/ml, respectively. TNF-α 
level, in response to LPS, steadily increased over time, anti-MARCO antibody had little 
effect. In contrast, cells treated with PJ-34 showed steady reduction of TNF-α over the 
incubation period (Fig. 4.8).  
Figure 4-7: The TNF-α secretion by PMA-differentiated THP-1 cell in response to E. coli LPS. 
THP-1 cells differentiated with PMA 5 ng/ml for 72 hrs were incubated with 10µg anti-human CD14, 
TLR4 and TLR2 monoclonal antibody for 30 mins prior to stimulation with LPS 100 ng/ml for 4 hrs. 
Supernatants of samples were collected hourly by centrifugation. The cell culture supernatant was 
transferred to a clean Eppendorf tube and kept in -80
0
C. The TNF-α level in culture supernatant was 
determined by ELISA. Data were analysed statically by two way analysis variance (ANOVA). (NS) non-
significant difference, (*) Significant difference of cell treated with LPS V control, whereas (#) significant 
difference p<0.05 cells treated with PJ-34 and LPS V cells treated with LPS. Values represent the mean ± 
SD from three experiments. 
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The role of LPS receptors and the effect of PJ-34 on the production of IL-1β by PD/THP-
1 cells, following LPS treatment was analysed by ELISA (Fig. 4.9 and 4.10). LPS-
stimulated THP-1 cells produced IL-1β over time, peaking at~181 pg/ml at 4 hrs 
stimulation with LPS (Fig. 4.9). In contrast, untreated cells (control) produced very little 
IL-1β. Incubation of cells with anti-human CD14, TLR4 and TLR2 for 30 mins prior to 
stimulation with LPS cause to reduction in the amount of IL-1β released (p<0.05). This 
reduction was slightly increased over the incubation period.  The greatest reduction of IL-
1β was observed during the first hr of incubation in THP-1 cells treated with anti-CD14 
 
Figure 4-8: The TNF-α secretion by PMA-differentiated THP-1 cell in response to E. coli LPS. 
THP-1 cells differentiated with PMA 5 ng/ml for 72 hrs were incubated with 10µg anti-human MARCO 
monoclonal antibody and 10 µM PJ-34 for 30 mins prior to stimulation with LPS 100 ng/ml for 4 hrs. 
Supernatants of samples were collected hourly by centrifugation. The cell culture supernatant was 
transferred to a clean Eppendorf tube and kept in -80
0
C. TNF-α level in culture supernatants was 
determined by ELISA. Data were analysed statically by two way analysis variance (ANOVA). (NS) non-
significant difference, (*) Significant difference of cell treated with LPS V control, whereas (#) significant 
difference p<0.05 cells treated with PJ-34 and LPS V cells treated with LPS. Values represent the mean ± 
SD from three experiments. 
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(Fig. 4.9). The IL-1β level continued to fall, reaching ~92.1 pg/ml after 4 hrs stimulation 
with LPS. Cells treated with anti-TLR4 and anti-TLR2 antibodies released considerably 
higher levels of IL-1β for same period of incubation with LPS compared to cells treated 
with anti-CD14 antibody. At 4 hours stimulation with LPS, cells treated with anti-TLR4 
produced ~110 pg/ml IL-1β. Cells incubated with anti-TLR2 the level of IL-1β secreted 
peaked at ~159.5 pg/ml (Fig. 4.9).  
 
 
 
Figure 4-9: Secretion of IL-1β by PMA-differentiated THP-1 cells in response to E. coli LPS.  
THP-1 cells differentiated with PMA 5 ng/ml for 72 hours were incubated with 10µg anti-human 
CD14, TLR4, and TLR2 monoclonal antibody for 30 mins prior to stimulation with LPS 100 
ng/ml for 4 hrs. Supernatants of samples were collected hourly by centrifugation. The cell culture 
supernatant was transferred to a clean Eppendorf tube and kept in -80
0
C. The IL-1β level in 
culture supernatants was determined by ELISA. Data were analysed statically by two way 
analysis variance (ANOVA). (NS) non-significant difference, (*) Significant difference of cell 
treated with LPS V control, whereas (#) significant difference p<0.05 cells treated with PJ-34 and 
LPS V cells treated with LPS. Values represent the mean ± SD from three experiments. 
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When the cells were incubated with anti-MARCO antibody and PJ-34 a significant 
reduction of IL-1β was observed, in response to LPS, at 4 hours. The level of IL-1β 
reached was ~174.2 pg/ml and ~140.3 pg/ml, respectively, after anti-MARCO and PJ-34 
treatment. Anti-MARCO antibody invoked little protection effect, in respect of limiting 
IL-1β production in response to LPS, compared to anti-CD14, TLR4 and TLR2, and 
effect of this antibody declined over the time. PJ-34 increased the reduction of IL-1β 
secretion over incubation time. 
 
 
 
Figure 4-10: Secretion of IL-1β by PMA-differentiated THP-1 cells in response to E.coli LPS. 
PMA-differentiated THP-1 cells, treated with 5 ng/ml for 72 hrs, were incubated with 10µg anti-human 
SR (MARCO) monoclonal antibody and  10 µM PJ-34 for 30 mins prior to stimulate with  100 ng/ml 
LPS for 4 hrs. Supernatants of samples were collected hourly by centrifugation. The cell culture d 
supernatant was transferred to a clean Eppendorf tube and kept in -80
0
C. The IL-1β level in culture 
supernatant was determined by ELISA. Data were analysed statically by two way analysis variance 
(ANOVA). (NS) non-significant difference, (*) Significant difference of cell treated with LPS V 
control, whereas (#) significant difference p<0.05 cells treated with PJ-34 and LPS V cells treated with 
LPS. Values represent the mean ± SD from three experiments. 
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4.3.4 The effect of PJ-34 and activation of NF-κB and JNK on TNF-α  
and IL-1β secretion by PD/THP-1 cells after LPS stimulation 
 
NF-κB has long been considered a prototypical proinflammatory signaling pathway, 
largely based on the activation of NF-κB by proinflammatory cytokines such TNF-α and 
IL-1β. CD14 recognize and bind to LPS then bind to TLRs and form LPS/CD14/TLRs 
complex. This complex trigger LPS signaling into cytoplasm and activate transcription 
factors such as NF-κB  (Uematsu & Akira, 2008)   and MAPK signalling pathway(Guha 
& Mackman, 2001; Kim & Kim, 2014). Activation of NF-κB  by LPS signaling required 
TLRs such TLR2,4, result in activation of IkB and free NF-κB  translocate into nucleus 
and  cause  DNA damage and subsequently activation of PARP-1, and  release 
transcription factor gene of many proinflammatory cytokines (e.g. TNF-α and IL-1β).  
Activation of c-Jun N-terminal kinase (JNK) member of MAPK family, mediate 
downstream signalling events leading to the activation of AP-1 and NF-κB, which results 
in induction of a range of inflammatory cytokines (Guha & Mackman, 2001; Kim & Kim, 
2014). Therefore, inhibition of the activation of MAPKs, Akt, NF-κB and AP-1 may have 
potential therapeutic applications (Park et al., 2011).  In this study  induce inhibition of 
the NF-κB transcription factor and JNK signal  pathways in the production of TNF-α and 
IL-1β, and the effect of PJ-34 in activating these pathways in response to LPS. PD/THP-1 
cells were stimulated with LPS (100 ng/ml) for 4 hours in presence and absence of 10µg 
of anti- human NF-κB antibody (poly 6226) and anti-human JNK antibody (poly 6331), 
or 10 µM of PJ3-4. The levels of TNF-α and IL-1β were determined with ELISA.  
TNF-α level in LPS-stimulated PD/THP-1 cells increased over the incubation period 
compared to untreated cells (Fig. 4.11).Whereas, the cells treated with anti-human JNK 
anti-NF-κB or PJ-34 prior to LPS stimulation displayed a reduction in the amount of 
TNF-α released over the incubation time. PD/THP-1 cells treated with anti-NF-κB 
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showed a pronounced reduction in the level of TNF-α in response to LPS (85%) and 
roughly reaching 91.2 pg/ml at 4 hours of stimulation. Anti-JNK antibody had less effect 
and the cells displayed high levels of TNF-α compared to cells incubated with anti-NF-κB 
antibody or the cells incubated with PJ-34. The level of TNF-α reached ~590.3 pg/ml at 4 
hours of stimulation, but the amount produced by the cells treated with PJ-34 reached 
peak ~ 411.7 pg/ml at the same time (Fig.4.11). 
 
 
Figure4-11: The TNF-α production by PMA-differentiated THP-1 cells in response to E. coli LPS. 
THP-1 cells differentiated with PMA 5 ng/ml for 72 hrs, were incubated with 10µg anti-human NF-κB , 
anti-JNK monoclonal antibody or 10 µM PJ-34 for 30 mins prior to stimulation with LPS 100 ng/ml for 4 
hrs. Supernatants of samples were collected hourly by centrifugation.  The cell culture supernatant was 
transferred to a clean Eppendorf tube and kept in -80
0
C. TNF-α level in culture supernatants was 
determined by ELISA. Data were analysed statically by two way analysis variance (ANOVA). (NS) non-
significant difference, (*) Significant difference of cell treated with LPS V control, whereas (#) significant 
difference p<0.05 cells treated with PJ-34 and LPS V cells treated with LPS. Values represent the mean ± 
SD from three experiments. 
 
 
 
128 
 
The level of IL-1β produced by PD/THP-1 cells in response to LPS increased over the 
period of LPS incubation compared to  untreated (control) cells (Fig. 4.12) After 4 hrs 
LPS stimulation, the level of IL-1β  reached ~191 pg/ml. IL-1β levels in LPS-stimulated 
cells peaked at ~143 pg/ml and 115 pg/ml after treatment with anti-JNK and anti-NF-κB  
antibodies, respectively (Fig .4.12), thus showing significant reduction in the amount of 
IL-1β produced.  The level of IL-1β secreted by PJ-34-treated cells was ~113 pg/ml (Fig. 
4.12). The level of IL-1β released by PD/THP-1 might relate to availability of NF-κB and 
subsequently release more IL-1β transcription factor gene and producing more IL-1β.  
Differentiated cells show in increase in cell size and amount of NF-κB in the cytoplasm.    
 
Figure 4-12: The production of IL-1β by PMA-differentiated THP-1 cells in response to E. coli LPS. 
THP-1 cells differentiated with PMA 5 ng/ml for 72 hrs, were incubated with 10µg anti-human NF-κB, anti-
JNK monoclonal antibody or 10 µM PJ-34 for 30 mins prior to stimulation with 100 ng/ml LPS for 4 hrs.  
Sample supernatants were collected hourly by centrifugation. The cell culture supernatant was transferred to 
a clean Eppendorf tube and kept in -80
0
C. IL-1β levels in culture supernatants were determined by ELISA. 
Data were analysed statically by two way analysis variance (ANOVA). (NS) non-significant difference, (*) 
Significant difference of cell treated with LPS V control, whereas (#) significant difference p<0.05 cells 
treated with PJ-34 and LPS V cells treated with LPS. Values represent the mean ± SD from three 
experiments. 
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4.3.5 Role of PJ-34 in NF-κB and JNK activation in response to LPS  
 
The effect of PJ-34 on NF-κB and JNK activation (phosphorylation) in THP-1 and 
PD/THP-1 cells in response to LPS (100 ng/ml) was assessed by Western blotting (Figs 
4.13 and 4.14). NF-κB was detected by loading15 µg of cytoplasmic cell lysate, while 
JNK was detected in whole cell lysate. Proteins were separated by SDS-PAGE and then 
blotted on a PDVF membrane, which was probed with either primary polyclonal rabbit 
anti-human NF-κB antibody or polyclonal rabbit anti-human JNK antibody and then the 
membrane were incubated with primary mouse anti-human α-tubulin (control). For 
detection of NF-κB and JNK, membranes were incubated with secondary antibody 
IRDye® 700 CW PE donkey anti-rabbit antibody (Red). While, α-tubulin detected with 
IRDye® 800 CW FITC goat anti-mouse antibody (Green). Then the membrane was 
scanned on a LI-COR scanner using odyssey software. 
 Figure 4.13 shows the activation of NF-κB in THP-1and PD/THP-1 cells in response to 
LPS in the presence and absence of PJ-34. NF-κB activation was detected by the presence 
of the bands at a molecular weight of 70 kDa. Differences of band intensity correlate 
roughly with the amount of expression of NF-κB. Cells treated with PJ-34 only, showed 
no significant difference in the level of NF-κB expressed in the cell cytoplasm.  However 
cells treated with LPS showed reduction in the expression of cytosolic NF-κB, indicating 
an increase in NF-κB activation and its translocation into the nucleus. In contrast, cells 
treated with PJ34 for 30 mins prior to stimulation with LPS showed increased expression 
of NF-κB, indicating its reduced activation and limited translocation into the nucleus (Fig. 
4.13 [A & C]). The α-tubulin was used as controls to equalize the amount of proteins 
were loaded on the gels. NF-κB expression was plotted (Fig. 4.13 B & D) after 
normalized the band intensity of the NF-κB with it is internal α-tubulin.  
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 Figure 4.14 shows the expression of c-Jun N-terminal kinase (JNK-1) in THP-1 cells and 
PD/THP-1 cells. Increase in JNK activation detected by decreased in band intensity in 
response to LPS. Treatment of cells with PJ34 prior to their stimulation with LPS did not 
affect JNK expression in response to LPS. The expression of JNK was plotted (Fig. 4.14 
B and D) after normalizing the band intensity with internal α-tubulin.  
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Figure 4-13: The effect of PJ-34 on the activation of NF-κB in response to LPS. THP-1 cells, or 
THP-1 cells differentiated with  5ng ml PMA for 72 hrs, were left untreated or treated with 10µM of 
PJ-34 for 30 mins prior to stimulation with E. coli LPS (100 ng/ml) for the indicated times. 
Cytoplasmic extracts from the cells were separated by SDS-PAGE and then Western blotted with 
primary monoclonal antibody mouse anti-human α-tubulin (TU10D8) as a loading control and 
polyclonal rabbit-anti-human NF-κB p65 antibody (Poly6226). The blotting membrane was then 
incubated with secondary antibody IRDye® 800CW goat anti-mouse IgG or IRDye® 700CW 
donkey anti-rabbit. Finally the membrane was scanned using a Li-COR infrared image scanner using 
odyssey software. [A & C] represents Western blot expression of NF-κB and α-tubulin in THP-1 
cells and PMA-differentiated THP-1 cells. [B & D] shows the level of NF-κB expressed by the cell 
samples after normalized to it is relevant αtubulin band to avoid any loading error of the proteins. 
The percentage of was then calculated for each sample using Image Studio Lite software (LI-COR 
Biosciences). Data were analysed statically by two way analysis variance (ANOVA). (NS) non-
significant difference, (*) Significant difference of cell treated with LPS V control, whereas (#) 
significant difference p<0.05 cells treated with PJ-34 and LPS V cells treated with LPS. Values 
represent the mean ± SD from three experiments. 
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Figure4-14: The effect of PJ-34 on the activation of JNK-1 in response to LPS. 
THP-1 cells or THP-1 cells differentiated with  5ng ml PMA for 72 hrs were left untreated or treated 
with 10µM of PJ-34 for 30 mins prior to stimulation with E. coli LPS (100 ng/ml) for the indicated 
times. Cytoplasmic extracts from the cells were separated by SDS-PAGE and Western blotted with 
primary monoclonal antibody mouse anti-human α-tubulin (TU10D8) as a loading control and 
polyclonal antibody rabbit anti-human phosphorylated-JNK-1 antibody (Poly6331). The membrane was 
then incubated with secondary antibody IRDye® 800CW goat-anti-mouse IgG or IRDye® 700CW 
donkey anti-rabbit. Finally the membrane was scanned Li-COR infrared image scanner using odyssey 
software.  [A & C] represents Western blot expression of JNK-1 and α-tubulin in THP-1 cells and 
PMA-differentiated THP-1 cells. [B & D] represents the levels of JNK-1 expressed by the cell samples 
after normalized to it is relevant αtubulin band to avoid any loading error of the proteins. The 
percentage was calculated for each sample using Image Studio Lite software (LI-COR Biosciences). 
Data were analysed statically by two way analysis variance (ANOVA). (NS) non-significant difference, 
(*) Significant difference of cell treated with LPS V control. The immunoblot image is a representative 
of three experiments.  
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4.3.6 The effect of PJ-34 on production of nitric oxide in response to 
LPS. 
 
NO formation was investigated by measuring nitrite (NO2
–
), one of two primary, stable 
and nonvolatile breakdown products of NO. The Griess assay was used to measure NO2
–
. 
This technique relies on a diazotization reaction (Griess, 1879). 
To ensure accurate nitrite quantitation, a reference curve was plotted, constructed using a 
nitrite standard solution. To assess NO production in untreated and PD/THP-1 cells (1x 
10
6
) were stimulated with 100 ng/ml of LPS in the present and absence of 10 µM of PJ-34 
for 6 hrs. A highest level of NO was produced by THP-1 cells in response to LPS at 6 hrs. 
In both native THP-1 and DP/THP-1 cells, NO concentration steadily increased over the 
time of incubation with LPS (Fig.4.15 A & B). PD/THP-1 cells produced a much higher 
concentration of NO than did native THP-1 cells. Untreated cells (control) did not 
produce NO. In contrast, cells incubated with 10 µM PJ-34 for 30 mins prior to LPS 
stimulation displayed significant reduction in NO production in both cell lines. High 
levels of NO produced by activated macrophages in response to LPS, represent a major 
cytotoxic principle of these cells (Connelly et al., 2003). In addition, higher 
concentrations of NO can directly interfere with the DNA damage of target cells, and 
excessive NO production by iNOS plays a crucial role in septic shock (Kitasato et al., 
2007).  
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4.4 Conclusion 
  
Differentiated macrophages are the resident tissue phagocytes and patrol cells of the 
innate immune response. PMA and vit.D3 are stimuli commonly used to induce 
macrophage differentiation in THP-1 cell line. The phenotype of the THP-1 cell line after 
differentiation utilising Vit.D3 and PMA compared undifferentiated THP-1 cells, both 
stimuli induced changes in cell morphology indicative of differentiation. Activation of 
vit.D3 or PMA differentiated THP-1 cells was induced by treating these cells with LPS for  
4 hrs which resulted in production of high level of TNF-α and IL-1β by the cells. While, 
undifferentiated THP-1 cells produced less amount of TNF-α and IL-1β compared to 
differentiated THP-1 cells. The level of TNF-α produced by undifferentiated and vit.D3 or 
PMA differentiated THP-1 cells was much higher than IL-1β for the same incubation. 
The level TNF-α and IL-1β produced by PD/THP-1 was much higher than vit.D3 
 
Figure 4-15: The effect of PARP inhibitor PJ-34 on NO production in THP-1 cells in response to LPS. 
The concentration of nitrite was calculated using a nitrite standard curve. A: Untreated cells and B: PMA-
differentiated THP-1 cells (1x10
6
/ml) were stimulated with 100ng/ml of LPS in the presence and absence of 
10µM PJ-34 for the times indicated. The supernatant was collected hourly by centrifugation of the cell culture 
and the supernatant was kept at -80
0
C until used. Data were analysed statically by two way analysis variance 
(ANOVA). (*) Significant difference of untreated cells V cells treated with LPS, whereas (#) significant 
difference p<0.05 cells treated with PJ-34 and LPS V cells treated with LPS 
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differentiated cells, therefore vit.D3 differentiated cells were not investigated all 
experiment. The production of TNF-α and IL-1β in both undifferentiated   and PD/THP-1 
cells with 100 ng/ml LPS were increased significantly over the incubation time. Whereas, 
incubation of cells with 10 µM PJ-34 prior to stimulate with LPS shows a significant 
decrease in TNF-α and IL-1β production in both groups of cells. Monocytes/macrophages 
express different LPS receptors served a variety role toward effecting TNF-α and IL-1β 
production in response to LPS in undifferentiated and PD/THP-1 cells.  In this study a 
significant reduction of TNF-α and IL-1β production was observed in cells incubated with 
anti-CD14, anti-TLR4 and anti-TLR2 antibodies prior to LPS stimulation in compare 
with that stimulated with LPS alone. This finding is consistent with previous study which 
has shown that CD14 is LPS receptor, which it lacks a cytoplasmic domain and does not 
participate directly in LPS signalling(Gangloff et al., 2005). TLRs have recently been 
shown to be important components of the CD14/LPS signaling. TLR2 and TLR4 have 
been shown to contribute to the LPS response (Chowdhury et al., 2006). CD14/LPS/TLRs 
complex induce LPS signaling which results in NF-κB activation and translocation into 
the nucleus. Activated NF-κB bind DNA and subsequently activate PARP-1 and then 
release transcription factors gene of TNF-α and IL-1β. Also our results show that 
incubation PD/THP-1 cells with anti-TLR2 and anti-TLR4 impaired NF-kB activation 
which is required for LPS signaling.  MARCO is another receptor which is needed for 
LPS-induced inflammatory responses in macrophages (Yu et al., 2012). MARCO bind to 
LPS and its association with TLR4 increase macrophages response to LPS. Incubated 
cells with anti-MARCO had less effect on TNF-α and IL-1β production because of the 
NF-κB activation-LPS signalling is not impaired by blocking MARCO receptor, this was 
thought to be du and LPS signaling activated NF-κB via other LPS receptors. The effects 
of all antibodies declined over the time of incubation. In contrast, the cells that treated 
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with PJ-34 showed increased reduction of TNF-α of IL-1β after LPS treatment. 
Activation of NF-κB by LPS signals release of NO production which contributes to 
immune system controlling bacterial infection. Over production of NO it's harmful and 
might cause cell dysfunction. A significant reduction of NO production was observed in 
undifferentiated and PD/THP-1 cells in response to LPS and its effect intensified with 
increasing incubation time. 
The role of LPS in activation of NF-κB and JNK signalling pathway of TNF-α and IL-1β 
production were examined. Incubation of undifferentiated and PD/THP-1 cells with anti-
NF-κB antibody, prior to exposure to LPS, significantly reduced TNF-α and IL-1β 
production, while anti-JNK-1 antibody was less effective than anti-NF-κB in reducing 
production of these cytokines. The effectiveness of the antibodies slightly reduced over 
the time of incubation. In contrast, cells treated with PJ-34 showed increased TNF-α and 
IL-1β secretion in response to LPS over time incubation period. These results reveal that 
activation of NF-κB is more essential for TNF-α and IL-1β production in response to LPS 
than the JNK-1 pathway. The Western blot results show that PJ-34 had a significant role 
in prolonging NF-κB activation in response to LPS, but it had very little effect on JNK-1 
activation in response to LPS. 
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CHAPTER 5: The role of CD14 and MARCO receptors in response to 
LPS 
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5.1 Introduction  
 
The Mammalian innate immune system relies on numbers of receptors molecules known 
as pathogen recognition receptors (PRPs) which have ability to recognize specific 
molecules expressed by the invaded microorganism known as pathogen-associated 
molecules patterns (PAMPs) and directly activate array of anti-microbial immune 
responses via induction of various proinflammatory cytokines, chemokines.  These 
immune responses also play a vital role for initiate long term adaptive immunity through 
B, T lymphocytes cells. These receptors in addition to CD14 the main receptor for 
invaded microbial molecules include toll like receptors family (TLRs) (Uematsu & Akira, 
2008; Kumar et al., 2011). 
Septic shock, and inflammatory response syndrome remain one of the main reason causes 
of death in intensive care units, for example in united states there is more than 750,000 
patients admitted to intensive care unit annually and resulting in 215,000 deaths(Angus et 
al., 2001) . Lipopolysaccharide (LPS) the major component of outer membrane of gram 
negative bacteria, is play a critical role in inducing sepsis during infection with gram 
negative bacteria. When it reach blood stream will recognised and bind to LPS receptors 
expressed on monocytes and macrophages and slightly less on other type of cells mainly 
CD14 (Schaaf et al., 2009; Thorgersen et al., 2013), CD14 is upregulated by exposure to 
LPS in both in vivo and in vitro (Landmann et al., 1996; Thorgersen et al., 2013). The 
mechanism by which LPS induce septic shock relies on its ability to bind to CD14 and 
initiate a signal transduction pathway, since CD14 it lacks a transmembrane domain; 
therefore it is incapable to trigger a signal downstream into the cytoplasm. It believed that 
LPS bind CD14 signal cascade initiate via TLR4 and resulting in activation of NF-κB , 
subsequently release transcriptional factor gene of many proinflammatory cytokines 
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(Schaaf et al., 2009). LPS internalization by CD14 is dependent on the physical state in 
which LPS presented to the cell (Kitchens & Munford, 1998). 
MARCO is expressed by monocytes/macrophages and dendritic cells and certain 
endothelial cells. It is well known that SRs involved in lipid metabolism and bind 
modified low-density lipoproteins, and they play a vital role in uptake and clearance of 
modified host molecules and apoptotic cells. In addition they recognise bind and 
internalising products of gram positive bacteria such as lipoteichoic acid, 
lipopolysaccharide product of Gram-negative bacteria and initiate an immune response 
which result in secretion of proinflammatory cytokines such as TNF-α and IL-1, 
implicated in pathogenesis of sepsis  and alter the expression and morphology of the cells 
(El Khoury et al., 1996; Peiser et al., 2002; Canton et al., 2013). Studies show in a murine 
model of pneumococcal pneumonia, MARCO
−/−
 mice displayed an impaired ability to 
clear bacteria from the lungs, increased pulmonary inflammation and cytokine release, 
and diminished survival. In vitro binding of Streptococcus pneumoniae and in vivo uptake 
of unopsonized particles by MARCO
−/−
AMs were dramatically impaired, indicating an 
important role of MARCO in mounting an efficient and appropriately regulated innate 
immune response against pathogens (Arredouani et al., 2006; Goh et al., 2010; Uza et al., 
2011) 
In this chapter PMA-differentiated THP-1 cells was used to investigate the relation 
between CD14 and SR MARCO and possible role of PARP inhibitor PJ-34 in the 
membranous and gene expression of these receptors and LPS up-take by MARCO in 
response to LPS. 
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5.2 Methods 
5.2.1 Flow cytometry  
 
The level expression of CD14 and SR MARCO were assessed on PMA-differentiated 
THP-1 cell in presence and absence of 10 µM PJ-34 in response to LPS. Briefly, 25x10
4
 
cells treated with or without PJ-34 for 30 minutes prior to stimulate with LPS for 6 hours. 
Cells were prepared for flow cytometry assay as described in section 2.2.3.1 and samples 
were read with flow cytometry Accuri 6 and the results were analysed with flow-jo 
software. 
 
 
5.2.2 Colocalisation  
5.2.2.1 Immunofluorescence staining  
 
Un-differentiated THP-1 cells or THP-1 cells differentiated in the Lab-Tek chamber 
slides (Nunc) with PMA (5 ng/ml) for 72 hrs and monolayer cells were incubated with or 
without PARP inhibitor PJ-34 10 µM for 30 mins prior to stimulate with 100 ng/ml LPS 
(Sigma Aldrich, UK) for 2 hours. Untreated cells (control cells) left to grow in culture 
media only. Cells were immunofluorescently stained as previously described in section 
2.2.4.3. 
 
 
5.2.2.2 Confocal microscopy  
 
Cells which stained with immunofluorescent probes were imaged at single cell level for 
colocalisation studies as described in section 2.2.5.2.  
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5.2.2.3 Colocalisation analysis and visuatisation 
  
Comprehensive technique for colocalisation analysis and visualisation of data results 
already mentioned in section 2.2.5.3 & 2.2.5.4. 
 
 
5.2.3Real time PCR (qRT-PCR) 
 
Differentiated THP-1 cells with 5 ng/ml PMA for 72 hours were cultured on glass culture 
plate until confluent (10
7
-10
8
 cells/plate), treated with 100 ng/ml of LPS in presence and 
absence of 10µM PJ-34 for 15 mins, 30 mins, 1 hr, 2 hrs, 3 hrs and 4 hrs. Afterward the 
RNA was extracted with TRI reagent see section 2.2.8.2 and cDNA for sample conditions 
were prepared as described in section 2.2.8.3. PCR primer pairs for CD14, MARCO and 
cyclophillin were designed with pearl primer software to span intron-exon splice sites to 
avoid amplification of any genomic DNA. To amplify each gene of CD14 and SR 
MARCO, cyclophillin was used as house-keeping gene. The qRT-PCR reaction (20 µl) 
per sample was prepared as following; Master mix SYBR green 10 µl, sterile double 
distilled water 7.4 µl, 1.6 µl from mixed primers of  forward and reverse each at 
concentration of (5 µM), cDNA 1 µl were aliquot in 96 well PCR well plate in triplicate 
and qRT-PCR plate sealed with an qRT-PCR film seal and the plate spun briefly to insure 
that the liquid placed in the bottom of the wells and then the plate was placed on the qRT-
PCR machine (CFX 96, Bio-Rad) The results were analysed with CFX manager software. 
Following gene sequences was designed with pearl primer software and three steps PCR 
condition was used, first step is denaturing at 95
o
C for 2 minutes then second step involve 
39 cycles each cycle started at 95
o
C for 0.10 seconds and 60
o
C for 0.10 seconds and 72
o
C 
 
 
142 
 
for 0.10 seconds and then 95 for 0.10 seconds and finally melting temperature from 65
o
C 
to 95
o
C from 0.05-0.5 seconds plus plate read.  
CD14 (F): 5'AAAGAAGCTAAAGCACTTCCAG3' 
CD14(R):'CAGCGGAAATCTTCATCGTC5' 
SR (MARCO) (F): 5'ATTCTGATGCCATTGTCTTCTG3'   
SR (MARCO) (R):3'ACACTGAACATTATCCAGCC5' 
Cyclophillin (F): 5' TGGCACAGGAGGAAAGAGCATC3'  
Cyclophillin (R):3' AAAGGGCTTCTCCACATCGAT5' 
 
 
5.2.4 Immunoprecipitation 
 
The interaction between CD14 and SR MARCO in response to LPS and the effect of PJ-
34 on this interaction were assessed with immunoprecipitation assay. Briefly, THP-1 and 
PMA-differentiated THP-1 cells, at density of 7x 10
6
  per culture plate were treated with 
100 ng/ml of LPS for 4 hrs in present and absence of  10 µM PJ-34. Cells then lysate and 
equal amount of each sample were load on 12% SDS page gel and separated in 
electrophoresis apparatus. Protein interaction was detected with infrared LICOR image 
scanner using odyssey software see section 2.2.10.1. 
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5.3 Results 
5.3.1 The effect of PJ-34 on the expression of CD14 and SR (MARCO) in 
 response to LPS 
 
A figure [5.1&5.2] represents PMA-differentiated THP-1 cells stimulated with LPS in 
present and absence of PARP inhibitor PJ-34.  Expression of CD14 was increased in 
response to LPS over time incubation in the cells that stimulated with LPS alone. 
Whereas, the cells that treated with PJ-34 for 30 mins prior to stimulate with LPS shows 
decrease in the level expression of CD14 fig. 5.1. However the situation was completely 
different with cells that incubated with anti-human MARCO antibody, fig. 5.2 shows 
decrease in the expression of MARCO receptor on the cells that stimulated with LPS 
alone over the time incubation. In other hand the cells that treated with PJ-34 prior to 
stimulate with LPS shows increase in the level.  
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Figure 5-1 (I) & (II): Represents the expression of CD14 on PMA-differentiated THP-1 cells in 
response to LPS in presence and absence of PJ-34. THP-1 cells were differentiated with PMA 5 ng/ml 
for 72 hrs. Cells were incubated without or with 10 µM of PJ-34 for 30 mins prior to stimulation with LPS 
100 ng/ml in RPMI 1640 media supplemented with 10% (v/v) FCS in humidified atmosphere at 37
0
C for 6 
hrs. Cells were washed and incubated with primary mouse anti-human CD14 monoclonal antibody for 45 
mins. Following washing cells incubated with secondary antibody (Goat anti-mouse IgG labelled FITC) for 
30 mins and washed. IgG1K was used as the isotype for CD14. Samples were analysed using Accuri6 flow 
cytometer (DB Biosciences) and Flow-Jo Software v.10 (Centre of biotechnology, Turku University, 
Finland) was used to analyse the data. A: Dot plot Column, B: Isotype (negative control), C: Untreated 
cells, D, E, F, G, H and I represents cells treated with PJ-34 and then stimulated with LPS for 1, 2, 3, 4, 5 
and 6 hours respectively. Filled histograms represents isotypes, blacks histograms representCD14 
expression on cells stimulated with 100ng/ml LPS and dotted histograms representCD14 expression on 
cells treated with 10 µM PJ-34 prior to simulate with 100ng/ml LPS.  
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Figure 5.2(I) & (II): Represents the expression of SR (MARCO) on PMA-differentiated THP-1 cells 
in response to LPS in presence and absence of PJ-34. THP-1 cells were differentiated with  PMA (5 
ng/ml) for 72 hrs, and then cells were incubated without or with 10 µM of PJ-34 for 30 mins prior to 
stimulation with LPS 100 ng/ml in RPMI 1640 media supplemented with 10% (v/v) FCS in humidified 
atmosphere at 37
0
C for 6 hrs. Cells were washed and incubated with primary mouse anti-human MARCO 
monoclonal antibody for 45 min. Following washing cells incubated with secondary antibody (Goat anti-
mouse IgG labelled FITC) for 30 mins and washed. IgG1K was used as the isotype for MARCO. Samples 
were analysed using Accuri6 flow cytometer (DB Biosciences) and Flow-Jo Software v.10 (Centre of 
biotechnology, Turku University, Finland) was used to analyse the data. A: Dot plot Column, B: Isotype 
(negative control), C: Untreated cells, D, E, F, G, H and I represents cells treated with PJ-34 and then 
stimulated with LPS for 1, 2, 3, 4, 5 and 6 hours respectively. Filled histograms represents isotypes, 
blacks histograms represents MARCO expression on cells stimulated with LPS 100ng/ml and dotted 
histograms represents MARCO expression on cells treated with 10 µM PJ-34 prior to simulate with 
100ng/ml LPS. 
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5.3.2 Confocal microscopy 
 
Immunofluorescently stained cells were imaged at single-cell level and surface receptors 
were visualised individually with different wavelength, appearing as green and red spots 
in the image (Figure 5.3). Confocal microscopic images of cells shows CD14 and SR 
MARCO receptors labelled with antibodies appeared as masses of spherical blurred spots 
distributed all over the cell surface.  Each CD14 and SR (MARCO) receptors pair under 
study, antibody-labelled surface receptors were imaged separately at different 
wavelengths, resulting as diffraction-limited isotropic spots of identical size in each 
channel. As the resolution is poorer in axial (z) direction than laterally (xy), the 3D 
receptors appear as cigar-shaped (Fig. 5.3). For CD14 and SR (MARCO) receptors 
colocalisation study, CD14 was labelled with rabbit anti-human antibody Alexa Flour 
cy555 seen as red spots and SR  
(MARCO) was labelled with Alexa 488 and seen as green spots, while yellow/orang spots 
indicates co-expressed of CD14 and SR (MARCO) on THP-1. The negative control 
samples were stained with mouse IgG isotype and secondary antibodies and no signals 
above background fluorescence are observed. The cell nucleus stained with DAPI (blue 
colour) figure 5.4. 
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Figure 5-3: A representative of single cell image acquired by Nikon confocal microscope. 
Monocytic leukaemia cell stained for SR (MARCO) (green) and CD14 (red). Colocalised receptors appear 
yellow. A: represents 3D view of single plane of THP-1 cell in the xy, yz and xz direction. The cutting 
planes are indicated by the grey horizontal and vertical lines. B: represents single channel staining of SR 
(MARCO) green and CD14 red and colocalised receptors appear in yellow. Scale bar 5 μmTHP-1.  
 
 
148 
 
 
 
 
 
 
 
 
 
 
Figure 5-4: Confocal microscopy images of unstained cells and negative control samples of 
undifferentiated and PMA-differentiated THP-1 cells. Cell only images, represents cells stained with 
green 488nm and red 555nm wavelength lasers to quantity the cell auto fluorescence. Isotype control 
images, represents cells stained with Isotype control IgG primary and Alexa Flour 488 and Alexa Fluor 555 
secondary antibodies Blue colour shows DAPI stained cell nucleus stained with DAPI (blue colour), 
whereas DIC is differential interference contrast image of corresponding cell. Scale bar 5µm. 
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5.3.2.1 Colocalisation analysis of CD14 and SR (MARCO) 
 
Monocytic leukaemia cell line THP-1 cell were used in this study to investigate whether 
CD14 and SR (MARCO) receptors colocalising in response to LPS, and also to assess the 
role of PARP inhibitor PJ-34 in this colocalisation since the both receptors express by the 
cell line. Undifferentiated and PMA-differentiated THP-1 cells were immunostained with 
suitable primary antibody followed by a secondary antibody. CD14 was labelled with 
Alexa Fluor® (red) and SR (MARCO) was labelled with Alexa Fluor® (green). Merging 
the green and the red channels considered the colocalisation of two receptors. To analyse 
the colocalisation of CD14/SR a novel method mentioned in Jabeen et al (2013) and 
Obara et al (2013) was followed. Figure 5-5 3D images represents the colocalisation of 
CD14/SR the 3D on cell surface of  undifferentiated and PMA-differentiated THP-1 cells 
in response to LPS in presence or absence of PARP inhibitor PJ-34, which were acquired 
in stack, with z-direction step size 0.14 μm using NIS element. This method 
ofcolocalisationanalysis calculate the total number of CD14 and SR receptors per cell and 
the number of colocalized CD14/SR receptor pairs per cell. Red and green receptors 
colocalized on the surface of individual cells using a threshold ranging between 0.059-
0.21 µm.  
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Figure 5-5: Localisation of CD14 and SR (MARCO) on the cell surface of undifferentiated and 
PMA-differentiated THP-1 cells, determined by confocal microscopy analysis. Green and red indicate 
pairings as follows: SR (MARCO) green and CD14 (red).Yellow/orange fluorescence reveals the 
potential colocalisations of CD14/SR. 3D images were acquired in stacks, with z-direction step size 0.14 
μm. Single-plane section of z-stack is shown in three directions as xy, yz and zx. The cutting planes of the 
cell section are indicated by gray/pale horizontal and vertical lines. A representative single cell from each 
cell condition is shown. Scale bar 10 μm. 
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Figure 5-6 shows the colocalisation percentage of CD14 and SR receptors on 
undifferentiated and PMA-differentiated THP-1 cells.  The average percentage CD14/SR 
(Average of CD14/SR counted on each cells) colocalisation in undifferentiated cells (cell 
only) was 16.99% ± 4.23%, whereas PMA-differentiated cells (cell only) was 25.31% ± 
5.32%. Both undifferentiated and PMA-differentiated THP-1 cells treated with PARP 
inhibitor PJ-34 alone shows no effect on the percentage of CD14/SR colocalisation. Both 
cell line shows a significant increase in CD14/SR colocalisationin response to LPS 
indicated with (*) p< 0.05 and reached peak of 22.73% ± 2.418 and 36.57% ± 3.647% in 
Undifferentiated and PMA-differentiated THP-1 cells respectively. The cells that 
incubated with PJ-34 for 30 min prior to stimulate with LPS shows a significant reduction 
in the number of CD14/SR receptors colocalized in response to LPS indicated with # p< 
0.05 and reached level of 14.39 % ± 2.34 for undifferentiated cells and level of 17.43% ± 
7.18% for PMA-differentiated cells. 
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Figure 5-6: The effect of PJ-34 on the localisation percentage of CD14 and SR (MARCO) receptors 
by undifferentiated and PMA-differentiated THP-1 cells in response to LPS. Comparison of 
fractions of CD14/SR receptors colocalisation, between undifferentiated THP-1 cells 
(Blue bars) and PMA-differentiated THP-1 cells (Red bars) stimulate with LPS in 
presence or absence of PJ-34. Cell only (untreated) or cells treated with PJ-34 used as 
(control). Each data point represents mean ± SD of three independent experiments. Data 
were statistically analysed using two ways ANOVA. (NS) non-significant difference, (*) 
p<0.05 represents the significant difference of cells treated with LPS V cells only. 
Whereas (#) p<0.05 represents the significant difference of cells treated PJ-34/LPS V 
cells treated with LPS only. Values represent three different experiments. 
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5.3.3 Interaction of CD14 and SR (MARCO) in response to LPS 
 
To assess whether a physical protein-protein association occurs entirely between the 
human CD14 and SR (MARCO) receptors on both undifferentiated and PD/THP-1 cells 
in response to LPS and determine the role of PARP inhibitor PJ-34 in this protein 
association. A co-immunoprecipitation technique was used to carry out this investigate. 
Cell lysate was extracted from undifferentiated and PD/THP-1 cells cultivated in the 
RPMI 1694 supplement with 10% of FCS left untreated (control) or stimulated with LPS 
in presence or absence of PJ-34. The lysate from undifferentiated andPD/THP-1 cells 
were incubated with anti-CD14 afterward incubated with protein A/G loaded on a gel and 
blotted on PDVF membrane. Finally the membrane incubated either with anti-CD14 
antibody for immunoprecipitation of CD14 or anti-SR (MARCO) antibody for co-
immunoprecipitation between CD14 and SR (MARCO). 
CD14 first pulled down by immunoprecipitation in undifferentiated and PD/THP-1 cells 
(Fig. 5.7 A & 5.8 A). The protein interaction of CD14 and SR (MARCO) were 
demonstrated by co-immunoprecipitation (Fig.5.7 B & 5.8 B) revealed that CD14 
interacted with SR (MARCO) in both undifferentiated and PD/ THP-1 cell. In general the 
interaction between CD14 and SR (MARCO) is less on undifferentiated THP-1 cells in 
comparison with cells differentiated with PMA. Furthermore, this interaction even 
increased on both cell lines in response to LPS which can be detected with increasing in 
band intensity. The cells that treated with PJ-34 prior to stimulate with LPS shows 
decrease in the band intensity. Bands of CD14 and SR (MARCO) are corresponding for 
the antibody coupled to the magnetic beads, were observed in all the samples. In addition 
no bands were observed with protein G beads alone, which were loaded as the negative 
control (Lane 2). 
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Figure 5- 7: Immunoprecipitation of CD14 and co-immunoprecipitation  to study the interaction of 
CD14 and SR (MARCO) in undifferentiated THP-1 cells. Cell lysates from undifferentiated THP-1 
cells was separated by 12% SDS-PAGE. Blots were probed with mouse anti-human CD14 and mouse 
anti-human SR (MARCO) antibodies. (A) Immunoprecipitation was subjected to pull down CD14 from 
the cells lysate. (B) Co-IP was applied to study the interaction of CD14/SR (MARCO). Lane 1: represents 
molecular mass in kDa, lane 2: G beads only with no cell lysate (negative control), lane 3: cell only, lane 
4: cell treated PJ-34, lane 5: cells treated LPS and lane 6: cells incubated with PJ-34 for 30 min and the 
stimulated with LPS. Data represent three different experiments. 
Figure 5-8: Immunoprecipitation (IP) of CD14 and coimmunoprecipitation (Co-IP) to study the 
interaction of CD14 and SR (MARCO) in PMA-differentiated THP-1 cells. Cell lysates from PMA-
differentiated THP-1 cells was separated by 12% SDS-PAGE. Blots were probed with mouse anti-human 
CD14 and mouse anti-human SR (MARCO) antibodies. (A) Immunoprecipitation was subjected to pull 
down CD14 from the cells lysate. (B) Co-IP was applied to study the interaction of CD14/SR (MARCO). 
Lane 1: represents molecular mass in kDa, lane 2: G beads only with no cell lysate (negative control), lane 
3: cell only, lane 4: cell treated PJ-34, lane 5: cells treated LPS and lane 6: cells incubated with PJ-34 for 
30 min and the stimulated with LPS. Data represent three different experiments 
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5.3.4 The effect of PJ34 on mRNA CD14 and mRNA SR (MARCO)  
expression in response LPS 
 
The purpose of this experiment was to investigate the effect of PARP inhibitor PJ-34 on 
the on the expression of CD14 and SR (MARCO) at gene level in cells treated with LPS. 
THP-1 cells differentiated with PMA was stimulated with  100 ng/ml of LPS in presence 
and absence of PJ-34 for (15 mins, 30 mins, 1 hr, 2 hrs, 3 hrs and 4 hrs), RNA was 
extracted and cDNA prepared as mentioned previously. Quantitive real time PCR was 
conducted see section 5.2.3. Figure 5-9 represent cells stimulated with LPS which show a 
significant increase in the level expression of CD14 mRNA in compare with control 
(untreated cells) and this expression  increased with time incubation and indicated with 
(*) p<0.05 and the highest level of mRNA CD14 was reached at 4 hrs incubation with 
LPS. Whereas, the cells that treated with PARP inhibitor PJ-34 prior to stimulate with 
LPS shows significant decrease in the level expression and it is continued with time 
incubation indicated with (#) p<0.05. 
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The cells show a significant decrease in the level expression of SR (MARCO) mRNA in 
response to LPS and this decreasing continued the time incubation indicated with (*) 
p<0.05 and the lowest level of mRNA MARCO expression was detected at 4 hrs 
incubation with LPS. While, the cells treated with PARP inhibitor PJ-34 prior to stimulate 
by LPS shows significant increase in the level expression of SR (MARCO) mRNA 
indicated with (#) p<0.05 and this continuous with increasing  the time incubation (Fig.5-
10).  
 
Figure 5-9:  Expression of CD14 mRNA in PMA-differentiated THP-1 in response to LPS in 
presence and absence of PJ-34using RT-qPCR. RT-qPCR was performed on the cDNA obtained from 
PMA-differentiated THP-1 cells using Master mix SYBR green 10 µl, PCR reaction. a. Cyclophillin was 
used as the housekeeping gene to normalise the target genes (CD14) and the expression values were used 
to construct bar figure. Sample designed as following; untreated cells and cells treated with PJ-34 or 
negative control used as a control, cells treated with LPS in presence and absence of PJ-34 30 mins prior to 
stimulate with LPS. Two way-ANOVA analysis performed to calculate the significance difference, NS 
represents non-significant difference. (*) p<0.05 represents the significant differences of mRNA CD14 
expression by cells treated with LPS only V control. Whereas (#) p<0.05 represents the significant 
differences of mRNA CD14 expression by the cells treated with PJ-34 and stimulated with LPS V cells 
treated with LPS only.  
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5.3.5 The effect of PJ-34 on LPS uptake 
 
Since scavenger receptors are expressed by monocytes/macrophages cells and play a vital 
role in immune regulation in response to LPS. Human alveolar macrophages ( AM), express 
scavenger  MARCO which play a vital role in  defense against inhaled particles and pathogens, was 
inhibited by anti- human MARCO antibody (PLK1).This experiment was designed to 
investigate the role of SR (MARCO) in uptake of LPS-labelled FITC (100ng/ml) in 
presence and absence of 10µl of PJ-34 for (15', 30', 60', and 120'). The LPS uptake was 
Figure 5-10:   Expression of MARCO mRNA in PMA-differentiated THP-1 in response to LPS in 
presence and absence of PJ-34using RT-qPCR. RT-qPCR was performed on the cDNA obtained from 
PMA-differentiated THP-1 cells using Master mix SYBR green 10 µl, PCR reaction .Cyclophillin was used 
as the housekeeping gene to normalise the target genes (CD14) and the expression values were used to 
construct bar figure. Sample designed as following; untreated cells and cells treated with PJ-34 or negative 
control used as a control, cells treated with LPS in presence and absence of PJ-34 30 mins prior to stimulate 
with LPS. Two way-ANOVA performed to calculate the significance difference, Two way-ANOVA 
performed to calculate the significance difference, NS represents non-significant difference. (*) p<0.05 
represents the significant differences of SR (MARCO) mRNA expression by the cells treated with LPS 
only V control. Whereas (#) p<0.05 represents the significant differences of SR (MARCO) mRNA 
expression by cells treated with PJ-34 and stimulated with LPS V cells treated with LPS only.  
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observed by fluorescent microscopy (Nikon widefield). Figure (5.11) the uptake of LPS 
was detected with a fluorescence tag bound to LPS (Arredouani et al., 2005). The uptake 
of LPS was great at 15 and 30 mins of incubation (Fig. 5.11 [B&C]) and the uptake 
slightly reduced at 60 mins. The maximum reduction of LPS uptake was observed at 120 
min after incubation (Fig. 5.11 E). No fluorescence was detected in PD/THP-1 cells 
incubated with PJ-34 only (negative control) (Fig. 5.11 A1). In contrast, PD/THP-1 cells 
incubated with PJ-34, then with LPS shows increase in LPS uptake for 60 min and 120 
min of incubation compared with the cells that stimulated with LPS only (Fig. 5.11 D1& 
E1).  
 
 
 
Figure 5-11: The effect of PARP inhibitor PJ-34 on the up taking of LPS labelled FITC by SR 
(MARCO). THP-1 cells at density of 25x10
3 
were differentiated with PMA in LabTek 8-well chamber 
slide for 72 hours and the media replaced with media free serum (RPMI 1640). Cells then stimulated with 
LPS labelled FITC in absence or presence of PARP inhibitor PJ-34 for indicated times. A- Represents cell 
only (negative control), whereas (B, C, D, and E) represents cells treated with LPS only. A1- Represents 
cells treated with PJ-34 (negative control), while (B1, C1, D1, and E1) represents cells that treated with PJ-
23 for 30min prior to stimulate with LPS. The data represent three different experiments. Scale bar 10µm. 
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5.4 Conclusion 
PD/differentiated THP-1 cells were stimulated with LPS 100ng/ml in presence and 
absence of PARP inhibitor PJ-34 and subjected for flow cytometry examination and the 
cell that treated with LPS alone shows increase in the expression of CD14 and decrease in 
the expression of MARCO receptor with increasing the incubation time. Whereas, the 
cells incubated with PJ-34 30 min prior to stimulate with LPS shows decrease in CD14 
expression and increase of MARCO with time incubation. The physical association 
between CD14 and MARCO was investigated with confocal microscopy on 
undifferentiated and PD/THP-1 cells in response to LPS in presence and absence of PJ-
34. Undifferentiated cells show minor interaction between CD14 and MARCO, while in 
PD/THP-cells (without treatment) was increased with no significant effect of PJ-34 on 
this interaction in both undifferentiated and PD/THP-1 cells. Cells treated with LPS 
significantly upregulated the interaction between CD14 and MARCO, whereas, PJ-34 
down regulated this interaction significantly. This interaction was confirmed by 
immunoprecipitation technique which detects the intracellular interaction between CD14 
and MARCO. Undifferentiated and PD/THP-1 cells shows increases CD14 mRNA in 
response to LPS with increased time of incubation, while MARCO mRNA decreased with 
increased incubation time. In contrast, PJ-34 down regulates the expression of CD14 
mRNA in response to LPS, while it increases the expression of MARCO mRNA in 
response to LPS with incubation time. MARCO has an important role in LPS clearance 
and this property was investigated by confocal microscopy which showed decreased in 
fluorescence intensity (which represents the LPS uptake) at 60 min and disappeared at 
120 min of incubation. In contrast treatment with PJ-34 prior to LPS treatment there was 
continues LPS uptake even after 120 min of incubation.   
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CHAPTER 6: Proteomic analysis of PMA-differentiated THP-1 cells 
stimulated with LPS in presence and absence of PJ-34 
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6.1 Introduction 
 
The aim of proteomics is to characterise the proteome, the entire complement of proteins 
produced by an organism, system, or biological context, including modifications made to 
specific proteins. Proteomes vary under different conditions and at different times and the 
goal of proteomics is to analyse the varying proteomes, highlighting the differences 
among them. Proteomics has three main categories or subdivisions. Structural proteomics 
seeks to define the 3-dimensional structure of each protein encoded by a given genome. 
Expression proteomics is the study of dysregulated proteins as a function of stimulation or 
condition.  Interaction proteomics aims to distinguish interactions between proteins and to 
characterise protein complexes in order to determine function. Proteomics data can   
provide important clues to the nature of mechanisms involved in the complex process of 
LPS recognition and signaling. 
Two-dimensional gel electrophoresis (2-DE), which facilitates the separation of complex 
protein samples, has become a powerful and widely used technique for proteomic 
analyses. 2-DE accommodates a large ass range and is able to resolve all peptide 
components of a complex mixture by separating proteins by two stages. Proteins are first 
separated by isoelectric focusing (IEF) using an immobilized pH-gradient (IPG), the first 
dimension. This is followed by the second dimension, sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) The resolved proteins are identified by 
mass spectrometry (MS) or tandem mass spectrometry (MS/MS) (Issaq & Veenstra, 
2008).  
Resolved protein spots can be analysed with suitable software for comparison among 
different samples and can be used for MS analysis. However, this method has some 
disadvantages, such as the occurrence of gel-to-gel variation (Goldfarb, 2007). Low 
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protein solubility and a high tendency for aggregation may additionally result in protein 
absorption and aggregation during application of both IEF and gel protein separation. Use 
of thiourea in addition to urea as a chaotrope, and of zwitterionic amphiphilic  compounds 
such as chaps is able to resolve  protein solubility problems (Natarajan et al., 2005; 
Trevino et al., 2008). 
The proteome is very dynamic in nature because of post-translational modifications 
(Gupta et al., 2007; Witze et al., 2007; Kamath et al., 2011). Therefore, in order to 
recognize the physiological and pathological events that occur in health and disease, it is 
important to detect and analyse proteins from their native proteome. 
 The 2-DE technique was here used to investigate the effect of the PARP-1 inhibitor PJ-
34 on the immune response of THP-1-cells after pre-treatment with LPS. The ExPASy 
tool (http://web.expasy.org/tagident/) was used to identify and quantify THP-1 cell 
proteins expressed. This investigation will assist understanding of the molecular aspects 
septic shock and potential use of PARP inhibitors in the treatment of severe sepsis and 
septic shock. 
 
 
6.2 Methods 
6.2.1 Cells growth conditions 
 
THP-1 cells were cultured in 100 mm cell culture dishes (Nunc) and differentiated with 
PMA 5 ng/ml for 72 hours. Then the media was replaced with fresh media and the cells 
rested for 24 hours. The cells were then either left untreated (control) or treated with 100 
ng/ml LPS in presence or absence of PJ-34 for 2 h hours. Protein concentrations were 
quantified as mentioned in section 2.2.12.1 and 2.2.6.1. 
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6.2.2 Two-Dimensional gel electrophoresis 
 
Lysate from PMA-differentiated cells exposed or not exposed to PJ-34 was used for 2-DE 
as mentioned previously (section 2.2.12.1).  
 
6.3 Results 
6.3.1 Two dimensional gel analysis of the effect of PJ-34 on PMA- 
differentiated THP-1 cells in response to LPS 
 
THP-1 cells have been used in this study as a model for septic shock and to study 
differential expression of the THP-1 proteome in the presence and absence of PJ-34 
following LPS pre-treatment. 2D-gel-based proteomic analysis was employed, followed 
by protein spot analysis. Total proteins in samples of cell lysate were separated by first 
dimension isoelectric focusing on the basis of the isoelectric point (IP) of the proteins. 
The isoelectrically focused proteins are then resolved by second dimension SDS-PAGE 
on the basis of their molecular weight (Figure 6.1). An ultrasensitive silver stain method 
was used to visualise proteins spots in the SDS-PAGE gels. 2-DE gels of LPS-treated 
THP-1 cells treated or not treated (control) with PJ-34 are shown in figure 6.1. Gel 
images from three independent experiments were analysed using Progenesis SameSpot 
software (Nonlinear Dynamics Limited). Image analysis was performed by comparison of 
control gels and gels loaded with samples. This revealed differentially expressed proteins 
in LPS and PJ-34-treated cells. Differentially expressed polypeptide spots are indicated in 
figure 6.2 by a blue line and a spot number is given to each spot. The 3D view tool in 
Progenesis SameSpot was used to visualise and analyse protein spots resolved because of 
different experimental conditions (Fig. 6.3). Table 6.1 shows differentially expressed 
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spots on the reference gel image (untreated cells), with IP and molecular weight shown. 
Treatment of PMA-differentiated cells resulted in disappearance of many polypeptide 
spots, disappearing in response to LPS.  These protein spots were present on gels loaded 
with samples from THP-1cells treated with LPS that had been pre-treated with PJ-34 
(Table 6.2). The results from this analysis provide initial data on the effect of PJ-34 on 
differential polypeptides expression after LPS exposure. 
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Figure 6-1: Two-dimensional gel images of cell lysate proteins from PMA-differentiated THP-1 
cells untreated cells or treated with LPS in presence and absence of PJ-34. A- Control (untreated 
cells). B-Cells treated with 10 μM of PJ-34. C-Cells treated with LPS 100 ng/ml. D-Cells treated with 
10 μM of PJ-34 for 30 mins followed by LPS 100 ng/ml. All incubations were for 2 hrs. In the first 
dimension, 50 μg total soluble protein was separated on immobiline IPG strips (17 cm, pH 4-7 NL). 
IEF was performed on IPG phor unit. The second dimension was performed on 12% SDS-PAGE. 
Gels were silver stained and image analysis was performed with Progenesis SameSpot software. MW-
Molecular mass standards are shown on the left hand side (kDa- kilo Daltons). Differentially 
expressed selected protein spots in four gels are circled with blue.  
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Figure 6-2: Reference image of cells only (control) showing all differentially expressed polypeptide 
spots. The reference image of PMA-differentiated cell only was used for analysis using Progenesis 
SameSpot software to compare the potential differentially expressed protein spots on cells stimulated with 
LPS in presence and absence of the PARP inhibitor PJ-34. Isoelectric points IP range represents protein 
separation based on pH) shown at the top. The left side shows the molecular weight and second dimension 
(SDS-PAGE) and protein separation based on molecular weight, indicated with arrow. 
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Figure 6.3: 3dimenional views of polypeptide spots derived from PMA-differentiated THP-1 cells, 
analysed by Progenesis SameSpot software. Three-dimensional views of protein spots show the different 
protein expression in untreated PMA-differentiated THP-1 cells (control) and THP-1 cells treated with LPS in 
the presence and absence of PARP inhibitor PJ-34.The image shows that PJ-34  protects against  protein 
degradation in response to LPS. 
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Table 6.1: Summary of the polypeptides found using the reference image showing all differentially 
expressed spots derived from untreated PMA-differentiated THP-1 cell lysate (Control) by their IP 
and molecular weight. 
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Table 6.2: Representitive and Comparison of polypeptides spots expressed by untreated PMA-
differentiated THP-1 cells (control) and cells treated with LPS in the presence and absence of PJ-
34 PARP inhibitor. PMA-differentiated THP-1 cells were either untreated or stimulated with 100 
ng/ml LPS in presence and absence of 10 µM of PJ-34 PARP inhibitor for 2 hrs. Cell lysate from all cell 
condition was subjected to isoelectric focusing (first dimension). The second dimension of protein 
separation was performed using a 12% SDS-PAGE. Protein spots were visualised by staining the gel 
with silver stain and then scanning with a gel scanner. Gel images were analysed by Progenesis 
SameSpot software. A plus sign (+) indicates the presence of protein spots before or after treatment, 
while a minus sign (--) indicates the absence of protein spots before or after treatment. Four spots out of 
23 polypeptide spots (highlighted in bold) were selected randomly and analysed using ExPASY tool. 
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6.4 Conclusion 
 
Proteomic analysis of 2-DE gels loaded with proteins from LPS-treated PMA-
differentiated THP-1 cells, performed using Progenesis SameSpot software, revealed a 
number of polypeptidesexpressed by PJ-34-untreated cells which were not expressed by 
PJ-34-treated cells.  These polypeptide proteins are present in THP-1 cells incubated with 
PJ-34 30 minutes prior to LPS exposure. Some spots were not present in untreated cells, 
or cells treated with PJ-34, or in cells treated with LPS alone.  However, these spots 
appear in the cells that had been incubated with PJ-34 30 minutes prior to stimulation 
with  LPS. It was found that PJ-34 PARP inhibitor imparts a protective effect, allowing 
sustained cell survival after LPS was administered.  Further study of the polypeptide 
proteins found to be differentially expressed is now necessary in order to establish their 
role in sepsis, and to assess the role of PJ-34 in cell survival during LPS-induced toxemia 
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CHAPTER 7: Discussion 
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7.1 Discussion 
 
The innate immune system recognises microbial infections and products and activates the 
first line of defence following infection. Innate immunity involves the production of 
proinflammatory cytokines such as TNF-α, IL-1β and NO and activation of transcription 
factors such as NF-κB and interferon regulatory factor 3. This study investigated the 
immunomodulation of PRRs in human monocyte/macrophage (THP-1) cells by the 
nuclear enzyme PARP-1, within the context of the innate immune response triggered by 
the LPS component of the Gram-negative bacterial cell wall. LPS is the prototypical 
endotoxin, binding to the CD14/TLR4/MD2 receptor complex especially in monocytes, 
macrophages, dendritic cells and B cells. CD14 andTLR4, and also TLR2 and the 
scavenger receptor MARCO  play a crucial role in the protective functions of the 
macrophage/monocyte lineage  They are also important in the pathogenesis of sepsis and 
septic shock and other inflammatory diseases (Szabo et al. 1997; Oliver et al., 1999, Jiang 
et al., 2000). In this study, the PARP-1 inhibitor PJ-34 was used to investigate the role of 
PARP in septic shock via regulation of the LPS receptors CD14, TLR2, TLR4 and 
MARCO, and LPS-induced transcriptional activation. 
LPS is an outer membrane component of all Gram-negative bacteria with an essential 
barrier function. It is recognised by PRRs, including TLRs that invoke the production of 
pro- and anti-inflammatory mediators (Ulevitch and Tobias, 1995). It has been established 
that production of proinflammatory cytokines and activation of NF-κB, following 
stimulation of monocytes/macrophages with LPS, involves CD14, TLR4, TLR2 and 
MARCO. However, the regulations of these receptors are still unclear. In this study, the 
expression of CD14, TLR4, TLR2 and MARCO in THP-1cells was investigated to 
determine whether they interact between each other and also to study the effect of PARP 
on the expression of these receptors. In addition, the role of the PJ-34 on the activation of 
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NF-κB and JNK was examined. The production of TNF-α and IL-1β by THP-1 and PMA-
differentiated cells stimulated with LPS was also measured.  
The first stage of this research entailed establishing an in vitro cell line suitable to provide 
reproducible and testable data that served as a model system. The human monocytic 
leukemia THP-1 cell line is isolated from the peripheral blood of a 1-year old male patient 
suffering from acute monocytic leukemia (Tsuchiya et al., 1980). This cell line has been 
widely used to study immune responses while cells are not only in the monocyte state but 
also can be differentiate in the macrophage-like state THP-1 macrophages, when 
stimulated with LPS, expressed MD2, CD14 and MyD88 genes, which are also required 
for LPS signaling in vivo (Daigneault et al., 2010). THP-1 cell line is easy and safe to use 
as it has been reported that there is no evidence for the presence of infectious viruses or 
toxic products, and also it can be cultured in vitro up to 25 passages without changes of 
cell sensitivity and activity (Mangan & Wahl, 1991). THP-1 cells can be stored for a 
number of years can be recovered without any obvious effects on monocyte–macrophage 
features and cell viability. The disadvantages of the use of cell lines is that the malignant 
background and the cultivation of cells under controlled conditions (outside their natural 
environment) might possibly result in different sensitivities and responses compared to 
normal somatic cells in their natural environment (Schildberger et al., 2013). Also, 
possibly relevant interactions between the target cells and surrounding cells, as in natural 
tissues, cannot be easily mimicked. However, in vitro co-cultivation of THP-1 cells with 
neighbouring cells might be an option to overcome this drawback. 
It has been reported that oxidative reagents might cause  irreversible DNA damage, and 
cell recovery from DNA oxidative damage is related to its extent (Stewart et al., 2000; 
Norbury & Zhivotovsky, 2004; Duan et al., 2005). In this study, the cytotoxic effect of 
PMA-differentiated THP-1 cells treated with H2O2 was clearly observed. PARP-1 binds 
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to DNA via two zinc-finger domains (Zn 1 and Zn II); the second determines specificity 
for single-strand breaks in DNA. DNA binding activates PARP-1’s catalytic domain 
(bearing an NAD
+
 binding site), which cleaves NAD
+
 into nicotinamide and ADP-ribose 
polymers. The new synthesised ADP-ribose chains are added to a number of nuclear 
acceptor proteins including histones, transcription factors and PARP-1 itself. Over 
activation of PARP in the presence of extensive DNA damage can lead to NAD
+
 
depletion. To redress this loss, cells use ATP to synthesize more NAD
+
. This is thought, 
ultimately, to lead to an energy crisis that causes cell death (Ha & Snyder, 1999; Kim et 
al., 2004; Putt & Hergenrother, 2004; Pacher & Szabo 2007; Lou and Kraus, 2012). 
Consistent with this mechanism, the results demonstrated heightened activation of PARP-
1 in the presence of major H2O2–induced DNA damage, which was dependent on the 
concentration of H2O2. It was observed here that 100µM of H2O2 was the maximum 
concentration causing PARP activation without adversely affecting cellular function, and 
this should be used in future experiments. Previously published research has shown that a 
decrease in NAD
+
 content and energy charge does not seem implicated within the context 
of PARP inhibition in conditions such as haemorrhagic shock, colitis, and cerebral 
ischemia,  which has no deleterious effect (Popoff et al., 2002; Liaudet et al., 2002; 
Paschen & Doutheil, 1999). In conclusion, it has been shown that H2O2 caused DNA 
oxidative damage of PMA-differentiated THP-1 cells. The present results appear to be 
consistent with those of Szabo et al. (1996), regarding the activation level of PARP in the 
presence of intensive DNA damage, which was dependent on the concentration of H2O2.  
 
The role of PJ-34 PARP inhibitor in the attenuation of PARP activity induced by H2O2 
was studied. It was first necessary to ensure that the concentration of PJ-34 used would 
not interfere with the obtained results due to it possible toxic effect. 
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 High concentrations of PJ-34 are toxic, since complete arrest of PARP-1 activity leads to 
cell dysfunction (Carrillo et al., 2005; Cepeda et al., 2006; Peralta-Leal et al., 2009; 
Krishnakumar & Kraus, 2010; Murai et al., 2012). This reveals the  importance of PARP-
1 in normal cell growth and cell survival  (Wang et al., 1997; Herceg & Wang, 2001; 
Yelamos et al., 2011; Luo & Lee Kraus, 2012). 10µM of PJ-34 was found to be the 
highest concentration of PJ-34 that blocked PARP activity with lower or no effect on 
PMA-differentiated THP-1 cell viability. Therefore, this concentration was used as the 
maximum dose in all experiments   
 
NF-κB has been reported to be essential for the transcription of cyclin D1, which 
promotes cell growth (Joyce et al., 2001; Arnold & Papanikolaou, 2005).  PARP-1 acts as 
co-activator for NF-κB (Veres et al., 2003; Hassa et al., 2001; Geraets et al., 2007; Hunter 
et al., 2012). Thus, the effect of PJ-34 on cell growth might be explained by the 
attenuation of NF-κB activation, as caused by the inhibition of PARP.  Given the fact that 
PARP activity plays an important role in genomic stability, it is also possible that PARP 
inhibition, caused by a high concentration of PARP inhibitor, leads to chromosomal 
instability. This could affect cell growth and survival (Wang et al., 1997; Patel et al., 
2011; Murai et al., 2012).  
 
The use of PARP inhibitors below their toxic threshold has beneficial effects, and they 
have been used in treatment of inflammatory, neurodegenerative and ischema-
reperfusion- based diseases (Refs). Two mechanisms are responsible for their beneficial 
impact. First, PARP inhibitors inhibit cell death due to over activation of PARP-1. 
Second, PARP inhibitors inhibit signal transduction and the production of 
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proinflammatory mediators through interaction with number of transcription factors such 
as NF-κB. (Erdelyi et al., 2005; Racz et al., 2010).  
 
In order to investigate the effect of PJ-34 on PRR levels and cytokines secretion in 
response to LPS, the expression of receptors that are essential for LPS recognition was 
assessed in undifferentiated and differentiated THP-1 cells. Undifferentiated THP-1 cells 
show a moderate expression of CD14, TLR2, TLR4 and MARCO. The levels of these 
receptors were slightly up-regulated in response to LPS 100 ng/ml. 
 
To enhance the expression of CD14, TLR2, TLR4 and MARCO, THP-1 cells were 
treated with PMA and Vit.D3, known to be  potent inducers of differentiation (Kohro et 
al., 2004; Huang et al., 2008; Aldo et al., 2013). PMA-differentiated THP-1 cells display 
a macrophage-like morphology, are strongly adherent and do not proliferate. Vit.D3-
differentiated THP-1 cells exhibit a rounded morphology, are weakly adherent and are 
proliferative. Both PMA and Vit.D3 increased PRR expression in THP-1 cells after LPS 
exposure. The level of PRR expression was greater in cells differentiated with Vit.D3. 
 
 Fluorescence analysis of PMA-differentiated THP-1 cells revealed that CD14, TLR2 and 
TLR4 proteins were up-regulated after treatment with 100 ng/ml LPS for 4 h. In contrast, 
cells that treated with PJ-34 showed reduced expression of these receptors in response to 
LPS. MARCO expression was down-regulated in PMA-differentiated THP-1 cells when 
treated with LPS, while the presence of PJ-34 resulted in up-regulation of MARCO after 
treatment with LPS in the same cells. Thus, it appears that PARP activity prohibits the 
expression of LPS receptors inTHP-1 cells in response to LPS. Inhibition of PARP 
activity resulted in reduced expression of CD14, TLR2 and TLR4 but not of MARCO. 
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 Many studies have studied the role of PARP-1 in the pathogenesis of LPS-induced 
inflammation, which focused on the relationship between PARP-1 and NF-κB .  Using the 
electrophoretic mobility shift assay, Chang and Alvarez-Gonzalez (2001), studied the 
molecular mechanism by which PARP-1 activates the sequence-specific binding of NF-
κB to its oligo deoxynucleotide, NF-κB-p50 DNA binding was dependent on the presence 
of βNAD
+
. NF-κB transcriptional activity was dependant on the availability of βNAD
+
. 
  
PJ-34 has the ability to block the enzymatic activity of PARP enzyme. Therefore It is 
possible that NF-κB activity is dependent upon the enzymatic activity of PARP by 
facilitating the binding of NF-κB -P50 to its DNA by inhibiting protein-protein 
interaction between NF-κB -P50 and PARP-1. 
 
 Oliver et al. (1999) reported that cells from PARP-1-deficient mice exhibit defective NF-
κB activation, leading to abrogation of TNF-α, IL-1β and iNOS expression. Treatment of 
mice with anti-TNF-α or anti-IL-1β  reduced the effect of LPS, and lead to an increase of  
CD14 on the cell membrane and  CD14 messenger RNA (Kimura et al., 2000; Vives-Pi et 
al., 2003; Jessen et al., 2007). This finding may suggest that inhibition of PARP-1 activity 
disrupts indirect LPS up-regulation of innate receptors via abrogating the NF-κB 
dependant transcription of these inflammatory cytokines.  
 
The CD14 gene promoter includes  binding sites for the SP-1 and AP-1 nuclear binding 
proteins, which are believed to be  vital for CD14 transcriptional regulation  (Zhang et al., 
1994; Wheeler & Thurman, 2003; Fujioka et al., 2004; Nareika et al., 2008). The 
transcription factor AP-1 has a serves to increase  CD14 expression in epithelial cells 
after Gram-negative bacterial infection (Iwahashi et al., 2000). It has been shown in many 
studies that the activity of a number of transcription factors involved in LPS signaling, 
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such as NF-κB , SP-1 and AP-1 in glia cells, is altered by poly (ADP-ribose) polymerase 
activity (Ha et al., 2002; Virág, 2005). The activation of transcription factors such as NF-
κB  and AP-1 is attenuated by PARP-1 inhibitors, including, 4 hydroxyquinazoline (4-
HQN), during  LPS-induced endotoxic shock (Veres, 2004). In addition, PARP-1 
inhibition is able to abolish the DNA-binding activity of AP-1 in murine macrophages 
(Andreone et al., 2003). 
 
CD14 bind to lipid A moiety of LPS, hence many studies show that CD14 is one of LPS 
receptor and involves in LPS stimulation of CD14 positive cells such as macrophage and 
neutrophil. Stimulated macrophages by LPS produce prostaglandin E2 (PGE2), which 
stimulate gene expression of CD14 via protein kinase A, also PGE2 has the ability to 
stimulate AP-1-mediated expression of CD14 in mouse macrophages via cAMP-
dependent protein kinase A. Iwahashi et al., (2000) showed that PGE2 both in vitro and in 
vivo can activate the transcription of CD14 gene in mouse macrophages by activating AP-
1. Also Hofer et al. (2004) showed that PGE2 can stimulate the expression of LPS 
receptors in the human Mono Mac 6 cell line. 
 
Innate immunity is regulated by cytokines, which are produced mainly by monocyte/ 
macrophage lineage cells and dendritic cells. In this study two different cytokines TNF-α 
and IL-1β, which are key regulators of innate immune and proinflammatory responses 
have been studied. This study demonstrated that PARP activity regulates the production 
of TNF-α and IL-1β and the release of NO in LPS stimulated THP-1 cells in vitro. These 
cells produced low level of TNF-α, IL-1β and NO in response to LPS, while THP-1 cells 
differentiated with Vit. D3 or PMA produced higher levels. The highest concentration of 
TNF-α, IL-1β and NO, following LPS-exposure, was observed in PMA-differentiated 
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cells. The data obtained indicate that PJ-34 has the capacity to decrease the production of 
TNF-α, IL-1β and NO in response to LPS. 
These results clearly demonstrate that activation of NF-κB and JNK-1 in response to LPS 
is regulated by TNF-α, IL-1β and NO production. This regulation could be as a result of 
suppression effect of PARP inhibitor on the activation of NF-κB, a key transcription 
factor which is involved in chemokine generation in immunostimulated cells. These 
results are consistent with previous work by; (Shaposhnikov et al., 2011; Castri et al., 
2014) which investigated the regulation of  the JNK-1  dependent transcriptional pathway. 
Haskó and coworkers (2002) showed that the production of TNF-α was suppressed in 
both PARP deficient mice and in the prescence of PARP inhibitor. The production of 
inducible NO synthase by many types of cells in response to inflammatory stress 
(Olivenza et al., 2000; Lamon et al., 2010; Peng et al., 2012) was suppressed by PARP 
inhibition of the  endotoxin–induced NO pathway in macrophages (Huang, 2009). 
 
LPS–induced iNOS expression in human monocytes is reduced in the prescence of the 
PARP inhibitors DPQ and PJ-34 (Scalia et al., 2013). PARP inhibition also reduces  
edema formation within the context septic and non-septic models of lung inflammation by 
reducing the level of NO  in plasma (Sidorkina et al., 2003; Murakami et al., 2004).  
The present study highlights the role of LPS receptors in production of TNF-α andIL-1β, 
and in NO production. Blocking CD14, MARCO, TLR2 and TLR4 with appropriate 
monoclonal antibody resulted in much lowered LPS-induced production of TNF-α, IL-1β, 
and NO. The LPS receptors (CD14, MARCO, TLR2 and TLR4) act differentially in 
production of proinflammatory cytokines. These findings reflected the importance of 
these receptors in LPS signaling. LPS-induced TNF-α release was partially inhibited by 
TLR4 blockade, suggesting that LPS utilizes both TLR4-dependent and independent 
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mechanism. Blockade of CD14 also resulted in inhibition of TNF-α release, confirming 
that CD14 is essential for production of TNF-α (Eva et al., 2009). Therefore, this study 
indicates that TNF-α production depends on LPS binding to CD14 not only association 
with TLR4, but also with other TLR2 and/or MD2. Blockage of LPS receptors could help 
to prevent the release of proinflammatory cytokines and prevent the harmful effect of 
inflammatory responses caused by Gram-negative bacteria (O Neil 2003). The 
transcription factor NF-κB  plays a vital role in regulation of proinflammatory cytokines 
production in response to LPS signaling.  
 
The mechanism by which LPS induces septic shock involves  its ability to activate  NF-
κB /Rel family transcription factor members, which results in expression of several 
critical genes involved in septic shock pathogenesis, including  TNF-α, IL-1β and NO 
(Reimer et al., 2008; Schreck et al., 2009; Vallabhapurapu & Karin, 2009; Ghosh & 
Hayden, 2008). NF-κB  is consist of P65 and P50 proteins subunits.(Gupta et al., 2010) 
NF-κB  in unstimulated cells localised in cytoplasm by binding to I-KB and I-KB to 
prevent nuclear translocation (Gamble et al., 2012). Activation of cells with LPS leads to 
phosphorylation of I-kB kinase, which results in degradation of NF-κB  and translocation 
to the nucleus where it binds to region of target gene which is responsible for production 
of different proinflammatory cytokines such as TNF-, IL1, IL-6 and IL-8 (Bonizzi & 
Karin, 2004b; Lawrence, 2009; Gupta et al., 2010). In agreement with previously 
published results, it was observed that PJ-34 was able to inhibit the translocation of NF-
κB into the nucleus (Soriano et al., 2001; Pacher et al., 2002; Pacher & Szabó, 2005).  
 
The role of PARP in regulating the expression of inflammatory mediators has been 
intensively investigated. Many studies have focused on whether the catalytic activity of 
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PARP or the presence of the protein itself is required for inflammatory gene expression. 
Binding of NF-κB to DNA has been found to depend on the availability of NAD
+
; this 
activity is blocked in the presence of PARP inhibitor. This indicates that this binding  is 
protein poly (ADP-ribosyl)ation dependent (Hassa et al., 2001). The present results show 
that regulation of TNF-α, IL-1β and NO and activation of NF-κB by PARP-1 depends on 
the activity of the PARP enzyme. Consistent with previous studies, PJ-34 was found to 
regulate the  expression of TNF-α, IL-1β (Oliver et al., 1999; Liaudet et al., 2002b; Leung 
et al., 2012).  
The scavenger receptor MARCO is expressed by macrophages and binds and is regulated 
by LPS (Kraal et al., 2000; Perez et al., 2010; Thelen et al., 2010). It has been suggested 
that MARCO has a role in microbial recognition and phagocytosis (Peiser et al., 2000; 
Areschoug & Gordon, 2009). MARCO may also modulate TLR4-mediated responses to 
LPS, since SR-A-mediated internalization of LPS leads to its degradation, but does not 
induce cellular activation (Chen et al., 2010). It has been found that SR-A knockout mice 
are more sensitive to LPS (Arredouani et al., 2006; Mukhopadhyay et al., 2006). The 
finding that MARCO is down-modulated  in THP-1 cells in response to LPS may in part 
be due to LPS-induced TNF-α biosynthesis; most of the inhibitory activity of LPS on the 
macrophage scavenger receptors can be blocked with an antibody to TNF-α, (van Lenten 
& Fogelman, 1992; Hsu et al., 1996; Buechler et al., 2000) indicating that TNF-α  
mediates the LPS effect. It has been proposed that TNF-α regulates macrophage 
scavenger receptor expression in macrophage-like PD/THP-1 cells  by transcriptional and 
post-transcriptional mechanisms (Hsu et al., 1996), but principally by destabilization of 
macrophage scavenger receptor mRNA. This interpretation was supported, in that the 
half-life of MARCO mRNA was significantly reduced in cells treated with TNF-α 
relative to untreated cells. Up-regulation of MARCO, caused by PJ-34-induced PARP-
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1inactivation that results in inference of NF-κB activation, may thus be correlated with 
down-modulation of TNF-α expression. The real time PCR shows that the expression of 
CD14 and MARCO were regulated at mRNA level in response to LPS. 
CD14 is the major innate receptor that recognizes and binds  LPS and it has a vital role in 
the LPS signaling pathway (Triantafilou & Triantafilou, 2002b; Jiang et al., 2005; Anas et 
al., 2010). CD14 is anchored on the plasma membrane by GPI tail and has no intracellular 
signaling moiety. Signaling is initiated through TLR4 after LPS binds to CD14 and forms 
a complex of LPS-CD14, bypassing this barrier. LPS signalling trigger activation of NF-
κB, inducing production of proinflammatory cytokines. MARCO,  expressed in 
monocytes/macrophages, plays an importance role in the clearing of circulating LPS 
(Peiser et al., 2002b; Plüddemann et al., 2009). Hence, MARCO knockout mice are  
susceptible to LPS induced lethality (Mukhopadhyay et al., 2006).  
 
This study obtained the first evidence indicating physical interaction between CD14 and 
MARCO on the cell surface of THP-1 cells. The colocalisationof cell-surface CD14 and 
MARCO increased upon the differentiation PMA.  It further increased in response to 
LPS. Treatment of THP-1 cells with PJ-34 prior to stimulation with LPS led to a 
reduction in the number of CD14 and MARCO molecules colocalized on THP-1 cell and 
DP/THP-1 cells. The average percentage of each CD14 and MARCO receptor colocalized 
was calculated out of the total colocalized receptors. The ratio of receptor pairs 
colocalized was calculated by considering total colocalized molecules out of total red and 
green spots per cell. This calculation approach allowed a comparison to be made between 
treated and untreated groups. The relative ratio of colocalized CD14 and MARCO 
increased in response to LPS treatment in both THP-1 cells and DP/THP-1 cells. In 
contrast, cells treated with PJ-34 prior to stimulation with LPS showed significant 
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reduction in the number of receptors colocalized in response to LPS. This physical 
association of CD14 and MARCO in response to LPS might play a vital role in 
modulation of the immunoresponse to LPS, since MARCO-deficient mice are susceptible 
to LPS induced lethality.  
 
The physical association of CD14 and MARCO was detected through 
immunoprecipitation and co-immunoprecipitation of cell extracts from untreated THP-1 
cells and cells treated with LPS. The LPS-treated cells displayed heightened expression of 
CD14 and MARCO. However, cells treated with PJ-34 showed a reduction in the number 
of CD14 and MARCO proteins colocalized in response to LPS. The role of MARCO in 
the DP/THP-1, in terms of its ability to take up LPS, and the effect of PJ-34 in this 
process, were studied. THP-1 cells were treated with PJ-34 30 min before stimulation 
with FITC-labelled LPS. Clearance of LPS was found to be reduced with increasing of 
time incubation (Fig. 5-11). MARCO LPS clearance activity peaked between 15 min and 
30 min, declined   at 1 h and was abolished at 2 h. The time-course data for cells treated 
with PJ-34 differ, showing continuous up-take of LPS during 2 h incubation with LPS.  
This indicates that MARCO has an important role in binding of LPS, but there is a 
noteworthy discordance between the low expression level of MARCO and its high 
binding capacity which might be due to LPS molecules size which are large enough to 
engage MARCO receptor  (Arredouani et al., 2004). LPS clearance  is mediated by 
phagocytosis, a process that is either opsonin-dependent or opsonin- independent 
(Mukhopadhyay et al., 2006 ; Benard et al., 2014). Recent studies on opsonin-
independent recognition of microorganisms and apoptotic cells have shown involvement 
of scavenger receptors, including SR-AI/II. MARCO, however, is identified as a main 
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receptor for binding unopsonized microorganisms and particles, and this indicates an 
important function of MARCO in human host defence (Arredouani et al., 2013).  
The proteomic study of the effect of PJ-34 in DP/THP-1 cells in response to LPS, using 2-
D gel electrophoresis, was performed to identify the differences between untreated and 
treated DP/THP-1 cells after exposure to LPS. The effect of PJ-34 on the cells prior to 
stimulation with LPS was initially investigated. Amongst the 2-D PAGE-resolved 
proteins 23 protein spots were identified in DP/THP-1 cells as interesting  spots suitable 
further analysis, based on IP and MW (Table 6-1). The ExPASY tool, a UniProKB 
programme with high-quality and free accessible recourse of protein sequence and 
functional information, yielded several potential useful results, and was used to analyse 
four random selected polypeptide spots, highlighted in Table 6.1. For example, 
polypeptide spot number 568 correlated with a member of the histone deacetylase 
(HDAC) class of enzymes, which have an IP of ~5 and a MW of 120 kDa. It is believed 
that HDACs play a role in innate immunity.  This is based on the observation that HDAC 
inhibition by HDAC inhibitor (LAQ824) alters TLR4–dependent activation and the 
function of macrophages and dendritic cells  (Brogdon et al., 2007). Enzymes such as 
histone acetyltransferases and HDACs regulate the dynamics of chromatin structure and 
function by removing acetyl groups from a ε-N-acetyl lysine amino acid. This process is 
essential in modulating gene transcription through chromatin organization, and plays an 
important role in many key biological processes. Disruption of this process results in 
aberrant gene transcription and causes diseases (Huang et al., 2003). Non-histone 
transcription factors  such as p53, HSP90, and STAT3,  have been  identified as substrates 
of HDACs, indicating a novel mechanism of action of HDACs in modulating gene 
function (Minucci & Pelicci, 2006). 
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The polypeptide spot 875 is believed to be related to mitogen-activated protein kinase 
(MAPK) which has an IP of ~6 and a MW of 90 kDa. MAPK proteins that play a crucial 
role in signal transduction pathways and gene expression in response to cell stimulants.  
Polypeptide spot number 797, which has an IP of ~ 6 and a MW of 103 kDa, shares 
similarity to the 80-kDa LPS-binding membrane protein (LMP80).  This is expressed  in 
monocytes, erythrocytes, and in  endothelial cells and interacts with LPS (El-Samalouti et 
al., 1999). LMP80 is similar to CD55, the decay-accelerating factor (DAF). CD55 is a 
complement regulatory molecule that is  present in almost all cells that are in contact with 
the blood stream (Alegretti et al., 2010). It protects the cells from autologous complement 
lysis by accelerating the decay of the C3 convertases of the classical and the alternative 
complement pathways (Harris et al., 2006). 
 
The polypeptide spot 2266, which has an IP of ~ 5.6 and a MW of 11 kDa, is similar to 
cytochrome c (Cytc) and cytochrome c oxidase (COX), which catalyses the terminal 
reaction of the mitochondria electron transport chain (ETC), through which the reduction 
of oxygen to water occurs. Both Cytc and COX play a crucial role in health and disease 
together with ATP synthase, which provides the vast majority of cellular energy and 
drives all cellular processes. Under stress conditions, the ETC generates reactive oxygen 
species, which cause cell damage and trigger death processes. In acute inflammation (e.g. 
sepsis), COX is inhibited, leading to energy depletion due phosphorylation of COX. In 
ischemia/reperfusion injury the hyperactive ETC complexes generate pathologically high 
mitochondrial membrane potentials, leading to excessive ROS production, with cell death 
occurring via energy deprivation or ROS-triggered apoptosis (Hüttemann et al., 2012) .  
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The current study has found a number of proteins in the sepsis model system that is 
differentially expressed in response to LPS action; it has examined the effect of PARP 
inhibitor in the regulation of these proteins. The data presented here could be used as 
baseline for further detailed investigation. In this regard, functional assays need to be 
employed to further validate the data presented. Further analysis by mass spectrometry is 
also required to identify protein sequences and differentially observed polypeptide spots. 
 
In this study PARP activation has been found to upregulate the expression of CD14, 
TLR2 and TLR4 in response to stimulation with LPS and the expression of SR (MARCO) 
was down regulated. This was proven by blocking PARP enzyme with PJ-34 a potent 
PARP inhibitor. Inhibition of PARP with PJ-34 does not overcome the effect of the LPS. 
The confocal microscopy results have shown the association between CD14 and MARCO 
which has been increased in response to LPS and down regulated by inhibition of PARP 
activity. 
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